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Abstract
Host recognition of intracellular bacterial pathogens results in the formation of a multiprotein complex
termed the inflammasome, which leads to the recruitment and activation of inflammatory caspases.
These caspases promote IL-1 family cytokine release and pyroptosis, a lytic form of cell death, which are
critical for anti-bacterial defense. In mice, interferon-gamma (IFN-) is a potent inducer of the both the
noncanonical and canonical inflammasomes. Specifically, a family of IFN-inducible GTPases known as
guanylate binding proteins (GBPs) promote inflammasome responses to a variety of bacteria in mice. The
functions of the mouse GBPs include stimulating the rupture of pathogen-containing vacuoles and
bacteriolysis of cytosolic bacteria in order to release pathogen-derived products, such lipopolysaccharide
(LPS), into the cytosol for downstream host sensing and inflammasome activation. In contrast to mice,
which possess 11 GBPs, humans have 7 GBPs and their role in inflammasome activation in human
macrophages is poorly understood. Here, we use Legionella pneumophila, a vacuolar intracellular gramnegative bacterium, to elucidate the functions of human GBPs on inflammasome responses in
macrophages. We determined that human GBP1 is essential for maximal inflammasome responses to L.
pneumophila as well as is important for disrupting the L. pneumophila-containing vacuole (LCV) in order
to make this vacuolar bacterium more accessible for cytosolic sensing. In addition, LPS can possess
different acylation states within the same or different species of gram-negative bacteria. The
noncanonical inflammasome mediates inflammatory responses to intracellular LPS and is comprised of
caspase-11 in mice, and the two putative orthologs in humans, caspase-4 and caspase-5. While tetraacylated LPS variants evade caspase-11 detection, caspase-4 was found to be activated by a tetraacylated LPS variant. However, it is still unclear whether caspase-4 and caspase-5 recognize different LPS
variants and whether their activation is promoted by IFN-. Here, we use primary or THP-1-derived
macrophages and CRISPR/Cas9 technology to test human noncanonical inflammasome responses to
LPS variants from different bacteria and whether IFN- and human GBPs promote these responses in
macrophages. Our findings elucidate aspects of human innate immune response to gram-negative
bacterial pathogens and may provide insight into developing therapeutics to prevent gram-negative
sepsis.
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ABSTRACT

ELUCIDATING HUMAN INFLAMMASOME RESPONSES TO
LEGIONELLA PNEUMOPHILA AND LIPOPOLYSACCHARIDE VARIANTS

Antonia R. Bass
Sunny Shin

Host recognition of intracellular bacterial pathogens results in the formation
of a multiprotein complex termed the inflammasome, which leads to the
recruitment and activation of inflammatory caspases. These caspases promote IL1 family cytokine release and pyroptosis, a lytic form of cell death, which are critical
for anti-bacterial defense. In mice, interferon-gamma (IFN-g) is a potent inducer of
the both the noncanonical and canonical inflammasomes. Specifically, a family of
IFN-inducible GTPases known as guanylate binding proteins (GBPs) promote
inflammasome responses to a variety of bacteria in mice. The functions of the
mouse GBPs include stimulating the rupture of pathogen-containing vacuoles and
bacteriolysis of cytosolic bacteria in order to release pathogen-derived products,
such lipopolysaccharide (LPS), into the cytosol for downstream host sensing and
inflammasome activation. In contrast to mice, which possess 11 GBPs, humans
have 7 GBPs and their role in inflammasome activation in human macrophages is
poorly understood. Here, we use Legionella pneumophila, a vacuolar intracellular
gram-negative bacterium, to elucidate the functions of human GBPs on
vii

inflammasome responses in macrophages. We determined that human GBP1 is
essential for maximal inflammasome responses to L. pneumophila as well as is
important for disrupting the L. pneumophila-containing vacuole (LCV) in order to
make this vacuolar bacterium more accessible for cytosolic sensing. In addition,
LPS can possess different acylation states within the same or different species of
gram-negative bacteria. The noncanonical inflammasome mediates inflammatory
responses to intracellular LPS and is comprised of caspase-11 in mice, and the
two putative orthologs in humans, caspase-4 and caspase-5. While tetra-acylated
LPS variants evade caspase-11 detection, caspase-4 was found to be activated
by a tetra-acylated LPS variant. However, it is still unclear whether caspase-4 and
caspase-5 recognize different LPS variants and whether their activation is
promoted by IFN-g. Here, we use primary or THP-1-derived macrophages and
CRISPR/Cas9 technology to test human noncanonical inflammasome responses
to LPS variants from different bacteria and whether IFN-g and human GBPs
promote these responses in macrophages. Our findings elucidate aspects of
human innate immune response to gram-negative bacterial pathogens and may
provide insight into developing therapeutics to prevent gram-negative sepsis.
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CHAPTER 1: INTRODUCTION
Microbial organisms are all around us; some microbes can benefit the host
by providing either a commensalism or mutualism relationship, while other
microbes, known as pathogens, can be detrimental to the host and cause disease.
Mammalian organisms have several lines of defense in order to combat invading
pathogens. The initial protection mechanisms are the skin and mucous
membranes, which provide physical and chemical barriers by preventing entry of
pathogens into the underlying tissues as well as trapping unwanted organisms and
destruction of them by antimicrobial enzymes. However, when these primary
defenses are damaged the pathogen can now take advantage and enter the body,
which is when the next host defense mechanism takes over—nonspecific innate
immunity. The innate immune response is the second line of defense against
microbial pathogens and is essential for the clearance of these pathogens and host
survival. An array of host factors are involved in initial responses to invading
bacteria, viruses, parasites and fungi and lead to downstream events including the
production of antimicrobial peptides, proinflammatory cytokines, interferon, and/or
initiation of cell death pathways. Interplay between these pathways may promote
a greater response to combat infection. Additionally, some bacteria are able to
evade innate immune pathways by using effector molecules or by altering their
morphology to be unrecognizable by host sensors. Here, we highlight the
importance of innate immune responses to gram-negative bacterial pathogens and
how interferon (IFN) can promote these responses.

1

1.1. Pattern recognitions receptors and their ligands
In order to detect pathogenic microbes, the host relies on its germlineencoded sensors termed pattern recognition receptors (PRRs) (Janeway, 1989).
PRRs function in the surveillance of conserved microbial structures known as
pathogen-associated molecular patterns (PAMPs) or endogenous danger signals
released from dying cells called damage-associated molecular patterns (DAMPs)
(Krakauer, 2019). Recognition of these PAMPs and DAMPs by PRRs leads to
downstream signaling events including the release of proinflammatory cytokines
and cell death. Upon secretion of cytokines, many different immune responses
occur including the recruitment of additional immune cells to the site of infection
for host defense and clearance of pathogens as well as the production of host
proteins such as interferons and antimicrobial peptides. Furthermore, activation of
PRRs can lead to cell death, ultimately eliminating the replicative niche for the
pathogen.
There are currently five main classes of PRRs: Toll-like receptors (TLRs),
C-type lectin receptors (CLRs), nucleotide-binding oligomerization domain-like
receptors (NLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), and
absent in melanoma 2 (AIM2)-like receptors (ALRs) (Jang et al., 2015). Within
each family of PRRs, there are subfamilies of the receptors that each recognize a
specific ligand or signal. This allows the host to initiate an immune response to
multiple pathogenic components or danger signals for maximal defense against
invading pathogens.
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The first family of PRRs that was discovered is the membrane bound TLR
family. The Toll pathway was initially identified in a genetic screen for genes that
are important for early embryonic development of Drosophila melanogaster
(Hashimoto, Hudson, & Anderson, 1988). However, it was eventually found that
Toll was also essential for immune response in Drosophila and that this pathway
is conserved in mammals (Wasserman, 1993). There are 10 TLRs in humans
(TLR1-10) and 12 TLRs in mice (TLR1-9, TLR11-13), and each TLR recognizes a
different stimulus (Broz & Monack, 2013). TLR1-9 are present in both mice and
humans, whereas TLR11-13 are only expressed in mice and TLR10 is only
expressed in humans since it is a pseudogene in mice. The structure of TLRs
consists of an N-terminal leucine-rich repeat (LRR) domain important for ligand
sensing, a hydrophobic transmembrane domain, and a cytoplasmic C-terminal Toll
IL-1 receptor (TIR) domain essential for signaling (Botos, Segal, & Davies, 2011).
TLRs have been shown to localize to two different sites within a cell such as a
macrophage. TLR1, TLR2, TLR4, TLR5, and TLR6 mainly localize to the plasma
membrane, whereas TLR3, TLR7, TLR8, TLR9, TLR11, TLR12, and TLR13
localize to endosomal compartments (Broz & Monack, 2013). Regardless of their
location, TLR activation leads to recruitment of adaptor molecules to the TIR
domain for signaling; these adaptor proteins include myeloid differentiation primary
response 88 (MyD88) and TIR-domain-containing adaptor protein inducing IFN-b
(TRIF) which predominantly signal through NFkB to upregulate proinflammatory
cytokine production and through IRF3 to induce IFN production (O'Neill, Bryant, &
Doyle, 2009).
3

As previously mentioned, each TLR recognizes one or more specific
microbial ligands. For the TLRs that come into contact with bacterial components
in the extracellular milieu, TLR1 recognizes bacterial triacyl lipopeptides, TLR2
recognizes lipoproteins, peptidoglycan, and lipotechoic acid (LTA), TLR4
recognizes

the

gram-negative

bacterial

outer

membrane

component

lipopolysaccharide (LPS), TLR5 recognizes flagellin, and TLR6 recognizes LTA
and diacyl lipopeptides (Broz & Monack, 2013). In general for TLRs that recognize
their corresponding ligands in endosomal compartments, TLR3, TLR7, TLR8, and
TLR9 recognize nucleic acids. Until recently, the location and ligand for human
TLR10 was unknown; it was reported that TLR10 localizes to endosomes and its
ligand is dsRNA, like TLR3, and that TLR10 negatively regulates TLR3 by
competing for dsRNA binding and upregulating the TLR3 signaling inhibitor
SARM1 (S. M. Lee et al., 2018). For the remaining mice endosome-localized TLRs,
TLR11 recognizes flagellin and profilin, an actin-binding protein found in the
parasite Toxoplasma gondii as well as Escherichia coli, TLR12 recognizes profilin,
and TLR13 recognizes bacterial ribosomal RNA (Broz & Monack, 2013).
In order for downstream TLR signaling to occur, TLR monomers must first
bind to their cognate ligand. This binding results in conformational change and
formation of a dimer between two ligand-binding domains of TLRs bringing the
transmembrane and cytoplasmic TIR domains of the two TLRs into close proximity,
which leads to initiation of the signaling cascade (Botos et al., 2011). TLRs may
either homodimerize or heterodimerize, depending on the type of TLR. For
instance, TLR1 and TLR2 heterodimerize to recognize triacylated lipopeptides, as
4

well as TLR2 and TLR6 heterodimerize to recognize diacylated lipopeptides
(Oliveira-Nascimento, Massari, & Wetzler, 2012). Once dimerization occurs
between two TLR monomers, conformational change allows the TIR domains to
recruit TIR-domain-containing adaptors. The five TLR adaptors are MyD88, TRIF,
MyD88-adaptor-like (MAL), TRIF-related adaptor molecule (TRAM), and sterile aand armadillo-motif-containing protein (SARM) (O'Neill et al., 2009). MAL and
TRAM are ‘linking adaptors’ where MAL recruits MyD88 and TRAM recruits TRIF
to the TLR TIR domains; however, these additional adaptors are not always
required for signaling. Specifically, only TLR1, TLR2, TLR4, and TLR6 recruit MAL
which further recruits MyD88 for downstream NFkB signaling to produce
proinflammatory cytokines (O'Neill et al., 2009). TLR4 also recruits TRAM which
recruits TRIF for downstream IRF3 signaling for production of IFN-b or other IFNinducible genes; nevertheless, it was also found that TLR4-TRIF-dependent
signaling also activates NFkB for proinflammatory cytokine production. TLR3 does
not signal through MyD88, but it recruits TRIF for IRF3 and NFkB signaling. The
remaining TLRs (TLR5, TLR7, TLR8, TLR9, TLR11, TLR12, TLR13) recruit MyD88
for NFkB activation and, in the case of the endosome-localized TLRs, for IRF7
activation to upregulate IFN-a and IFN-inducible genes. More studies need to
address the role of TLR10, but it is thought that its function is to negatively regulate
MyD88 and TRIF signaling (Jiang, Li, Hess, Guan, & Tapping, 2016). Distinctive
from the other four TIR-domain-containing adaptors, SARM is the negative
regulator of MyD88- and TRIF-dependent signaling (Carlsson, Ding, & Byrne,
2016; Carty et al., 2006).
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CLRs are another family of membrane-bound PRRs that have been
implicated in immune responses to microbial pathogens. CLRs are predominantly
expressed in myeloid cells and they possess at least one C-type lectin-like domain
(CTLD), which is important for binding carbohydrates (mannose, fucose, and
glucan) located on bacteria, viruses, parasites, and fungi (Brown, Willment, &
Whitehead, 2018). Importantly, CLRs are essential for both innate and adaptive
immunity by production of inflammatory mediators and phagocytosis followed by
antigen presentation to T lymphocytes, respectively (Chiffoleau, 2018). Examples
of CLRs involved in intracellular signaling pathways are Dectin-1, Dectin-2, and
macrophage-inducible C-type lectin (Mincle). Dectin-1 directly signals using its
immunoreceptor tyrosine-based activation motif (ITAM) found on the cytoplasmic
end of the receptor, whereas Dectin-2 and Mincle indirectly signal by associating
with an ITAM-containing adaptor (Hoving, Wilson, & Brown, 2014). ITAM further
recruits Syk tyrosine kinase for downstream NFkB and mitogen-activated protein
kinase (MAPK) signaling. These signaling events lead to cellular responses such
as the production of proinflammatory cytokines or activation of the adaptive
immune system via cross-presentation.
Some microbial pathogens are uptaken by a host cell through phagocytosis
or receptor-mediated endocytosis, resulting in a vacuole-enclosed pathogen. The
goal of the host cell is to destroy these phagosomes or endocytosed pathogens by
lysosomal degradation. However, pathogens such as bacteria have quickly
learned to evade these destructive pathways by using effector molecules either to
escape the phagosome and survive in the cytosol or to live within the phagosome
6

by remodeling their vacuole. In addition, viruses have evolved to hijack the host
cell’s endocytic machinery to invade the cell and initiate its replication. In response,
host cells developed additional immune defenses within the cytosol that recognize
PAMPs and DAMPs, similar to extracellular TLRs and CLRs. These cytosolic
PRRs are the NLRs, RLRs, and ALRs and are essential for controlling intracellular
infections and promoting host survival.
NLRs are a family of intracellular PRRs that initiate immune responses to
pathogenic microbes and cellular stress signals. All NLR proteins have 3 domains:
an N-terminal effector domain, a central NACHT nucleotide-binding and
oligomerization domain, and a C-terminal LRR domain (Y. K. Kim, Shin, & Nahm,
2016). There are four subfamilies of NLRs based on the structure of the Nterminus, which are the NLRA, NLRB, NLRC, and NLRP subfamilies. The NLRA
subfamily has only one member known as MHC-II transactivator (CIITA), which
possesses an N-terminal acidic transactivation domain and its function is to
regulate the expression of MHC genes. The NLRB subfamily has one member in
humans called the NLR Family Apoptosis Inhibitor Protein (NAIP), whereas mice
have seven NAIPs (NAIP1-7) and they all contain three N-terminal baculoviral
inhibition of apoptosis repeat (BIR)-like domains. The NLRC subfamily has six
members, three of which have at least one caspase activation and recruitment
domain (CARD) at the amino-terminus (NOD1, NOD2, NLRC4), whereas the
remaining three members have an N-terminal domain that is still unknown but are
placed in this subfamily due to their homology with the CARD-containing NLRC
proteins (NLRC3, NLRC5, NLRX1). The largest NLR subfamily is the NLRP
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subfamily containing 14 members which all have an N-terminal pyrin domain (PYD)
(NLRP1-14). In general, NLRs are activated upon the binding of cytosolic ligands
by the LRR domain, which leads to a conformational change and release of the
NLR from its autoinhibitory state. Subsequently, the NACHT domain undergoes
oligomerization, which forms an N-terminal scaffold for adaptor proteins followed
by effectors to bind. Activation of these NLRs lead to immune responses including
inflammasome formation, NFkB and MAPK signaling, and autophagy (Y. K. Kim
et al., 2016).
Different NLRs are activated in response to various stimuli such as bacterial
flagellin, lethal toxins, and even cell stress responses (i.e. reactive oxygen species
(ROS)). These specific ligands lead to the activation of NLRs involved in the
formation of inflammasomes, which are cytosolic multimeric protein complexes
that promote cell death and proinflammatory cytokine release. Some of the NLRs
involved in inflammasome formation include NAIP, NLRC4, NLRP1, and NLRP3
and will be discussed in detail in the ‘canonical inflammasome responses to
bacterial components’ section.
RLRs are another family of intracellular PRRs that predominantly recognize
viral RNA. There are three members within the RLR family: RIG-I, MDA5
(melanoma differentiation-associated 5), and LGB2 (laboratory of genetics and
physiology 2) (Rehwinkel & Gack, 2020). All three members of the RLR family are
comprised of a central helical domain followed by a carboxy-terminal domain, both
of which are essential for RNA detection (Rehwinkel & Gack, 2020). RIG-I and
MDA5 also contain two CARDs at their amino-terminus for signaling transduction,
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while LGB2 does not possess these domains and is thought to regulate RIG-I and
MDA5. Upon the sensing of viral RNA by RIG-I and MDA5, conformational change
results in exposure of their CARDs for interaction with the adaptor mitochondrial
antiviral-signaling protein (MAVS) and leads to NFkB activation for type I IFN
production. Although RLRs detect nucleic acids derived from viruses, another
identified PRR family recognizes nucleic acids from both viruses and bacteria and
is known as the ALR family.
The ALR family is the third known family of intracellular PRRs and are
important for detecting cytosolic-exposed bacterial and viral DNA. The two
members of the ALR family are AIM2 and interferon-inducible protein 16 (IFI16).
Their structure is comprised of an N-terminal PYD domain followed by a C-terminal
DNA sensing domain known as the 200-amino-acid domain (HIN) (Liao et al.,
2011). AIM2 consists of only one HIN-200 domain, while IFI16 contains two
domains: HIN-A and HIN-B (Liao et al., 2011). AIM2 interaction with bacterial or
viral DNA results in recruitment of the adaptor ASC via PYD-PYD interactions
followed by caspase-1 recruitment and activation (Hornung et al., 2009; Rathinam
et al., 2010). Caspase-1 activation results in inflammasome responses involving
the maturation and release of IL-1 family cytokines and cell death. In contrast,
IFI16 recruits the adaptor stimulator of interferon genes (STING) for IFN-b
production to combat viral infections (Unterholzner et al., 2010). In addition, studies
in murine macrophages showed that IFI204, the murine ortholog of IFI16, mediates
IFN-b production in response to DNA from intracellular bacterial infections (Storek,
Gertsvolf, Ohlson, & Monack, 2015; Unterholzner et al., 2010). Interestingly, IFI16
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is not only important for IFN-b induction, but has also been found to interact with
ASC and caspase-1 to initiate inflammasome responses to viral DNA infections as
well (Kerur et al., 2011; Monroe et al., 2014). Therefore, AIM2 and IFI16 are
considered to be the two inflammasome sensor proteins of the ALR family.

1.2. Canonical inflammasome responses to bacterial components
Upon recognition of intracellular bacterial pathogens, the host initiates the
formation of a multimeric protein complex termed the inflammasome. In order for
inflammasome activation to occur, a cytosolic sensor protein detects pathogen
components or cellular stress signals and recruits an adaptor protein followed by
the inactive cysteine protease, caspase-1 (CASP1). CASP1 undergoes
oligomerization and autoproteolysis into its mature form which goes on to cleave
IL-1b and IL-18 for their release from the cell. CASP1 also cleaves the cytosolic
protein gasdermin-D (GSDMD), which is known as the initiator protein for inducing
pyroptosis, a lytic form of cell death. GSDMD is made of an N-terminal and Cterminal fragment and upon its cleavage by CASP1, the GSDMD N-terminal
fragment translocates to the plasma membrane and oligomerizes to form a pore,
allowing release of cellular components and rupture of the cell through osmotic
influx. Thus, host cell death and proinflammatory cytokine release are key
indicators of inflammasome response to microbial infections.
The CASP1-containing inflammasomes are understood to be known as the
canonical inflammasomes. There are six identified canonical inflammasomes: the
NLRP1 inflammasome, the NLRP3 inflammasome, the NLRC4 inflammasome, the
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AIM2 inflammasome, the IFI16 inflammasome, and the Pyrin inflammasome.
Although inflammasome responses can be activated in response to bacterial, viral,
parasitic, and fungal pathogens, here only inflammasome responses to bacterial
components will be discussed.
The NLRP1 inflammasome is activated by different ligands in humans and
mice, although both engage in similar mechanism for downstream activation of the
cysteine protease caspase-1. The murine ortholog to human NLRP1 is NLRP1b
and it initiates an immune response upon sensing the enzymatic activity of lethal
toxin from Bacillus anthracis and also recently determined upon the direct Nterminal ubiquitination by E3 ubiquitin ligase IpaH7.8 encoded by Shigella flexneri
(Sandstrom et al., 2019). The ligand of human NLRP1 is muramyl dipeptide (MDP),
a bacterial cell wall component (Faustin et al., 2007). Both NLRP1 and NLRP1b
have a C-terminal function-to-find domain (FIIND) followed by CARD. The
mechanism of the NLRP1 inflammasome activation involves initial autoproteolysis
of the FIIND which results in two fragments that are noncovalently linked and is
essential for NLRP1 inflammasome activity (D'Osualdo et al., 2011; Finger et al.,
2012; Frew, Joag, & Mogridge, 2012). NLRP1 is subsequently activated by its
respective ligands which result in cleavage and ubiquitination of the N-terminal
NLRP1 fragment followed by its proteasomal degradation and release of the Cterminal fragment, which contains the FIIND C-terminal portion and the CARD.
This leads to the self-assembly of the C-terminal fragment, which recruits caspase1 to form the inflammasome complex. Some studies showed that the adaptor
molecule apoptosis-associated speck-like protein containing a CARD (ASC) is
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necessary for NLRP1 inflammasome activation by forming ASC dimers via their
PYD-PYD interactions and their free CARD domains mediate CARD-CARD
interactions between the NLRP1 CARD and caspase-1 CARD (Finger et al., 2012),
while others say that ASC is not required but enhances the NLRP1 inflammasome
response (Faustin et al., 2007).
The NLRP3 inflammasome is one of the most studied inflammasomes. In
order for this inflammasome activation to occur, two signaling events must happen:
a priming signal and activation signal (Kelley, Jeltema, Duan, & He, 2019). A
priming signal can include TLR ligands or endogenous cytokines including tumor
necrosis factor alpha (TNFa) and interleukin 1 beta (IL-1b). The purpose of priming
is to signal through NFkB to upregulate the expression of the NLRP3 protein and
pro-IL-1b. Additionally, priming induces post-translational modifications such as
phosphorylation

and

deubiquitylation

important

for

regulating

NLRP3

inflammasome activation (Yang, Liu, & Xiao, 2017). The NLRP3 activation signal
involves detection of cellular stress that is induced by diverse stimuli, rather than
direct binding of ligands as other inflammasomes do. These diverse stimuli include
bacterial and fungal toxins, viral DNA and RNA, ATP, nigericin, and alum (Kelley
et al., 2019). Upon these stimuli entering the host cell, they can cause different cell
stress responses including ion imbalances like potassium (K+) efflux, production of
ROS, and lysosomal disruption. All of these cellular events result in activation of
the NLRP3 inflammasome, which is then able to oligomerize through its NACHT
domain and recruit the adaptor ASC to its N-terminal PYD. Recruitment of ASC
leads to the formation of ASC filaments into a single helical structure known as an
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ASC speck. Following speck formation, caspase-1 is recruited to ASC through
homotypic CARD-CARD interactions, leading to cleavage and maturation of
caspase-1 into its active p20 and p10 subunits, which form a heterotetramer that
cleaves IL-18 and IL-1b. Although the NLRP3 inflammasome has been studied
extensively, there are still many unknowns about how it becomes activated since
it doesn’t directly bind to a ligand. Recent studies identified a member of the
mammalian NIMA-related kinase family known as NEK7 to be essential for
mediating NLRP3 inflammasome assembly and activation (He, Zeng, Yang, Motro,
& Nunez, 2016; Schmid-Burgk et al., 2016). It is possible that NEK7 is the
upstream sensor of NLRP3 and directly senses the cellular stress responses
followed by binding to NLRP3 and facilitating its oligomerization. NEK7 and NLRP3
interaction contributes to promoting pyroptosis in inflammatory bowel disease, thus
NEK7 could be a potential therapeutic target for inflammatory disorders or other
NLRP3-asssociated diseases (X. Chen et al., 2019; G. Liu, Chen, Wang, & Yuan,
2020).
The inflammasome containing NLRC4 is unique in that NLRC4 is not the
sensor NLR. Instead, NAIP is the sensor NLR and recognizes flagellin as well as
the type III secretion system (T3SS) components, the inner rod and needle
proteins. Specifically, for the murine NAIPs, NAIP1 recognizes the T3SS needle,
NAIP2 recognizes the T3SS inner rod, and NAIP5/6 recognize flagellin through
their NACHT domains (Franchi et al., 2006; Kofoed & Vance, 2011; Miao et al.,
2006; Yang, Zhao, Shi, & Shao, 2013; Zhao et al., 2011). In contrast, human NAIP
acts broadly and recognizes all three of these bacterial ligands, indicating that mice
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and human NAIPs function differently (Grandjean et al., 2017; Kortmann,
Brubaker, & Monack, 2015; Reyes Ruiz et al., 2017; J. Yang et al., 2013). Based
on cryo-EM structures, a single NAIP recruits NLRC4 and promotes the
polymerization of NLRC4 to form a ring-like structure (Tenthorey et al., 2017;
Zhang et al., 2015). NLRC4 interacts with caspase-1 directly via CARD-CARD
interactions; however, it is thought that the adaptor ASC may also be recruited to
stabilize the CARD-CARD interactions between NLRC4 and caspase-1, thus
enhancing inflammasome activation. The NAIP/NLRC4 inflammasome mounts
immune defense against a variety of bacterial pathogens such as Salmonella
enterica serovar Typhimurium, Pseudomonas aeruginosa, and Legionella
pneumophila. Although L. pneumophila does not have a T3SS, it has a type 4
secretion system (T4SS) and flagellin, so it is thought that L. pneumophila
activates the NAIP/NLRC4 inflammasome by inadvertently translocating flagellin
through the T4SS into the cytosol.
It is known that different inflammasomes form their own macromolecular
complex in response to a specific ligand or signal. However, during a normal
infection, multiple ligands can be released into the cytosol and various endogenous
danger signals can be present within a host cell. Therefore, multiple different
inflammasomes may be activated within the same cell in order to generate a
greater host response to clear pathogens. Interestingly, one study found that,
during infection with S. Typhimurium, the NLRC4 and NLRP3 inflammasomes are
both recruited to the same macromolecular complex which contains ASC,
caspase-1, as well as caspase-8 (Man et al., 2014). This shows two novel
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mechanisms of inflammasome activation: the first being that two different
inflammasome proteins are recruited to the same complex and the second that
caspase-8 can also be recruited to the ASC speck. Additional studies determined
that caspase-8 can be recruited to the NLRC4 inflammasome independent of
caspase-1, but dependent on ASC, thus triggering an alternative pathway when
caspase-1 is absent (Kumar, Radha, & Swarup, 2010; B. L. Lee, K. M. Mirrashidi,
et al., 2018; Man et al., 2013; Mascarenhas et al., 2017; Rauch et al., 2017).
Caspase-8 interaction with ASC PYD is facilitated by its death effector domain
(DED) (Vajjhala et al., 2015). Caspase-8 has classically been known to be initiator
caspase for apoptosis; however, these findings reveal that caspase-8 has a widerange of functions in different immune pathways.
The AIM2 inflammasome is activated upon direct binding to double stranded
DNA (dsDNA) followed by recruitment of ASC and caspase-1. Studies using
macrophages from AIM2-knockout mice or gene silencing of murine macrophages
by siRNA revealed that AIM2 is activated by a variety of bacteria including
Mycobacterium tuberculosis, Mycobacterium bovis, Francisella tularensis, and
Legionella pneumophila (Fernandes-Alnemri et al., 2010; Ge, Gong, Xu, & Shao,
2012; Rathinam et al., 2010; Saiga et al., 2012; Y. Yang et al., 2013). Infection with
these bacteria in AIM2-deficient or silenced murine macrophages resulted in
decreased caspase-1 activation and IL-1b or IL-18 release compared to wild-type
or untreated macrophages, indicating AIM2 is crucial for promoting inflammasome
response. Furthermore, there are additional bacterial pathogens that activate both
the AIM2 and NLRP3 inflammasomes in parallel to produce robust caspase-1
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activation and IL-1b production; these bacteria include Brucella abortus, Listeria
monocytogenes, and Porphyromonas gingivalis (Gomes et al., 2013; S. Kim et al.,
2010; E. Park et al., 2014). Therefore, it is most likely that multiple inflammasomes
are needed to control many other bacterial infections as well due to the presence
of various bacterial components that serve as ligands for different inflammasomes
and the triggering of cellular stress which typically results in NLRP3 inflammasome
activation.
Similar to the AIM2 inflammasome, the IFI16 inflammasome recognizes
genomic DNA as it is also within the ALR family. IFI16 was initially found to induce
IFN-b in a STING-dependent manner in response to viral DNA (Unterholzner et al.,
2010). Later, studies involving gene silencing of IFI16 or its murine ortholog IFI204
in human or murine macrophages, respectively, revealed that they had decreased
IFN-b production compared to control-treated macrophages during infection with
intracellular bacteria including L. monocytogenes, Francisella novicida, and M.
bovis (Chunfa et al., 2017; Hansen et al., 2014; Storek et al., 2015). Thus, IFI16
can recognize both viral and bacterial DNA to induce a type I IFN response.
Intriguingly, another study found that IFI204/IFI16 was important for killing of the
extracellular bacteria, Staphylococcus aureus, by enhancing bactericidal activity
which is a novel finding of a DNA sensor (W. Chen et al., 2019). Although there
are no reports of IFI16 involvement in caspase-1-dependent inflammasome
activation in response to bacteria, there are findings that show IFI16
inflammasome responses to viral infections that are dependent on ASC and
caspase-1 (Ansari et al., 2015; Ansari et al., 2013; Kerur et al., 2011). This IFI16
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inflammasome is initiated upon the binding of IFI16 to viral DNA in the nucleus,
followed by formation of the ASC-caspase-1 inflammasome which is translocated
into the cytoplasm for inflammasome activity.
The pyrin inflammasome is indirectly activated upon detection of the
inactivation of the Rho-GTPase, RhoA. Pyrin is composed of an N-terminal PYD,
followed by a B-box and coiled-coil domain (Heilig & Broz, 2018). Human pyrin
possesses a C-terminal B30.2 domain, which is absent in mice (Broz & Dixit,
2016). RhoA activates protein kinase 1 (PKN1) and 2 (PKN2) for their
phosphorylation of the N-terminal part of pyrin, leading to the binding of 14-3-3
proteins at these phosphorylation sites in order to inhibit pyrin inflammasome
activation (Y. H. Park, Wood, Kastner, & Chae, 2016). However, bacterial toxins
target and inactivate RhoA, resulting in inactivation of PKN1 and PKN2 and loss
of the interaction between pyrin and 14-3-3 proteins (Xu et al., 2014). This releases
pyrin from its inhibited state and allows for inflammasome activation, which
involves the recruitment of ASC followed by caspase-1 recruitment and activation.

1.3. Noncanonical inflammasome responses to gram-negative bacteria
Recently, an alternative mechanism of inflammasome activation, that does
not directly recruit caspase-1, in response to gram-negative bacteria was
discovered and is termed the noncanonical inflammasome. The noncanonical
inflammasome is comprised of caspase-11 in mice and the two putative
orthologous, caspase-4 and caspase-5 in humans (Vigano & Mortellaro, 2013).
Caspase-11, caspase-4, and caspase-5 all possess N-terminal CARD domains
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followed by large (p20) and small (p10) catalytic subunits (B. L. Lee, I. B. Stowe,
et al., 2018). All of these inflammatory caspases bind to intracellular LPS through
their CARD domains, which leads to the oligomerization and activation of caspase11 and caspase-4 (Shi et al., 2014). Although caspase-5 was shown to bind to
LPS, it is unclear whether it oligomerizes and additional studies on the mechanism
of caspase-5 function in response to gram-negative bacterial infections are
needed. Studies in murine macrophages showed that the caspase-11
noncanonical inflammasome is activated during infection with a number of gramnegative bacteria including L. pneumophila, Escherichia coli, and S. Typhimurium
(Aachoui et al., 2013; Broz et al., 2012; Case et al., 2013; Casson et al., 2013;
Kayagaki et al., 2011). Human caspase-4 also induces inflammasome activation
in response to L. pneumophila, S. Typhimurium, Yersinia pseudotuberculosis,
Francisella novicida, and E. coli in macrophages (Casson et al., 2015; Goddard et
al., 2019; Lagrange et al., 2018). In addition, murine and human epithelial cells
induce noncanonical inflammasome responses to Burkholderia pseudomallei,
Burkholderia thailandensis, and S. Typhimurium (Holly et al., 2020; Knodler et al.,
2014; Srisaowakarn, Pudla, Ponpuak, & Utaisincharoen, 2020; Wang et al., 2018).
Thus, the noncanonical inflammasome can be activated in different cell types.
Although there has been very little investigation focused on caspase-5,
there are a couple of studies that found interesting results in human monocytes
that were treated with LPS or infected with Pseudomonas aeruginosa membrane
vesicles (Bitto et al., 2018; Vigano et al., 2015). In one study, primary human
monocytes were treated with extracellular LPS, which led to the secretion of IL-1a
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and IL-1b in a caspase-4- and caspase-5-dependent manner (Vigano et al., 2015).
Intriguingly, only caspase-5 underwent processing in response to LPS
internalization, whereas caspase-4 was left uncleaved. These findings may
suggest that caspase-5 is differentially expressed in monocytes compared with
macrophages and may be a reason of why caspase-5 can stimulate this one-step
noncanonical inflammasome response to LPS. The other study found that only
caspase-5 is activated in response to P. aeruginosa outer membrane vesicles
(OMVs), which enter the monocytes via endocytosis (Bitto et al., 2018). In contrast,
caspase-4 was activated upon transfection of P. aeruginosa LPS. These results
indicate that caspase-4 and caspase-5 are differentially activated by LPS
depending on the form of LPS as well as its mechanism of entry into the cell.
Therefore, both of these caspase-5 studies highlight that extracellular treatment of
LPS or OMVs result in caspase-5 activation, suggesting that caspase-5 responds
to endocytosed vesicles containing LPS, rather than sensing LPS that is forcibly
introduced into the cell.
TLR4 was initially believed to be the sole LPS sensor, which recognizes
extracellular LPS through a defined mechanism involving an array of proteins that
present LPS directly to membrane-bound TLR4 (B. S. Park & Lee, 2013; Poltorak
et al., 1998; Takeuchi et al., 1999). Excessive LPS stimulation of cells leads to
endotoxic shock or sepsis. Two studies found that intracellular LPS can induce
endotoxic shock independent of TLR4 (Hagar, Powell, Aachoui, Ernst, & Miao,
2013; Kayagaki et al., 2013). These studies identified caspase-11 as the
noncanonical inflammasome that responds to transfected LPS from different gram19

negative bacteria including F. novicida, Yersinia pestis, and E. coli. Importantly,
the caspase-11 noncanonical inflammasome as well as caspase-1-dependent
inflammasomes require two signals for optimal inflammasome response to
bacterial pathogens: the priming signal for upregulation of inflammasome proteins
and proinflammatory cytokines and an activation signal involving recognition of
bacterial components or cell stress by a sensor protein (Kayagaki et al., 2011;
Mariathasan, 2007). In agreement with this general rule, these two studies found
that LPS-induced lethal sepsis occurred only when wild-type (WT) mice were first
primed with a TLR agonist followed by LPS challenge, whereas WT mice treated
with either the TLR agonist or LPS alone did not trigger lethality. Furthermore,
using these conditions, they showed that caspase-11 knockout (Casp11-/-) mice
were rescued from LPS lethality, whereas TLR4 knockout (TLR4-/-) mice
succumbed to the lethal dose of LPS; thus, these data conclude that caspase-11
is the alternative mechanism of LPS sensing within the cytosol (Kayagaki et al.,
2013).
In addition to TLR4, it was also previously thought that caspase-1, originally
known as the IL-1b converting enzyme (ICE), was important for inducing LPSinduced endotoxic shock in mice (Kuida et al., 1995; Li et al., 1995). However,
these published studies generated caspase-1 knockout (Casp1-/-) mice using 129
mouse strain embryonic stem cells, which have been found to produce an
inactivating passenger mutation of caspase-11 upon the targeting of ICE using
homologous recombination (Kenneth et al., 2012). Therefore, due to the close
proximity of caspase-1 and caspase-11, these generated Casp1-/- mice are
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actually deficient in both caspase-1 and caspase-11. In order to address this
concern, one study generated Casp11-/- C57BL/6 mice, caspase-1 and caspase11 double knockout (Casp1/11-/-) C57BL/6 mice, and Casp1-/- C57BL/6 mice by
injecting the caspase-11 transgene into Casp1/11-/- embryos (Kayagaki et al.,
2011). These mice helped to distinguish the roles of caspase-1 and caspase-11
during infection of gram-negative bacteria or stimulation with canonical activators
such as ATP. This study concluded that canonical stimuli did not activate caspase11, however non-canonical stimuli such as LPS and gram-negative bacteria led to
caspase-11 inflammasome activation as well as caspase-1 inflammasome
activation that was dependent on NLRP3 and ASC, but caspase-11 processing
and cell death was not dependent on NLRP3 and ASC. Therefore, caspase-11 is
upstream of caspase-1. Finally, they also found that caspase-11 deficiency, but
not caspase-1 deficiency, protected mice from LPS-induced endotoxic shock.
Since the NLRP3 and ASC proteins were required for inducing a caspase1-dependent inflammasome response to non-canonical stimuli and that caspase11 is upstream of caspase-1, it was unclear what the link was connecting caspase11 activation to downstream NLRP3 inflammasome activation (Kayagaki et al.,
2011). Activation of caspase-11 upon infection with various gram-negative bacteria
leads to downstream pyroptosis, a lytic form of cell death, and release of IL-1 family
cytokines (Hagar et al., 2013; Kayagaki et al., 2011; Kayagaki et al., 2013).
However, the mechanism involving pyroptosis initiation was largely unknown. It
was discovered that a 53 kDa protein known as gasdermin-D (GSDMD) was
essential for inducing noncanonical inflammasome signaling as GSDMD knockout
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(GSDMD-/-) murine macrophages had decreased cell death and IL-1b release and
looked similar to Casp11-/- macrophages (Kayagaki et al., 2015). Specifically, this
study found that caspase-11 cleaves GSDMD, which results in a p30 propyroptotic N-terminal fragment that also induces NLRP3-dependent caspase-1
activation. Following this breakthrough finding, additional studies determined that
the GSDMD N-terminal fragment binds to the plasma membrane to form a circular
pore, which results in loss of membrane integrity and osmotic lysis of the cell
(Aglietti et al., 2016; Sborgi et al., 2016). The GSDMD pore also disrupts ionic
gradients and can lead to potassium (K+) efflux, which is a trigger of the NLRP3
inflammasome. This idea was confirmed in a study that showed caspase-11
activated NLRP3 inflammasome by stimulating K+ efflux (Ruhl & Broz, 2015).
Thus, this provides a model in which intracellular LPS activates caspase-11 to
cleave GSDMD, resulting in its N-terminal fragment to oligomerize and form a pore
in the plasma membrane, which induces pyroptosis as well as K+ efflux for NLRP3ASC-caspase-1 inflammasome activation. This process is now well known as the
noncanonical NLRP3 inflammasome, which is essential for IL-1 cytokine release
due to the cleavage and activation of caspase-1.
Most of these noncanonical inflammasome studies regarding GSDMD and
downstream NLRP3 inflammasome have been conducted using mice or murine
macrophages, however there are studies that investigated the human
noncanonical inflammasome involved in these processes as well. Caspase-4 and
caspase-5 mediate downstream NLRP3 inflammasome activation upon the
recognition of intracellular LPS (Baker et al., 2015; Schmid-Burgk et al., 2015).
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Furthermore, all of the murine and human inflammatory caspases (caspase-1,
caspase-11, caspase-4, and caspase-5) were found to cleave GSDMD, which is
crucial for induction of pyroptosis (Shi et al., 2015). Therefore, downstream NLRP3
inflammasome activation by caspase-11/4/5 results in caspase-1-mediated
maturation of IL-1 family cytokines as well as cleavage of GSDMD, which further
promotes pyroptosis of the infected cell.
Intriguingly, the noncanonical inflammasome has been shown to respond
to other stimuli in addition to LPS. Caspase-4 is activated by the Shiga toxin 2
(Stx2)/LPS complex derived from pathogenic E. coli and caspase-11 detects
lipophosphoglycan (LPG) from Leishmania parasites (de Carvalho et al., 2019;
Platnich et al., 2018). In addition, the caspase-4 study also determined that
caspase-4-dependent GSDMD cleavage leads to N-terminal GSDMD fragment
enriched at the mitochondria, which resulted in mitochondrial ROS production for
NLRP3 inflammasome activation (Platnich et al., 2018). These data indicate that
GSDMD can activate the NLRP3 inflammasome in multiple ways including
induction of K+ efflux and ROS production.

1.4. Type I and II Interferon signaling
Interferons (IFNs) are cytokines that are classically known for their ability to
induce an antiviral gene program in response to viral infections. IFNs were named
so due to their ability to “interfere” with viral replication, resulting in host defense
against viruses (Isaacs & Lindenmann, 1957). There are three main classes within
the IFN family: type I, type II, and type III IFNs. Together, they induce the
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expression of hundreds of IFN stimulated genes (ISGs) (Platanias, 2005; Stanifer,
Pervolaraki, & Boulant, 2019).
Type I IFNs are produced by almost all cell types and are comprised of eight
different types: 13 subtypes of IFN-a (alpha), IFN-b (beta), IFN-d (delta), IFN-e
(epsilon), IFN-k (kappa), IFN-w (omega), IFN-z (zeta), and IFN-t (tau) (Platanias,
2005). All of the type I IFNs signal through the type I interferon receptor also known
as IFN a/b receptor (IFNAR), which is comprised of two subunits: IFNAR1 and
IFNAR2. Upon binding to type I IFNs, the cytoplasmic end of IFNAR1/2 interact
with the Janus activated kinase (JAK) family members, JAK1 and TYK2, leading
to the phosphorylation of STAT1 and STAT2 for complex formation with IFNregulatory factor 9 (IRF9). The following STAT1-STAT2-IRF9 complex binds to the
IFN-stimulated response element (ISRE) for transcription of hundreds of IFNstimulated genes. Although type I IFNs were primarily thought to control viral
infections, type I IFNs have been shown to promote host defense against bacteria
and parasites as well (Boxx & Cheng, 2016; Silva-Barrios & Stager, 2017).
Similar to the type I IFN signaling pathway, type II IFN also signals through
the JAK-STAT pathway and is essential for controlling bacterial and parasitic
infections in addition to viral infections (Czarniecki & Sonnenfeld, 1993; Lykens et
al., 2010; Platanias, 2005). In contrast to type I IFNs, type II IFNs consist of only
one type, IFN-g, which are primarily produced by NK cells, activated T cells, and
macrophages. IFN-g binding to its receptor made up of IFN gamma receptor 1
(IFNGR1) and IFN gamma receptor 2 (IFNGR2) leads to JAK1 and JAK2
association, followed by phosphorylation of STAT1 and production of STAT124

STAT1 homodimers, which bind to the IFN-g activated site (GAS) for gene
transcription. Type I IFN signaling can also lead to STAT1 homodimers for GAS
gene activation. Therefore, type I IFNs can upregulate different genes depending
on the combination of STAT complexes for binding either GAS, ISRE, or both.
Type III IFNs are a new class of IFNs and are known as IFN-ls (lambdas)
(Stanifer et al., 2019). They have four family members including IFN-l1, IFN-l2,
IFN-l3, and IFN-l4 that signal through a heterodimeric receptor IFNLR1 and IL10R2 that undergoes JAK-STAT signaling similar to type I IFN signaling through
GAS and ISRE elements, however their function is restricted to epithelial cells
(Stanifer et al., 2019). These IFNs also protect epithelial barriers from bacterial
immunity, further highlighting that type I, II, and III IFNs are essential for host
defense against bacterial infections (Odendall, Voak, & Kagan, 2017).

1.5. Interferon-inducible GTPases: Guanylate binding proteins
As it was previously mentioned, type I and II IFNs upregulate a vast
repertoire of genes in response to viruses, bacteria, and parasites. Among the
most notable family of ISGs are the IFN-inducible GTPase superfamily, which
includes the 65-73 kDa guanylate binding proteins (GBPs), 21-47 kDa immunity
related GTPases (IRGs), 72-82 kDa myxoma (Mx) resistance proteins, and 200285 kDa very large inducible GTPases (B. H. Kim, Shenoy, Kumar, Bradfield, &
MacMicking, 2012). Specifically, GBPs and IRGs are the two subfamilies involved
in cell-autonomous immune responses against intracellular bacterial pathogens.
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GBPs are upregulated by type I and II IFNs, however they are more robustly
induced by the type II IFN, IFN-g (Man, Place, Kuriakose, & Kanneganti, 2017).
Mice possess 11 GBPs and 2 pseudogenes located on chromosomes 3 and 5.
Mouse chromosome 3 contains Gbp1, Gbp2, Gbp3, Gbp5, Gbp7, and one
pseudogene, while chromosome 5 has Gbp4, Gbp6, Gbp8, Gbp9, Gbp10, Gbp11,
and the second pseudogene (Olszewski, Gray, & Vestal, 2006). In contrast,
humans only have seven GBPs located on chromosome 1. Structural and
biochemical analysis revealed that GBPs are part of the dynamin superfamily and
therefore undergo nucleotide-dependent oligomerization and GTPase activity
(Vestal & Jeyaratnam, 2011). Based on the structure of human GBP1, all GBPs
are comprised of an N-terminal globular large G domain, which is important for
nucleotide binding and GTPase effector activity, followed by an a-helical Cterminal domain (Prakash, Praefcke, Renault, Wittinghofer, & Herrmann, 2000).
The N-terminal LG domain is connected by the C-terminal domain by an
intermediate region made up of an a-helical domain and two b-sheets.
The C-terminal amphipathic a helices mediate protein-protein and proteinlipid interactions (B. H. Kim et al., 2012). In addition, human and mouse GBP1,
GBP2, and GBP5 possess a C-terminal ‘CaaX’ isoprenylation motif important for
facilitating protein-protein interactions as well as membrane binding. The ‘C’
signifies a cysteine amino acid residue, ‘aa’ indicates any aliphatic amino acids,
and ‘X’ signifies the amino acid that determines which lipid moiety is added, either
a leucine or serine. The terminal amino acid for human GBP1 and murine Gbp5 is
serine, therefore a C-15 farnesyl group is added at their CaaX motif. In contrast,
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human GBP2 and GBP5 as well as murine Gbp1 and Gbp2 have a terminal
leucine, which results in addition of a C-20 geranylgeranyl lipid. One study found
that membrane binding of human GBP1, GBP2, and GBP5 is dependent not only
on prenylation of the CaaX motif, but also dependent on oligomerization of the
GBPs (Britzen-Laurent et al., 2010). Here, they found that GBPs are able to
homodimerize or heterodimerize and that prenylated GBPs can recruit nonprenylated GBPs to their intracellular compartments. Specifically, human GBP1
localizes to the plasma membrane, GBP2 localizes to the perinuclear membrane,
and GBP5 to the Golgi. Heterodimerization between prenylated GBPs results in a
hierarchical positioning effect of GBPs; for instance, human GBP1 recruits GBP2
and GBP5 to the plasma membrane, whereas GBP5 repositions GBP2 to the
Golgi. These findings suggest that GBP1 is the primary recruiter for the remaining
GBPs in uninfected IFN-g-primed cells. However, infection studies have shown to
alter the positioning effects of GBPs to the pathogen directly, presumably to induce
host defense mechanisms.

1.6. GBPs role in inflammasome responses to bacteria
Studies in macrophages have proven that GBPs employ a variety of
functions in a pathogen-specific manner. Initial murine GBP findings showed that
GBPs can promote rupture of the pathogen-containing vacuole (PCV) or
bacteriolysis of cytosolic bacteria (B. C. Liu et al., 2018; Meunier et al., 2014;
Meunier et al., 2015). Upon infection with the vacuolar pathogen S. Typhimurium,
murine macrophages lacking GBPs on chromosome 3 (Gbpchr3-/-) showed
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decreased cell death and IL-1b release compared to WT macrophages, and more
specifically after conducting siRNA-mediated knockdown of individual GBPs,
found that Gbp2 is the sole GBP important for mediating this caspase-11dependent inflammasome response (Meunier et al., 2014). In addition, they
determined that Gbpchr3-/- macrophages had a decreased amount of galectin-8positive S. Typhimurium. Galectins are b-galactoside-binding lectins that bind to
the carbohydrates found in the inner leaflet of vacuolar membranes and therefore
serve as a marker of ruptured vacuoles. As expected due to this finding, they
further showed that Gbpchr3-/- or Gbp2-deficient (Gbp2-/-) macrophages had
decreased presence of cytosolic S. Typhimurium, indicating that GBPs mediate
lysis of the PCV of S. Typhimurium. In contrast, two studies revealed that murine
GBPs localize to the outer membrane of cytosolic F. novicida and L. pneumophila
DsdhA mutant. Specifically, murine Gbp2 and Gbp5 individually promote AIM2
inflammasome activation through their direct binding and lysis of F. novicida’s
outer membrane (Meunier et al., 2015). Additionally, the cytosolic DsdhA mutant
of L. pneumophila was shown to have lost its rod-like appearance in IFN-b-primed
WT murine macrophages, but retained the rod shape in Gbpchr3-/- macrophages,
indicating that murine GBPs induce bacteriolysis of cytosolic exposed bacteria (B.
C. Liu et al., 2018). They further reveal that GBPs on chromosome 3 are essential
for mediating the release of DNA from the DsdhA mutant. Interestingly, this study
also found that IFN-b priming resulted in destabilization of the vacuole of WT L.
pneumophila in both WT and Gbpchr3-/- macrophages, suggesting that there are
additional IFN-induced factors other than GBPs that are rupturing L. pneumophila’s
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vacuole. It is interesting that murine GBPs rupture the PCV of S. Typhimurium, but
not of L. pneumophila; thus, GBPs may take on different roles in a bacteriumspecific manner. Nevertheless, all three of these murine GBP studies discussed
so far conclude that GBPs control bacterial burden within the host.
In addition to promoting inflammasome responses to bacterial pathogens,
GBPs can initiate inflammasome activation in response to bacterial components
as well. GBPs promote caspase-11-dependent pyroptosis in response to
cytoplasmic LPS from E. coli, Salmonella minnesota, and L. pneumophila,
although the specific mechanism of how GBPs do this was unclear (Pilla et al.,
2014). It was revealed that murine and human GBP5 can form a tetramer that
binds to NLRP3 to promote ASC-caspase-1 inflammasome assembly in response
to pathogenic bacteria and bacterial components including LPS and muramyl
dipeptide (MDP) (Shenoy et al., 2012). Therefore, GBPs may similarly oligomerize
in response to LPS to enhance caspase-11 activation, possibly through binding
LPS and transporting it directly to caspase-11, acting in a similar manner as the
LPS binding protein (LBP) during TLR4 activation. Furthermore, GBPs on
chromosome 3 and more specifically Gbp2 are required for inflammasome
activation in response to OMVs derived from E. coli (Finethy et al., 2017). It was
later found that GBPs associate with OMVs and transfected LPS, indicating that
GBP binding to LPS is the main factor regulating GBP recruitment to OMVs
(Santos et al., 2018).
The precise mechanism that governs GBP recruitment to PCVs is poorly
understood. We know that GBPs bind to LPS on the outer membrane of bacteria,
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but whether there are specific microbial signatures on pathogenic vacuoles is
unclear. Two studies determined that murine GBPs are recruited to vacuolar
pathogens that contain bacterial secretion systems (E. M. Feeley et al., 2017;
Zwack et al., 2017). Specifically, GBPs are delivered to the pathogen-containing
vacuoles of L. pneumophila and Yersinia pseudotuberculosis in a manner
dependent on the presence of the Dot/Icm type IV secretion system and
hypersecretion of the Yersinia type III secretion system, respectively (E. M. Feeley
et al., 2017). However, it was determined that the presence of bacterial secretion
systems result in vacuolar membrane damage leading to initial recruitment of
galectin-3, the damaged vacuole marker, followed by recruitment of GBPs.
Galectin-3-deficient cells had a decreased amount of murine Gbp1 and Gbp2 to
the L. pneumophila-containing vacuoles and Yersinia-containing vacuoles,
indicating that galectin-3 controls GBP recruitment to PCVs. Furthermore, another
study showed that hyperinjection of the Yersinia translocon protein, YopD, leads
to its association with galectin-3 and Gbp2 and that GBPs on chromosome 3
contribute to Yersinia T3SS-induced inflammasome activation (Zwack et al.,
2017). Therefore, these findings provide a model wherein Yersinia translocon
proteins localize to the PCV resulting in galectin-3 recruitment followed by GBP
recruitment for promoting noncanonical inflammasome responses to Yersinia.
Besides the presence of bacterial secretion systems, there may be additional ways
in which GBPs are recruited to non-self vacuolar membranes.
The GBP research discussed so far has focused on murine GBPs. Since
mice have 11 GBPs and humans have 7 GBPs, there may be differences in the
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role that human GBPs play in response to bacterial infections. Recently,
investigation on human GBPs have revealed seminal findings on human cellautonomous immune responses on various bacterial pathogens. Initial studies on
the cytosolic bacterium Shigella flexneri highlighted that human GBPs are recruited
to the outer membrane in order to inhibit S. flexneri’s actin motility (Li et al., 2017;
Piro et al., 2017; Wandel et al., 2017). Human GBP1 is first recruited to S. flexneri,
followed by GBP2-4 and GBP6 to form a GBP coat around the bacteria (Piro et al.,
2017; Wandel et al., 2017). S. flexneri has developed mechanisms to counter host
cell defense by using their IpaH family of E3 ubiquitin ligases. Specifically, IpaH9.8
was found to ubiquitylate and degrade GBPs to allow for cell-to-cell spread, while
S. flexneri lacking IpaH9.8 maintained their GBP coats and were unable to undergo
actin-based motility (Li et al., 2017; Wandel et al., 2017). Thus, human GBP1
prevents bacterial spread of S. flexneri, which is a novel function of GBPs.
Additional findings on this process showed that GBP1 localization with S. flexneri
is dependent on its CaaX motif, GTPase activity, and triple arginine motif at the Cterminus. Human GBP1 also binds to the S. flexneri rough mutant which lacks the
O-antigen at a lower affinity compared to the WT S. flexneri, indicating that GBP1
binds directly to LPS on the outer membrane of S. flexneri (Piro et al., 2017).
Moreover, human GBP2 colocalizes with F. novicida to promote caspase-4dependent inflammasome responses (Lagrange et al., 2018). These findings show
that human GBPs can take on different roles in a bacterium-specific manner.
Human GBP1 not only is important for inhibiting the bacterial spread of S.
flexneri, but also plays an essential role in promoting caspase-4 inflammasome
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activation during infection with cytosolic exposed S. Typhimurium and S. flexneri
mutant that lacks the effectors IpaH9.8 and OspC3 as well (Fisch et al., 2019;
Kutsch et al., 2020; Santos et al., 2020; Wandel et al., 2020). GBP1 was initially
shown to promote the caspase-4 inflammasome in response to S. Typhimurium in
a GTPase and isoprenylation dependent manner (Fisch et al., 2019). In addition,
GBP1 localizes to S. Typhimurium and recruits caspase-4. However, this study
was not clear on whether GBP1 localizes to the vacuole or outer membrane of S.
Typhimurium. A recent study determined that GBP1 is recruited to the outer
membrane of cytosolic exposed S. Typhimurium in a CaaX motif and GTPasedependent manner and does not colocalize with galectin-3+ ruptured vacuolar
membranes (Santos et al., 2020). Intriguingly, in contrast to murine GBPs that
induce bacteriolysis of cytosolic F. novicida and L. pneumophila, human GBP1
does not induce bacteriolysis of S. Typhimurium but rather controls inflammasome
assembly at the bacterial surface. Furthermore, similar to the S. flexneri studies,
upon binding LPS on S. Typhimurium, GBP1 recruits GBP2-4 to form a complex,
which recruits caspase-4 for its activation. Although it was not clear how caspase4 is being activated, it could be due to a number of possibilities including a scenario
where the GBP complex transfers LPS to caspase-4 or that the GBP complex
weakens the bacterial membrane so that caspase-4 can directly target LPS. Two
studies investigate how caspase-4 is activated and it seems like latter of these two
possibilities is happening (Kutsch et al., 2020; Wandel et al., 2020). While GBP1
is the initiator GBP that recruits GBP2-4, the functions of these recruited GBPs
were finally established. GBP2 and GBP4 participate in caspase-4 recruitment,
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whereas GBP3 is essential for caspase-4 activation in response to cytosolic S.
Typhimurium as well as to S. flexneri that lacks the effectors IpaH9.8 and OspC3,
due to their inhibition of the caspase-4 inflammasome (Wandel et al., 2020).
Specifically, GBP1-4 assemble into a polyvalent protein array on the outer
membrane bacterial surface and leads to an LPS-dependent complex formation
with caspase-4. Thus, this investigation provides a model where the GBP complex
disrupts the membrane integrity for allowing access of capsase-4 to bind LPS.
Furthermore, another study looking at the mechanism of caspase-4 activation
showed that GBP1 polymers dock to the outer membrane of S. flexneri through
binding to the O-antigen of its LPS, resulting in GBP1 protein coats surrounding
the bacteria (Kutsch et al., 2020). They further conclude that GBP1 becomes
anchored in the bacterial membrane via their farnesyl tails, which disrupts the LPS
barrier and reveals lipid A for caspase-4 detection. Thus, rather than lysing the
cytosolic bacteria for release of bacterial components such as LPS for
inflammasome activation, human GBPs respond to cytosolic bacteria by
orchestrating an organized complex platform for direct access of caspase-4.
Human GBP1 has been involved in microbial restriction of other bacteria
and parasites as well. Human GBP1 localizes to the parasite Toxoplasma gondii
vacuole to restrict its infection in mesenchymal stromal cells and also mediates
restriction of C. trachomatis in THP-1 macrophages (Qin et al., 2017; Xavier, AlZeer, Meyer, & Daumke, 2020). Interestingly, GBP1 does not always interact with
the pathogen in order to control infection, since it was found that GBP1 does not
localize to vacuoles of T. gondii, C. trachomatis, or S. Typhimurium but restricts T.
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gondii replication in A549 lung epithelial cells (Johnston et al., 2016). Therefore,
human GBPs may have different functions in a cell-type-specific manner.

1.7. Interferon-inducible GTPases: Immunity related GTPases
Another IFN-inducible GTPase family that has been implicated in vacuolar
rupture and bacteriolysis are the IRGs. Mice possess 23 IRG proteins, whereas
humans possess two IRG proteins, IRGM and IRGC (Bekpen et al., 2005). In
contrast to murine IRGs, human IRGs are not IFN-inducible due to the loss of
interferon response elements upstream of their transcriptional start site. Therefore,
human IRGs would not be involved in IFN-dependent host defense pathways. The
murine IRGs are divided into two subfamilies: the GMS and GKS proteins, which
are named so because of the presence of either a GMS or GKS amino acid motif
on the first nucleotide-binding site (Hunn, Feng, Sher, & Howard, 2011). The GMS
proteins include the IRGM subfamily, while the GKS proteins contain the IRGA,
IRGB, IRGC, and IRGD subfamilies. The IRGMs are guanine nucleotide
dissociation inhibitors that control the localization of other IFN-inducible GTPases
including the GKS subfamily of IRGs and GBPs. The presence of IRGMs on
membranes prevents the binding of GBPs and GKS IRGs, and therefore the
IRGMs serve as regulators for IFN-inducible GTPases involved in vacuolar rupture
or bacteriolysis to determine “self” versus “non-self” (Ngo & Man, 2017). Indeed,
one study found that Irgm1 and Irgm3 did not localize to “non-self” pathogencontaining vacuoles, but instead localized to “self” organelles, such as lipid
droplets (Haldar et al., 2013). They found that when the IRGM proteins were
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knocked out, the GKS proteins Irga6 and Irgb6 localized to the lipid droplets,
indicating that IRGs and GBPs target membranes that are missing “self” IRGM
proteins.

1.8. IRGs role in inflammasome responses to bacteria
IRGs have been shown to destabilize vacuoles of pathogens and in one
case have been essential for mediating bacteriolysis of cytoplasmic bacteria. The
murine IRGs Irgm1 and Irgm3 are critical for directing Irga6, Irgb6 and Irgb10 to
the C. trachomatis inclusions to control bacterial replication (Coers et al., 2008;
Haldar et al., 2013). In addition, Irgm1 is important for controlling Mycobacterium
tuberculosis infection in the lungs (Tischler, Leistikow, Kirksey, Voskuil, &
McKinney, 2013). Although not in the context of bacterial infection, murine IRGs
have also been reported to localize to the parasitophorous vacuole of T. gondii in
a hierarchal manner in the order of Irgb6, Irgb10, Irga6, Irgm2, and Irgd in order to
disrupt the vacuole for killing of the intracellular parasite (Khaminets et al., 2010;
Martens et al., 2005).
Irgb10 is the only known murine IRG that has been implicated in inducing
bacteriolysis of cytoplasmic bacteria in order to liberate ligands for inflammasome
sensing (Man et al., 2016). Specifically, Irgb10 targets the intracellular bacteria F.
novicida and E. coli in a GBP dependent manner. Following bacterial targeting,
Irgb10 mediates bacteriolysis, which results in the release of bacterial components
including DNA for AIM2 inflammasome activation and LPS for noncanonical
capsase-11 inflammasome activation. Humans do not possess an ortholog of
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mouse Irgb10; however, human IRGM has been shown to be important for
controlling M. tuberculosis and S. Typhimurium infections through autophagy
induction (McCarroll et al., 2008; Singh, Davis, Taylor, & Deretic, 2006). While not
in the context of inflammasome activation, these findings show that IRGM is
important for activating alternative host defense pathways.

1.9. Legionella pneumophila infection in macrophages
My primary thesis project focuses on investigating IFN-induced innate
immune responses to Legionella pneumophila in order to gain an understanding
of human GBPs role during infection with this vacuolar pathogen. Legionella
pneumophila is a gram-negative, opportunistic intracellular bacterial pathogen that
is the causative agent for Legionnaires’ disease, a severe pneumonia that primarily
affects immunocompromised hosts, or to a lesser extent can cause Pontiac Fever,
a flu-like illness (Fields, Benson, & Besser, 2002; Fraser et al., 1977). L.
pneumophila was first identified during an outbreak that occurred in 1976 at the
56th annual American Legion Convention in Philadelphia (Fraser et al., 1977).
There was a total of 182 individuals diagnosed with severe pneumonia and 29
people died from the illness, revealing the detrimental effects of this intracellular
pathogen. L. pneumophila persists in aquatic environments and replicates within
their natural hosts, which are free-living amoebae. However, L. pneumophila can
also be found as a contaminant in freshwater reservoirs including water towers,
hot tubs, and air condition units and, therefore, can become an accidental
pathogen to humans upon the inhalation of aerosolized water droplets that are
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contaminated with L. pneumophila. Upon inhalation, these intracellular bacteria
gain access to the lungs where they infect and replicate in alveolar macrophages,
although it was determined that L. pneumophila can also replicate within
neutrophils as well (Copenhaver et al., 2014).
Upon uptake by macrophages, L. pneumophila resides within a specialized
compartment termed the L. pneumophila-containing vacuole (LCV) (Horwitz,
1983). However, in order to survive and replicate within the LCV, L. pneumophila
relies on its Dot/Icm type IVb secretion system (T4SS) (Berger & Isberg, 1993;
Berger, Merriam, & Isberg, 1994; Brand, Sadosky, & Shuman, 1994; Ensminger &
Isberg, 2009; Roy & Isberg, 1997). The T4SS translocates over 300 bacterial
effectors that are essential for manipulation of host cell processes as well as for
vacuolar remodeling (Hubber & Roy, 2010). Specifically, these effectors allow L.
pneumophila to evade the endocytic pathway by avoiding endosome-lysosome
fusion and to remodel the vacuole by recruiting ER-derived vesicles to the LCV
membrane (Ensminger & Isberg, 2009; Hubber & Roy, 2010). Modification of the
LCV with ER-derived vesicles results the establishment of an ER-like organelle
that is maintained by the host cell and, therefore, supports the replication of L.
pneumophila within this specialized vacuole (Roy, 2002). L. pneumophila begin to
replicate in the LCV at 4-6 hours upon initial uptake by a host cell. At around 14
hours post-uptake, L. pneumophila has replicated to large numbers and at this
point escape the LCV and rupture the host cell in order for L. pneumophila progeny
to infect additional neighboring cells. Although the T4SS is essential for the survival
of L. pneumophila within the LCV, the T4SS makes L. pneumophila susceptible to
37

host sensing and can activate innate immune pathways in the cytosol, such as the
inflammasome (Casson et al., 2013; Casson et al., 2015; Molofsky et al., 2006).
Most of the studies conducted involving L. pneumophila use strains that are
derived from the serogroup 1 clinical isolate Philadelphia-1, which was collected
from the 1976 outbreak. The two strains that were derived from the Philadelphia1 isolate are the JR32 strain and LP01 strain, both of which are replicative strains
(Rao, Benhabib, & Ensminger, 2013). Additional strains were produced
downstream from the LP01 strain. LP02 was derived from LP01 and is a thymidine
auxotroph; thus, it requires thymidine in order to undergo replication. Using this
strain is instrumental in understanding L. pneumophila’s influence on the immune
response without the confounding variable of replication. Furthermore, LP02 was
used to derive LP03, also known as the avirulent dotA mutant, which is a thymidine
auxotroph that lacks the dot/icm translocation system and is defective for
intracellular replication (Berger & Isberg, 1993; Berger et al., 1994). In my studies,
I use a flagellin deficient LP02 strain, DflaA, in order to investigate inflammasome
responses that are NAIP/NLRC4 inflammasome independent (Ren, Zamboni, Roy,
Dietrich, & Vance, 2006), as well as use DdotA LP03 strain and a dsREDexpressing JR32 strain. L. pneumophila has been shown to activate canonical
caspase-1 containing inflammasomes as well as noncanonical inflammasome
pathways (Case et al., 2013; Casson et al., 2013; Casson et al., 2015; Ge et al.,
2012; Miao et al., 2010; Zhao et al., 2011). However, whether IFN-g or human
GBPs promote inflammasome responses to L. pneumophila in human
macrophages has not been studied.
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1.10. Lipopolysaccharide (LPS): immunological consequence of acylation
state in macrophages
Lipopolysaccharide (LPS) is the major outer membrane lipid component of
gram-negative bacteria. It is composed made up of three components: the lipid A
moiety, core oligosaccharide, and O-antigen. LPS is an amphiphilic molecule
where the lipid A comprises the hydrophobic part and the polysaccharides within
the core and O-antigen make up the hydrophilic portion. The lipid A moiety is the
portion of LPS that is directly recognized by the extracellular and intracellular LPS
sensors, TLR4 and noncanonical inflammatory caspases 11, 4 and 5, respectively.
Specifically, lipid A is has two glucosamine residues that are connected by a β1’6 linkage that can be phosphorylated at the 1 and 4’ positions and are acylated at
the 2,3,2’, and 3’ positions (Bertani & Ruiz, 2018).
Intriguingly, LPS can possess different acylation or phosphorylation states
in various bacteria as well as within the same bacterial species. For instance, lipid
A can have different numbers and lengths of acyl chains and usually have either
one or two phosphate groups. Gram-negative bacteria’s ability to remodel their
LPS is important for their pathogenesis as it can allow these particular bacteria to
evade immune detection, including TLR4 and the noncanonical inflammatory
caspases. In particular for Helicobacter pylori, it has a tetra-acylated LPS and the
ability to remove phosphoryl groups from its 1 and 4’ positions through the use of
its phosphatases lpxE and lpxF, respectively, which lead to the attenuation of
TLR4-MD2 activation (Cullen et al., 2011). This in contrast to E. coli LPS, which is
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hexa-acylated and contains two phosphate groups and robustly activates the
TLR4-MD2 complex. Another gram-negative bacteria species that has the ability
to modify its LPS is Francisella novicida. F. novicida initially synthesizes a pentaacylated LPS with two phosphates and uses its phosphatase lpxF to remove the
4’-phosphate group and a deacylase to remove the 3’-hydroxyacyl chain (Raetz et
al., 2009). This process results in a tetra-acylated and monophosphorylated F.
novicida LPS, which evades the murine noncanonical inflammasome (Hagar et al.,
2013). Additionally, bacteria can switch between acyl states in response to its
surrounding environment. Specifically, Yersinia pestis can switch between being
tetra-acylated and hexa-acylated. Y. pestis is hexa-acylated when grown at 25°C,
the temperature of a flea vector, however it removes two acyl chains to become
tetra-acylated upon being grown at 37°C, which is the temperature of a mammalian
host (Rebeil, Ernst, Gowen, Miller, & Hinnebusch, 2004). Similar to tetra-acylated
F. novicida LPS, it was discovered that tetra-acylated Y. pestis evades murine
caspase-11 detection, whereas Y. pestis in its hexa-acylated form activates
caspase-11 (Hagar et al., 2013). These results are in agreement with another
study that found tetra-acylated H. pylori or lipid IVa, the precursor to E. coli LPS,
failed to activate the mouse noncanonical inflammasome as well as TLR4, while
hexa-acylated LPS from E. coli or S. Typhimurium robustly activates caspase-11
and TLR4 (Kayagaki et al., 2013). In contrast to what was found in mouse
macrophages, a recent study determined that tetra-acylated F. novicida LPS
activates capsase-4, suggesting that human noncanonical inflammasome can
recognizes under-acylated LPS (Lagrange et al., 2018). This data along with other
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human caspase-4 inflammasome studies indicates that caspase-4 can recognize
different types of LPS variants with different numbers of acyl chains (Casson et al.,
2015; Goddard et al., 2019; Knodler et al., 2014; Lagrange et al., 2018;
Srisaowakarn et al., 2020). However, there are no further studies that investigate
human noncanonical inflammasome responses to LPS variants that are
differentially phosphorylated or acylated.

1.11. Dissertation Aims
Gram-negative bacterial pathogens are responsible for a significant number
of hospital-acquired infections, making them a major public health concern.
Additionally, antibiotic resistance is on the rise, making it difficult to control many
bacterial infections. Inability to control these bacterial infections can lead to sepsis,
an overwhelming systemic immune response, and ultimately death if left untreated.
Although

there

are

successful

treatments

for

sepsis

in

mice

using

immunomodulators, these treatments fail to alleviate sepsis in humans. The
reasons for these failures are poorly understood, but one possible reason could be
due to the differences between mouse and human innate immune genes that may
play a role in the responses to gram-negative bacterial infections. Importantly,
mouse studies do not always translate to what happens in humans. Therefore, it
is important to understand human innate immune responses to gram-negative
bacterial infections in order to gain insight into the cellular components or signaling
pathways that can be targeted to enhance or limit the immune response. L.
pneumophila is a gram-negative, vacuolar pathogen that replicates in
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macrophages and serves as a valuable model pathogen as it robustly activates
immune response pathways including the inflammasome. IFN-priming promotes
murine inflammasome responses to L. pneumophila, but whether and how IFN
influences human inflammasome responses to L. pneumophila has not been
investigated. Additionally, LPS from gram-negative bacteria is a potent activator of
the intracellular noncanonical inflammasome; however, it appears that murine
caspase-11 is differentially activated depending on the LPS variant, while it is
unclear whether human caspase-4 is activated by different LPS variants. To better
understand human inflammasome responses to L. pneumophila in the context of
IFN-g or to different LPS variants, this dissertation will focus on the following aims
(Fig. 1.1):

Figure 1.1. Human inflammasome responses to L. pneumophila and LPS
variants. This dissertation will focus on the role of IFN-g and GBPs on human
inflammasome responses to L. pneumophila as well as the roles of caspase-4 and
caspase-5 responses to LPS variants.
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Aim 1: Determine how IFN-g promotes human inflammasome responses
during L. pneumophila infection
IFN-treatment in mice leads to upregulated inflammasome response to a
variety of bacteria, including L. pneumophila. Specifically, there are unknown IFNinduced factors that promote the rupture of the LCV, while murine GBPs induce
bacteriolysis for the release of DNA and LPS into the cytosol for inflammasome
sensing and activation. Mice and humans differ in the number of GBPs, and recent
findings indicate that human GBP2 promotes caspase-4 inflammasome in
response to the cytosolic bacteria, F. novicida. However, whether human GBPs
contribute to inflammasome responses to vacuolar pathogens is poorly
understood. In CHAPTER 2, we investigate whether IFN-g and human GBPs
promote inflammasome response to the vacuolar pathogen, L. pneumophila, and
found that human GBP1 mediates maximal inflammasome response and
promotes the rupture of the pathogen vacuole during L. pneumophila infection.

Aim 2: Determine human noncanonical inflammasome responses to
different LPS variants
Based on studies testing LPS from different gram-negative bacteria, underacylated variants evade caspase-11 detection in mice, while one study showed
that tetra-acylated LPS activates caspase-4 in humans. Whether the number,
position, or length of acyl chains on LPS as well as the number of phosphate
groups determines activation of the human noncanonical inflammasome has not
been studied. In CHAPTER 3, we investigate the activation of caspase-4 and
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caspase-5 in response to different lipooligosaccharide variants derived from Y.
pestis in order to determine whether there are differences or similarities in their
activation. Additionally, we employed CRISPR/Cas9 to knock out caspase-4,
caspase-5, GBP1, and GBP2 in THP-1 cell lines. Our preliminary results suggest
that caspase-4, but not caspase-5, is activated in response to E. coli LPS. Future
studies with these cell lines are needed to determine the role caspase-4 and -5 in
response to the Y. pestis LOS, as well as to determine the role of human GBPs
(GBP1 and GBP2) in response to LPS or LOS derived from L. pneumophila, E.
coli, and Y. pestis.
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CHAPTER 2

Human GBP1 promotes pathogen vacuole rupture and inflammasome
activation during Legionella pneumophila infection

This chapter contains large portions of a submitted manuscript titled “Human
GBP1 promotes pathogen vacuole rupture and inflammasome activation during
Legionella pneumophila infection” by Antonia. R. Bass and Sunny Shin.
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2.1. Abstract
The inflammasome is an essential component of host defense against
intracellular bacterial pathogens, such as Legionella pneumophila, the causative
agent of the severe pneumonia Legionnaires’ disease. Inflammasome activation
leads to recruitment and activation of caspases, which promote IL-1 family cytokine
release

and

pyroptosis.

In

mice,

interferon

(IFN)

signaling

promotes

inflammasome responses against L. pneumophila, in part through the functions of
a family of IFN-inducible GTPases known as guanylate binding proteins (GBPs).
Within murine macrophages, IFN signaling promotes rupture of the L.
pneumophila-containing vacuole (LCV), whereas GBPs are dispensable for
vacuole rupture. Instead, GBPs facilitate the lysis of cytosol-exposed L.
pneumophila. In contrast to mouse GBPs, the functions of human GBPs in
inflammasome responses to L. pneumophila are poorly understood. Here, we
show that IFN-g promotes caspase-1, caspase-4, and caspase-5 inflammasome
activation during L. pneumophila infection and upregulates GBP expression in
primary human macrophages. We find that human GBP1 is important for maximal
IFN-g-driven inflammasome responses to L. pneumophila. Furthermore, IFN-g
signaling promotes the rupture of LCVs. Similar to murine GBPs, human GBP1
and GBP2 target LCVs in a T4SS-dependent manner. However, in contrast to
murine GBPs, human GBP1 promotes vacuolar lysis of the LCV, resulting in
increased bacterial access to the host cell cytosol. Our findings show a key role
for human GBP1 in targeting and disrupting pathogen-containing vacuoles and
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reveal mechanistic differences in how mouse and human GBPs promote
inflammasome responses to L. pneumophila.

2.2. Significance Statement
The bacterial pathogen Legionella pneumophila, the causative agent of the
severe pneumonia Legionnaires’ disease, resides within a host-derived vacuole
inside macrophages. In response, the macrophage directs assembly of a
multiprotein signaling complex termed the inflammasome, which mediates cell
death and release of cytokines important for antibacterial defense. The cytokine
interferon-gamma (IFN-g) potentiates inflammasome responses by inducing
expression of host factors, including guanylate-binding proteins (GBPs). In mice,
IFN signaling promotes rupture of the L. pneumophila-containing vacuole (LCV).
Mouse GBPs do not mediate LCV disruption, but instead facilitate lysis of cytosolexposed bacteria. In contrast, the functions of human GBPs are poorly understood.
Here, we show that human GBP1 promotes inflammasome responses to L.
pneumophila. In contrast to mouse GBPs, we find that human GBP1 targets and
disrupts the LCV. These findings provide insight into the role of human GBPs in
antibacterial defense and reveal mechanistic differences in how mouse and human
GBPs function.

2.3. Introduction
The innate immune response to bacterial pathogens is essential for
mediating host defense and bacterial clearance. This response is initiated through
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the recognition of conserved microbial components known as pathogenassociated molecular patterns (PAMPs) by host pattern recognition receptors
(PRRs) (Janeway, 1989; Takeuchi & Akira, 2010). In particular for intracellular
bacteria, a subset of cytoplasmic PRRs that detect bacterial components
contaminating the host cell cytosol and other activities associated with invading
pathogens has been implicated in host defense. Upon activation, host sensors
such as the nucleotide-binding oligomerization domain-like receptors (NLRs)
mediate the formation of a multimeric protein complex termed the inflammasome.
Inflammasome activation triggers a cascade of immune responses that culminate
in the release of IL-1 family cytokines and an inflammatory form of cell death
termed pyroptosis. This response alerts the body of the infection and recruits other
innate immune cells to the site of infection, thereby promoting bacterial control and
clearance.
The two inflammasomes that have been described are the canonical and
noncanonical inflammasomes. In response to a diverse range of ligands, canonical
inflammasomes recruit and activate the cysteine protease caspase-1 to promote
the processing and secretion of the proinflammatory cytokines IL-1b and IL-18
(Martinon, Burns, & Tschopp, 2002; Ting, Willingham, & Bergstralh, 2008).
Additionally, an alternative caspase-1-independent inflammasome termed the
noncanonical inflammasome mediates inflammatory responses to gram-negative
bacteria (Aachoui et al., 2013; Broz et al., 2012; Case et al., 2013; Casson et al.,
2013; Kayagaki et al., 2011; Lamkanfi & Dixit, 2014; Rathinam et al., 2012). The
noncanonical inflammasome is formed by caspase-11 in mice and two orthologs
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in humans, caspase-4 and caspase-5; these caspases are activated upon binding
bacterial lipopolysaccharide (LPS), a potent PAMP and major outer membrane
lipid component of gram-negative bacteria (Hagar et al., 2013; Kayagaki et al.,
2013; Shi et al., 2014). Following their activation, these inflammatory caspases
cleave the substrate gasdermin-D (GSDMD). Upon cleavage, the GSDMD Nterminal fragment translocates to the plasma membrane and oligomerizes to form
a pore, leading to pyroptosis (Kayagaki et al., 2015; Shi et al., 2015). Death of the
infected cell eliminates the replicative niche for intracellular pathogens and leads
to the clearance of bacteria through various mechanisms including the uptake of
the bacteria within pore-induced intracellular traps (PITs) by neutrophils and
clearance by efferocytosis (Jorgensen, Zhang, Krantz, & Miao, 2016).
Inflammasome responses are potentiated by priming signals recognized by
plasma membrane receptors that upregulate the production of inflammatory
cytokines and inflammasome components. During an infection, toll-like receptors
play a major role in promoting the expression of innate immune genes.
Additionally, type I and type II IFNs produced during infection promote
inflammasome responses in mice. A subfamily of IFN-upregulated GTPases called
GBPs are particularly important in promoting inflammasome responses to gramnegative bacteria in mice (Balakrishnan, Karki, Berwin, Yamamoto, & Kanneganti,
2018; Finethy et al., 2017; B. H. Kim et al., 2016; B. C. Liu et al., 2018; MacMicking,
2004; Meunier et al., 2014; Meunier et al., 2015; Pilla et al., 2014; Shenoy et al.,
2012; Zwack et al., 2017). Mouse GBPs can localize to pathogen-containing
vacuoles or bacterial membranes of cytosol exposed bacteria (B. H. Kim et al.,
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2011; Man et al., 2016; Meunier et al., 2015; Piro et al., 2017; Santos et al., 2018;
Wandel et al., 2017). However, the precise steps regulated by GBPs in promoting
inflammasome activation are unclear. A study using Salmonella Typhimurium
indicated that mouse GBPs promote rupture of pathogen-containing vacuoles
(PCVs), whereas other studies with Francisella novicida and L. pneumophila
indicate that GBPs function downstream of PCV rupture and facilitate bacteriolysis,
resulting in cytosolic release of bacterial components that subsequently trigger
inflammasome activation (B. C. Liu et al., 2018; Man et al., 2015; Man et al., 2016;
Meunier et al., 2014; Meunier et al., 2015). Additionally, GBPs were found to
promote caspase-11 activation in response to transfected LPS and, therefore,
revealed that GBPs can operate downstream of vacuolar and outer membrane
lysis (Pilla et al., 2014). Mouse GBPs can also promote inflammasome responses
in the absence of targeting the PCV, as is the case with the vacuolar pathogen
Chlamydia muridarum (Finethy et al., 2015). It is still unclear how mouse GBPs
mediate these various functions, although one study showed that GBPs recruit the
immunity-related GTPase (IRG) IRGB10 to mediate bacteriolysis (Man et al.,
2016).
While studies in mice have linked the functions of IFN signaling and GBPs
to inflammasome activation, the degree to which the function of murine GBPs
mirror their human counterparts is unknown, as the significant differences in
immune genes between mice and humans, including in the GBP superfamily, could
translate into differences in immune mechanisms. Notably, mice have 11 GBPs,
whereas humans only have seven GBPs (Olszewski et al., 2006). The functions of
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human GBPs in host defense against gram-negative bacteria, particularly whether
human GBPs play a role in PCV rupture or bacteriolysis, is unclear. Human GBP1
colocalizes to the outer membrane of the cytosolic pathogen Shigella flexneri and
further recruits additional GBPs, specifically GBP2, 3, 4, and 6, to inhibit the actinbased motility of S. flexneri (Piro et al., 2017; Wandel et al., 2017). Additionally,
human GBP1 and GBP5 promote inflammasome responses to S. Typhimurium,
which can reside within a specialized vacuole or in the cytosol, while human GBP2
promotes inflammasome responses to the cytosolic pathogen F. novicida (Fisch
et al., 2019; Lagrange et al., 2018; Shenoy et al., 2012). These findings indicate
that different human GBPs function in a bacterium-specific manner. Furthermore,
human GBP1 associates with sterilely lysed host vacuoles, and therefore, it may
be possible that human GBPs can also associate with bacteria-containing
vacuoles that are host derived, similar to mouse GBPs (E. M. Feeley et al., 2017;
Piro et al., 2017).
Here, we sought to define the role of IFN-g signaling and human GBPs in
human inflammasome responses to the vacuolar pathogen L. pneumophila. L.
pneumophila is a gram-negative intracellular bacterial pathogen that infects
alveolar macrophages and is the causative agent of the severe pneumonia known
as Legionnaires’ Disease (Fraser et al., 1977). Upon uptake, L. pneumophila
resides within a L. pneumophila-containing vacuole (LCV) and relies on the
Dot/Icm type IV secretion system (T4SS) to survive within the LCV (Berger &
Isberg, 1993; Berger et al., 1994; Brand et al., 1994; Horwitz, 1983; X. Liu & Shin,
2019; Roy & Isberg, 1997). The T4SS injects over 300 effector proteins, many of
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which enable L. pneumophila to evade the endolysosomal pathway and modify its
LCV into an ER-derived replicative compartment (Ensminger & Isberg, 2009;
Hubber & Roy, 2010; Isaac & Isberg, 2014; Ninio & Roy, 2007; Roy, 2002; Vogel
& Isberg, 1999). Despite being essential for L. pneumophila virulence, T4SS
activity triggers robust canonical and noncanonical inflammasome activation in
human macrophages (Casson et al., 2015). The role of IFN signaling and GBPs in
promoting human inflammasome responses to L. pneumophila is unknown. A
recent study found that human GBP1 directly binds to L. pneumophila as well as
other gram-negative bacterial pathogens (Kutsch et al., 2020); however, this study
did not clarify whether GBP1 binds to the LCV or outer membrane.
In this study, we found that IFN-g promotes inflammasome responses to L.
pneumophila in a T4SS-dependent manner in both immortalized and primary
human macrophages. We further determined that human GBP1 was essential for
maximal inflammasome activation and that IFN-g-primed macrophages had a
significant increase in GBP1 and GBP2 localization to the LCV and/or outer
membrane of L. pneumophila compared to unprimed macrophages. GBP1 and
GBP2 were recruited to L. pneumophila’s vacuole and/or outer membrane in a
T4SS-dependent manner, indicating that human GBPs detect pathogencontaining vacuoles containing virulence-associated bacterial secretion systems.
Additionally, IFN-g treatment led to the increased rupture of LCVs and exposure of
L. pneumophila to the host cell cytosol, in part through a mechanism involving
GBP1. Overall, our findings indicate that IFN-g-dependent human GBP1
responses promote rupture of the LCV, facilitating bacterial detection in the cytosol
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to enhance inflammasome activation. Furthermore, as human GBP1 facilitates
LCV rupture, in contrast to mouse GBPs, which are dispensable for LCV rupture,
our findings suggest that mouse and human GBPs have evolved distinct functions.

2.4. Results
2.4.1. IFN-g promotes inflammasome activation in human macrophages
during L. pneumophila infection.
IFN-g promotes human inflammasome responses to the cytosolic pathogen
F. novicida (Lagrange et al., 2018). However, whether IFN-g upregulates
inflammasome responses to a vacuolar pathogen in human macrophages is poorly
understood; therefore, we sought to test this with L. pneumophila. To determine
whether IFN signaling increases inflammasome activation in response to L.
pneumophila, we primed macrophages with IFN-g prior to infection with L.
pneumophila. L. pneumophila requires a T4SS to translocate bacterial products
into the host cell cytosol; therefore, we also investigated whether IFN-g-mediated
inflammasome responses to L. pneumophila are dependent on its T4SS. Unprimed
or IFN-g-primed phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1
macrophages were infected with a L. pneumophila dotA mutant lacking a functional
T4SS (T4SS-) or a T4SS-sufficient (T4SS+) strain lacking flagellin (DflaA) in order
to focus on NAIP-independent inflammasome responses. Unprimed THP-1 cells
infected with T4SS- Lp or mock infected exhibited little to no cell death, whereas
cells infected with T4SS+ Lp underwent increased cell death and IL-1 family
cytokine release (Fig. 2.1 A and B), consistent with previous findings showing that
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L. pneumophila induces T4SS-dependent inflammasome responses in THP-1
cells (Casson et al., 2015). THP-1 macrophages that were primed with IFN-g and
infected with T4SS+ Lp had a significant increase in cell death compared to
unprimed macrophages (Fig. 2.1 A and 2.2 A). We observed a notable difference
in the amount of cell death for THP-1 cells depending on the assay used.
Specifically, we found that IFN-g-primed THP-1 cells infected with T4SS+ Lp
resulted in around 10% cell death by measurement of LDH at 2 hpi (Fig. 2.1 A),
whereas these same cells led to 75% cell death when measuring propidium iodide
(PI) uptake (Fig. 2.2 A). This difference may be due to the size of the GSDMD
pores in these THP-1 cells, which may be wide enough to allow PI to be easily
released due to its smaller size compared to the LDH molecule. IFN-g-primed
macrophages infected with T4SS+ Lp also had significantly elevated levels of IL1b and IL-18 secretion compared to unprimed macrophages (Fig. 2.1 B).
Interestingly, we noticed significantly increased secretion of IL-1b and IL-18 levels
in T4SS- Lp-infected THP-1 cells primed with IFN-g compared to unprimed cells.
However, unprimed and IFN-g-primed THP-1 cells infected with T4SS- Lp showed
significantly lower levels of cytokine release compared to their T4SS+ Lp infected
counterparts. This indicates that there is a T4SS-dependent cytokine release in
both unprimed and IFN-g-primed THP-1 cells, where the latter shows a more
dominant phenotype. Furthermore, we observed processing of IL-1b into its mature
p17 form in the supernatant of both T4SS- and T4SS+ Lp-infected THP-1 cells
primed with IFN-g (Fig. 2.1 C). These data indicate that IFN-g priming promotes
inflammasome responses to both T4SS- and T4SS+ L. pneumophila in THP-1
54

cells, although maximal inflammasome activation occurs in primed cells infected
with bacteria that harbor a functional T4SS.
We next asked whether IFN-g also enhances inflammasome responses to
L. pneumophila in primary human monocyte-derived macrophages (hMDMs)
derived from healthy human donors. IFN-g-primed hMDMs infected with T4SS+ Lp
also exhibited significantly increased levels of cell death (Fig. 2.1 D), as well as IL1b and IL-18 release (Fig. 2.1 E), compared to unprimed or IFN-g-primed hMDMs
that were uninfected or infected with T4SS- Lp. Overall, our data indicate that IFNg promotes inflammasome responses and IL-1 family cytokine release in response
to L. pneumophila infection in both PMA-differentiated THP-1 cells and primary
hMDMs.
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Figure 2.1. IFN-g promotes inflammasome activation in response to L.
pneumophila in human macrophages. Phorbol 12-myristate 13-acetate (PMA)differentiated THP-1 cells (A, B, C) or primary human monocyte-derived
macrophages (hMDMs) (D, E, F) were either left unprimed or primed with IFN-g
(100 U/ml) overnight and infected with T4SS- Lp, T4SS+ Lp, or mock-infected with
PBS for two or four hours, respectively. (A and D) Cell death was measured using
56

lactate dehydrogenase release assay and normalized to mock-infected cells. (B
and E) IL-1b and IL-18 levels in the supernatant were measured by ELISA. (C, F)
Immunoblot analysis was conducted on supernatants (sup) and lysates from THP1 cells (C) or hMDMs (F) for full-length IL-1b (pro-IL-1b), cleaved IL-1b (mature IL1b), full length caspase-1 (pro-casp1), cleaved casp1 (casp1 p20), pro-casp4,
cleaved caspase-4 (casp4 p32), pro-casp5, casp5 p35, full-length Gasdermin-D
(GSDMD), intermediate and cleaved GSDMD (GSDMD int. and GSDMD p30), and
b-actin. Western blots are representative of three independent experiments. (A and
B) Shown are the results representative of three independent experiments. *P<
0.05, **P< 0.01, and ***P< 0.001 by unpaired t-test. (D and E) Shown are the
pooled results of six independent experiments using hMDMs from different healthy
human donors. Each data point represents the mean of triplicate infected wells
from an individual donor. *P< 0.05, **P<0.01, and ***P< 0.001 by paired t-test.
2.4.2.

Caspase-1,

caspase-8,

and

additional

caspases

promote

inflammasome activation in response to L. pneumophila.
We next investigated which caspases are involved in promoting
inflammasome activation in response to L. pneumophila following IFN-g priming.
L. pneumophila activates the human noncanonical caspase-4 inflammasome in
macrophages that were not initially primed (Casson et al., 2015), but whether IFNg priming affects canonical or noncanonical inflammasome activation in L.
pneumophila-infected human macrophages has not been studied. We observed
caspase-1 processing into its mature p20 form in T4SS+ Lp-infected hMDMs
primed with IFN-g (Fig. 2.1 F). Both caspase-4 and caspase-5 were upregulated at
the RNA and protein level following IFN-g priming of THP-1 cells and hMDMs (Fig.
2.1 F and 2.2 B-D). Additionally, we observed release of full-length and processed
forms of caspase-4 and caspase-5, as well as GSDMD processing and release,
into the supernatants of IFN-g-primed hMDMs infected with T4SS+ Lp (Fig. 2.1 F).
Intriguingly, we noticed that the lysates of unprimed primary hMDMs either mock57

infected or infected with T4SS- Lp showed caspase-5 expression, suggesting that
it may be constitutively expressed in these cells (Fig. 2.1 F). Additionally, IFN-g
treatment resulted in the generation of processed caspase-5 p35 subunit in
primary hMDMs and THP-1 cells and indicates that caspase-5 is undergoing
autoprocessing in the presence or absence of infection. The upregulation of
caspase-4 and caspase-5 by IFN-g treatment in THP-1 cells and primary hMDMs
as well as the released processed forms of these caspases in the supernatant of
IFN-g-primed hMDMs may account for the observed increase in cell death and
cytokine release during L. pneumophila infection. Together, these data
demonstrate that caspase-1, -4, and -5 are processed into their mature forms upon
IFN-g priming and infection with T4SS+ Lp (Fig. 2.1 F).
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Figure 2.2. IFN-g promotes inflammasome activation in response to L.
pneumophila in human macrophages and upregulates caspase-4 and
caspase-5. (A) PI uptake time course of PMA-differentiated THP-1 cells that were
either left unprimed or primed with IFN-g (100 U/ml) for 24 h and infected with
T4SS+ Lp MOI=50. Data are representative of three independent experiments with
each data point representing the mean of triplicate infected wells. *P< 0.05, **P<
0.01, ***P< 0.001 by unpaired t-test. PMA-differentiated THP-1 cells (B) or primary
hMDMs (D) were either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20
hours, respectively. Transcript levels of caspase-4 (CASP4) and caspase-5
(CASP5) were determined by quantitative RT-PCR. Fold change was calculated
by normalizing to the housekeeping gene HPRT for each sample and then to the
unprimed sample. Relative expression of each gene was calculated by normalizing
to the housekeeping gene HPRT. Shown are pooled results of three independent
experiments (B) or six independent experiments using hMDMs from different
healthy human donors (D), with each data point representing the value for each
experiment (B) or an individual donor (D). *P< 0.05, **P< 0.01, and ****P< 0.0001
by paired t-test. (C) PMA-differentiated THP-1 cells were either left unprimed or
primed with IFN-g (100 U/ml) overnight and infected with T4SS- Lp, T4SS+ Lp, or
mock-infected with PBS for two hours. Immunoblot analysis was performed on
p=0.0480
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p=0.0042

PMA-differentiated THP-1 lysates for full-length caspase-4 (pro-casp4), full-length
caspase-5 (pro-casp5), caspase-5 intermediates (casp5 p44 and casp5 p35), and
b-actin (same b-actin blot as shown in Fig. 2.1C since from same experiment).
Western blots are representative of three independent experiments.
We next tested whether caspase activity is required for inflammasome
responses to L. pneumophila in the presence or absence of IFN-g. Our previous
data indicated that caspase-1 is cleaved and activated upon IFN-g priming and
infection with T4SS+ Lp (Fig. 2.1 F). Therefore, we wanted to confirm that caspase1 is involved in inflammasome responses to L. pneumophila through inhibitor
treatment. Additionally, recent studies have found novel functions of caspase-8
being implicated in inflammasome responses to a variety of bacteria
(Antonopoulos et al., 2015; Man et al., 2014; Man et al., 2013; Sarhan et al., 2018);
thus, we wanted to determine whether caspase-8 is also promoting inflammasome
responses to L. pneumophila. Cell death was significantly decreased in either
unprimed or IFN-g-primed hMDMs that were treated with the pan-caspase inhibitor
ZVAD prior to infection with T4SS+ Lp, compared to the levels of cell death
observed in vehicle control-treated cells (Fig. 2.3 A). Intriguingly, we observed
higher cell death in unprimed and IFN-g-primed hMDMs that were treated with
DMSO and infected with T4SS+ Lp compared to the unprimed and IFN-g-primed
hMDMs that were only infected with T4SS+ Lp in Fig. 2.1 D. This may suggest that
DMSO propagates cell death in the presence of T4SS+ Lp through additional
activation of cell stress pathways or inflammasomes, such as the NLRP3
inflammasome. IL-1b and IL-18 secretion was also significantly decreased in IFNg-primed hMDMs treated with ZVAD, compared to DMSO-treated hMDMs (Fig. 2.3
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B and C). In addition, IL-18 secretion was significantly decreased in unprimed
hMDMs treated with ZVAD. Importantly, treatment with the caspase-1-specific
inhibitor YVAD or the caspase-8-specific inhibitor IETD significantly reduced cell
death and IL-1b and IL-18 secretion in IFN-g-primed hMDMs, compared to DMSOtreated hMDMs. Similar to ZVAD treated cells, YVAD and IETD also significantly
reduced cell death and IL-18 release in unprimed hMDMs. Interestingly, we
observed lower amounts of cell death and IL-1 family cytokine release in hMDMs
treated with the broader-spectrum inhibitor ZVAD compared to treatment with the
caspase-1 or caspase-8 selective inhibitors. These data indicate that caspase-1,
caspase-8,

and

likely

additional

caspases

are

involved

in

promoting

inflammasome responses to L. pneumophila. Furthermore, we noticed that
unprimed and IFN-g-primed hMDMs infected with T4SS+ Lp had comparable
levels of IL-1b, which may be due to donor variability as well as to the low levels
of IL-1b production from lack of TLR priming. As both caspase-4 and caspase-5
are processed in IFN-g-primed T4SS+ Lp-infected hMDMs (Fig. 2.1 F), these
noncanonical inflammatory caspases may play a role together with caspase-1 and
caspase-8 to promote IFN-g-mediated inflammasome responses.
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Figure 2.3. Caspase-1, caspase-8, and additional caspases promote
inflammasome activation in response to L. pneumophila. (A, B, C) Primary
hMDMs were left unprimed or primed with IFN-g (100 U/mL) overnight and treated
with the inhibitors ZVAD, YVAD, IETD, MCC950, or DMSO control for one hour
followed by infection with T4SS+ Lp for four hours. (A) Cell death was measured
using lactate dehydrogenase release assay and normalized to mock-infected cells.
(B and C) IL-1b and IL-18 levels in the supernatant were measured by ELISA.
Shown are the pooled results of four to six independent experiments using hMDMs
from different healthy human donors. Each data point represents the mean of
triplicate infected wells from an individual donor. *P< 0.05, **P< 0.01, and ***P<
0.001 by paired t-test.
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We also wanted to determine whether the NLRP3 inflammasome plays a
role in response to L. pneumophila during IFN-g treatment, since it has been shown
that the NLRP3 inflammasome can be activated downstream of caspase-11 during
L. pneumophila infection (Case et al., 2013; Casson et al., 2013). While the NLRP3
inhibitor MCC950 did suppress inflammasome responses upon LPS and nigericin
treatment, the inhibitor had no effect on cell death or IL-1b and IL-18 levels in both
unprimed and IFN-g-primed hMDMs infected with L. pneumophila (Fig. 2.4). In
addition, ZVAD, YVAD, and IETD treatments significantly decreased IL-18 levels
in hMDMs treated with LPS and nigericin. These results suggest that the NLRP3
inflammasome does not play a role in response to L. pneumophila in the context
of IFN-g priming. However, it is still possible that the NLRP3 inflammasome
contributes to controlling L. pneumophila infection in human macrophages at a
later timepoint, since we only looked four hours after infection. Collectively, our
data show that caspase-1, caspase-8, and likely caspase-4 and caspase-5
participate in inflammasome responses to L. pneumophila infection in IFN-gprimed hMDMs.
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Figure 2.4. NLRP3 inflammasome activation is inhibited by MCC950, YVAD,
ZVAD, and IETD. (A) Primary hMDMs were primed with E. coli LPS (0.5 µg/mL)
for four hours and treated with nigericin (10 µM) for four hours. Inhibitors were
added one hour before addition of nigericin. IL-1b and IL-18 levels in the
supernatant were measured by ELISA. Shown are the results representative of
three independent experiments. *P< 0.05, ***P< 0.001, ****P< 0.0001 by unpaired
t-test.

2.4.3. IFN-g upregulates human GBPs.
IFN-g induces expression of a large number of genes that contribute to
antimicrobial defense. In mice, two IFN-inducible gene families that promote
inflammasome activation in macrophages are the GBPs and IRGs. Their assigned
functions include binding and rupturing the phagosome of vacuolar pathogens, as
well as directly lysing bacteria that escape the phagosome and enter the cytosol
(B. C. Liu et al., 2018; Man et al., 2016; Meunier et al., 2014; Meunier et al., 2015).
These activities lead to release of pathogen-derived products such as
lipopolysaccharide (LPS) and DNA into the cytosol, resulting in downstream
inflammasome activation. Mice have 11 GBPs and 23 IRGs, whereas humans
have seven GBPs and two IRG genes (Bekpen et al., 2005). Human GBPs, like
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their murine counterparts, are IFN-inducible, whereas human IRGs are not induced
by IFN stimulation (Bekpen et al., 2005; Lagrange et al., 2018; Qin et al., 2017).
Thus, we chose to test whether human GBPs might play a role in the
enhanced inflammasome responses of IFN-g-primed cells to L. pneumophila. We
first asked whether GBP expression is upregulated by IFN-g in THP-1-derived
macrophages and hMDMs. In THP-1 cells, we found that expression of all GBPs
was induced in response to IFN-g, and GBP1-5 mRNA levels were significantly
upregulated in hMDMs following IFN-g treatment (Fig. 2.5 A and B). Following IFNg-priming, we observed high relative expression of GBP1, GBP2, GBP3, GBP4,
and GBP5, whereas there was very low relative expression of GBP6 and GBP7 in
THP-1 cells (Fig. 2.6 A) and hMDMs (Fig. 2.6 B), in agreement with previous
findings (Lagrange et al., 2018). Furthermore, priming hMDMs with increasing
amounts of IFN-g led to a dose-dependent increase in GBP mRNA levels (Fig. 2.5
C and 2.6 C). Protein levels of GBP1, GBP2, GBP4, and GBP5 were also
increased in a dose-dependent manner in response to IFN-g (Fig. 2.5 D). Thus,
human GBPs are transcriptionally and translationally induced by IFN-g in
macrophages, in agreement with previous findings (Lagrange et al., 2018; Qin et
al., 2017).
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Figure 2.5. Human GBPs are transcriptionally and translationally
upregulated in response to IFN-g. PMA-differentiated THP-1 cells (A) or primary
hMDMs (B) were either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20
hours, respectively. (C and D) hMDMs were left unprimed or primed with IFN-g at
the indicated concentrations for 20 hours. (A, B, C) Transcript levels of GBP1-7
were determined by quantitative RT-PCR and fold change was calculated by
normalizing to the housekeeping gene HPRT for each sample and then to the
unprimed sample. Shown are the pooled results of three independent experiments
(A) or six independent experiments using hMDMs different healthy human donors
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(B), with each data point representing the value for each experiment (A) or an
individual donor (B). *P< 0.05, **P< 0.01, and ***P< 0.001 by paired t-test. (C)
Shown are the pooled results of four independent experiments using hMDMs from
different healthy human donors and each data point represents the value of an
individual donor. (D) Immunoblot analysis was conducted on lysates for GBP1,
GBP2, GBP4, GBP5, and b-actin. Western blot is representative of four
independent experiments using hMDMs from different healthy human donors.
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Figure 2.6. Human GBPs are transcriptionally upregulated by IFN-g in
macrophages. PMA-differentiated THP-1 cells (A) or primary hMDMs (B) were
either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20 hours,
respectively. (C) hMDMs were left unprimed or primed with IFN-g at the indicated
concentrations for 20 hours. (A, B, C) Transcript levels of GBP1-7 were determined
by quantitative RT-PCR and relative expression of each gene was calculated by
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normalizing to the housekeeping gene HPRT. Shown are the pooled results of
three independent experiments (A) or six independent experiments using hMDMs
from different healthy human donors (B), with each data point representing the
value for each experiment (A) or an individual donor (B). *P< 0.05 and **P< 0.01
by paired t-test. (C) Shown are the pooled results of four independent experiments
using hMDMs from different healthy human donors and each data point represents
the value of an individual donor.
2.4.4. Human GBP1 contributes to maximal IFN-g-dependent inflammasome
responses to L. pneumophila.
Since GBP1-5 were significantly upregulated in hMDMs, we next wanted to
test whether these GBPs play a role in human inflammasome responses to L.
pneumophila. We therefore individually silenced expression of GBP1-5 prior to
IFN-g treatment and T4SS+ Lp infection in hMDMs. Notably, specific knockdown
of GBP1 significantly decreased cell death and IL-1b and IL-18 secretion following
L. pneumophila infection in IFN-g-primed hMDMs, indicating that GBP1 plays a
non-redundant role in inflammasome responses against L. pneumophila infection
(Fig. 2.7 A and B). Importantly, we do not observe complete decrease of cell death
and cytokine release upon knockdown of human GBP1. This indicates that human
GBP1 plays a partial role in promoting inflammasome responses during L.
pneumophila infection, possibly through rupture of the LCV or bacteriolysis of the
outer membrane in order for release of L. pneumophila components into the
cytosol for inflammasome sensing. Additionally, we notice that the cell death is
around 20% upon GBP1 knockdown of IFN-g-primed hMDMs (Fig. 2.7 A), which is
comparable to the amount of cell death we observe in unprimed hMDMs (Fig. 2.1
D). Thus, the remaining cell death observed is most likely due to inflammasome
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activation by secreted T4SS effector molecules as well as cell stress signals that
are typically activated upon detection of L. pneumophila. GBP3 knockdown
resulted in significantly decreased IL-1b release but did not affect cell death or IL18 release. In contrast, knockdown with siRNAs against GBP2, 4, and 5 did not
decrease cell death or cytokine secretion. Furthermore, we examined the
knockdown efficiencies for hMDMs treated with siRNA for each GBP and found
that siRNA knockdown was specific for each GBP and did not affect the expression
levels of the remaining GBPs (Fig. 2.7 C). Collectively, these data indicate that
human GBP1 is important for promoting maximal cell death and IL-1 family
cytokine release.
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Figure 2.7. GBP1 is required for maximal inflammasome activation. Primary
hMDMs were transfected with 30 nM siRNA specific for individual GBP or
scrambled control siRNA (siControl), primed with IFN-g (100 U/mL) overnight, and
infected with T4SS+ Lp for four hours. (A) Cell death was measured using lactate
dehydrogenase release assay and normalized to mock infected cells. (B) IL-1b and
IL-18 levels in the supernatant were measured by ELISA. (C) Transcript levels of
GBP1-5 in ‘mock’ samples were determined by quantitative RT-PCR and fold
change was calculated by normalizing to the housekeeping gene HPRT for each
sample and then to the siControl sample. (A, B, C) Shown are the pooled results
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of three independent experiments using hMDMs from different healthy human
donors. (A and B) Each data point represents the mean of triplicate infected wells
from an individual donor. *P< 0.05, **P< 0.01, and ***P< 0.001 by paired t-test. (C)
Each data point represents the value of an individual donor.
2.4.5. IFN-g promotes GBP localization to L. pneumophila in a T4SSdependent manner.
Since our data indicated that human GBP1 is required for maximal
inflammasome activation during infection with L. pneumophila, we next wanted to
elucidate how GBP1 could be promoting this response. Mouse Gbp2 colocalizes
with S. Typhimurium and promotes the rupture of the Salmonella-containing
vacuole (SCV), while its predicted human ortholog, GBP1, was recently shown to
target and bind the outer membrane of S. Typhimurium to form a GBP complex
and disrupt the membrane integrity for recruitment and activation of caspase-4
(Fisch et al., 2019; Fisch et al., 2020; Kutsch et al., 2020; Meunier et al., 2014;
Santos et al., 2020; Wandel et al., 2020). In addition, recent findings showed that
human GBP1 directly binds to gram-negative bacteria including L. pneumophila,
although they did not determine whether GBP1 binds to the LCV or outer
membrane (Kutsch et al., 2020). We hypothesized that human GBP1 might play a
similar role as mouse Gbp2 during S. Typhimurium infection and would be
predicted to colocalize with the LCV for vacuolar rupture in IFN-g-primed
macrophages. To test this hypothesis, we infected IFN-g-primed and unprimed
hMDMs with dsRED-expressing T4SS+ Lp and stained for GBP1. While there was
little to no GBP1 expression or colocalization with L. pneumophila in unprimed
cells, there was a significant increase in the percentage of infected cells containing
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GBP1-positive L. pneumophila following IFN-g priming (Fig. 2.8 A and B).
Approximately 60% of infected cells contained L. pneumophila that colocalized
with GBP1. In contrast, GBP1 was distributed throughout the cytoplasm in
uninfected IFN-g-primed hMDMs (Fig. 2.9 A). The secondary antibodies used for
anti-GBP1 staining did not associate with L. pneumophila when used alone and
only stained cells when primary anti-GBP1 antibodies were used (Fig. 2.9 B).
These data indicate that GBP1 is recruited to L. pneumophila and/or the LCV within
IFN-g-primed hMDMs.
While it is unclear whether GBP1 binds to the LCV or the bacterial outer
membrane, human GBP1 colocalizes with the outer membrane of the cytosolic
bacterium, S. flexneri, and additional GBPs are also recruited to inhibit its actin
motility (Piro et al., 2017; Wandel et al., 2017). Thus, we tested whether GBP2
also localized to L. pneumophila. We also observed a significantly increased
percentage of hMDMs harboring GBP2+ L. pneumophila following IFN-g priming
compared to unprimed cells (Fig. 2.8 C and D), although to a lower extent
compared to GBP1+ L. pneumophila. Furthermore, secondary antibodies used for
anti-GBP2 staining did not stain when used alone and only colocalized with L.
pneumophila when primary anti-GBP2 antibodies were used (Fig. 2.9 C).
Collectively, these findings show that both GBP1 and GBP2 are recruited to L.
pneumophila and/or the LCV in IFN-g-primed hMDMs.
In mouse macrophages, colocalization of GBPs with L. pneumophila is
dependent

on

the

T4SS,

while

GBP

colocalization

with

Yersinia

pseudotuberculosis requires the presence of type III secretion system translocon
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components (E. M. Feeley et al., 2017; Zwack et al., 2017). These findings indicate
that murine GBPs respond to secretion systems that are key signatures of bacterial
virulence. It is also possible that GBPs associate with the virulence factors
secreted by these pathogens to aid in the process of PCV rupture and bacterial
access to the cytosol. However, whether human GBPs also detect PCVs that
contain bacteria expressing virulence-associated secretion systems is unclear.
Notably, only T4SS+ Lp, but not T4SS- Lp, exhibited robust colocalization with
GBP1 and GBP2 in IFN-g-primed hMDMs (Fig. 2.8 E-H). Collectively, these data
suggest that GBP1 and GBP2 are upregulated in response to IFN-g priming and
following infection, are recruited to L. pneumophila in a T4SS-dependent manner.
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Figure 2.8. IFN-g promotes the colocalization of GBP1 and GBP2
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pneumophila in a T4SS-dependent manner. (A-D) Primary hMDMs were either
left unprimed or primed with IFN-g (100 U/mL) overnight and infected with dsRED-
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expressing T4SS+ Lp for two hours. Representative fluorescence micrographs of
anti-GBP1 (A) or anti-GBP2 (C) antibody staining in dsRED-T4SS+ Lp-infected
hMDMs and quantification of the percentage of hMDMs containing GBP1+ Lp (B)
or GBP2+ Lp (D) out of total infected hMDMs. Graphs show the mean and s.d. of
technical triplicates and data are representative of three independent experiments
using hMDMs from different healthy human donors. **P< 0.01 by unpaired t-test.
(E-H) Primary hMDMs were primed with IFN-g (100 U/mL) overnight and infected
with dsRED-expressing T4SS- Lp or T4SS+ Lp for two hours. Representative
fluorescence micrographs of anti-GBP1 (E) or anti-GBP2 (G) antibody staining in
dsRED-T4SS- or dsRED-T4SS+ Lp-infected hMDMs and quantification of the
percentage of hMDMs containing GBP1+ Lp (F) or GBP2+ Lp (H) out of total
infected hMDMs. Graphs show the mean and s.d. of technical triplicates and data
are representative of two independent experiments using hMDMs from different
healthy human donors. *P< 0.05 and ****P<0.0001 by unpaired t-test.
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Figure 2.9. GBP1 is distributed throughout the cytoplasm in uninfected
hMDMs. Primary hMDMs were either left unprimed or primed with IFN-g (100
U/mL) overnight and infected with dsRED-expressing T4SS+ Lp or left uninfected
for two hours. (A) Representative fluorescence micrographs of anti-GBP1 staining
in uninfected hMDMs. (B and C) Representative fluorescence micrographs of
dsRED-T4SS+ Lp-infected hMDMs stained with only secondary-antibody antirabbit (B) or anti-mouse (C) Alexa Fluor 488. (A, B, C) Images are representative
of three independent experiments using hMDMs from different healthy human
donors.
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2.4.6. IFN-g and GBP1 promote the rupture of LCVs.
We next wanted to determine how IFN-g and GBP1 promote increased
inflammasome activation during L. pneumophila infection. We first tested whether
IFN-g treatment results in an increase of ruptured LCVs, which would allow L.
pneumophila to become more accessible for recognition by cytosolic
inflammasome sensors. We utilized a differential permeabilization assay to
distinguish between vacuolar and cytosolic L. pneumophila in the presence and
absence of IFN-g priming (Meunier & Broz, 2015). We compared unprimed and
IFN-g-primed hMDMs that were infected with dsRED-expressing T4SS+ Lp and
then treated with the detergent digitonin, which selectively permeabilizes the
plasma membrane while leaving intracellular membranes intact. The cells were
then immunostained with an antibody for L. pneumophila, followed by staining with
an Alexa 488-labeled secondary antibody that fluoresces green. Thus, dsREDexpressing L. pneumophila contained within an intact vacuole only fluoresce red,
while dsRED-expressing L. pneumophila within a ruptured vacuole will fluoresce
both green and red (Fig. 2.10 A). We found that a significantly increased
percentage of hMDMs primed with IFN-g contained L. pneumophila that stained
with anti-L. pneumophila antibody and fluoresced green compared to unprimed
cells (Fig. 2.10 B and C). We observed around 25% of unprimed hMDMs contained
cytosolic L. pneumophila, which may be due to additional IFN-independent host
factors that contribute to the targeting and destabilization of the LCV. Treatment
with the detergent saponin, which permeabilizes all cell membranes, resulted in
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similar percentages of unprimed and IFN-g-primed hMDMs containing bacteria that
were stained by anti-L. pneumophila antibody (Fig. 2.11 A and B). The secondary
antibody stained only in the presence of anti-L. pneumophila antibody (Fig. 2.11
C), indicating that the secondary antibody does not bind to L. pneumophila directly.
These results indicate that IFN-inducible host factors promote rupture of the LCV,
resulting in increased L. pneumophila exposure to the host cell cytosol.
Since GBP1 colocalizes with L. pneumophila (Fig. 2.8 A and B) and GBP1
is important for maximal inflammasome responses to L. pneumophila in IFN-gprimed hMDMs (Fig. 2.7), we hypothesized that GBP1 might contribute to the
disruption of LCV integrity. Therefore, we conducted the phagosome integrity
assay in GBP1-silenced IFN-g-primed hMDMs. We confirmed efficient and specific
GBP1 knockdown at the mRNA and protein levels compared to control siRNA
treatment (Fig. 2.10 D and E). Additionally, a significantly lower percentage of
infected hMDMs treated with GBP1 siRNA contained GBP1+ L. pneumophila
compared to control siRNA-treated hMDMs (Fig. 2.11 D and E). Interestingly, a
significantly decreased percentage of GBP1 siRNA-treated hMDMs contained
bacteria that were stained by anti-L. pneumophila antibody following digitonin
permeabilization compared to hMDMs treated with control siRNA (Fig. 2.10 F and
G), indicating that there is a significant decrease in the percentage of cells
containing ruptured LCVs following GBP1 knockdown. In contrast, following
saponin permeabilization of all cellular membranes, a similar percentage of
hMDMs contained bacteria that stained positive for anti-L. pneumophila antibody
following control or GBP1 siRNA treatment (Fig. 2.11 G and H), whereas staining
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with secondary antibody alone revealed negligible background staining (Fig. 2.11
F and I). Collectively, these findings indicate that GBP1 plays a key role in IFN-gdependent disruption of the LCV in primary human macrophages, thus allowing for
increased access of L. pneumophila to the host cell cytosol.
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Figure 2.10. IFN-g and GBP1 promote the rupture of LCVs in hMDMs. (A)
Schematic of vacuolar Lp, which fluoresces red, and cytosolic Lp, which is stained
green and fluoresces red. (B and C) Primary hMDMs were either left unprimed or
primed with IFN-g (100 U/mL) overnight and infected with dsRED-expressing
T4SS+ Lp for two hours. (B) Representative fluorescence micrographs of anti-Lp
antibody staining followed by Alexa 488-conjugated secondary antibody staining
in digitonin-permeabilized dsRED-T4SS+ Lp-infected hMDMs. (C) Quantification
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of the percentage of hMDMs harboring cytosolic Lp out of total infected hMDMs.
(D-G) Primary hMDMs were transfected with 5 pmol siRNA specific for GBP1
(siGBP1) or scrambled control siRNA (siControl) for at least 48 h, primed with IFNg (100 U/mL) overnight, and infected with dsRED-expressing T4SS+ Lp for two
hours. (D) GBP1 transcript levels in ‘mock’ samples were determined by
quantitative RT-PCR. Fold change was calculated by normalizing to the
housekeeping gene HPRT and then to the siControl sample. (E) Immunoblot
analysis was conducted on ‘mock’ lysates for GBP1, GBP2, and b-actin. (F)
Representative fluorescence micrographs of anti-Lp antibody staining followed by
Alexa 488-conjugated secondary antibody staining in digitonin-permeabilized
dsRED-T4SS+ Lp-infected hMDMs. (G) Quantification of the percentage of
hMDMs harboring cytosolic Lp out of total infected hMDMs. Graphs show the mean
and s.d. of technical triplicates and data are representative of three independent
experiments using hMDMs from different healthy human donors. *P<0.05 and **P<
0.01 by unpaired t-test. (D and E) Data are representative of three independent
experiments using hMDMs from different healthy human donors.
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immunostaining assay. (A-C) Primary hMDMs were either left unprimed or
primed with IFN-g (100 U/mL) overnight and infected with dsRED-expressing
T4SS+ Lp for two hours. (A) Representative fluorescence micrographs of anti-Lp
primary antibody and Alexa Fluor 488-conjugated anti-rabbit secondary antibody
staining in saponin-permeabilized unprimed and IFN-g-primed dsRED-T4SS+ Lpinfected hMDMs and (B) quantification of the percentage of anti-Lp antibody (Ab)
positive hMDMs out of total infected hMDMs. (C) Representative fluorescence
micrographs of unprimed and IFN-g-primed dsRED-T4SS+ Lp-infected hMDMs
stained with only secondary-antibody anti-rabbit Alexa Fluor 488 as a control for
digitonin phagosome integrity assay. (D-I) Primary hMDMs were transfected with
5 pmol siRNA specific for GBP1 (siGBP1) or scrambled control siRNA (siControl)
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for at least 48 h, primed with IFN-g (100 U/mL) overnight, and infected with dsREDexpressing T4SS+ Lp for two hours. (D) Representative fluorescence micrographs
of anti-GBP1 antibody staining in dsRED-T4SS+ Lp-infected hMDMs. (E)
Quantification of the percentage of hMDMs containing GBP1+ Lp out of total
infected hMDMs. (F) Representative fluorescence micrographs of IFN-g-primed
siControl and siGBP1 dsRED-T4SS+ Lp-infected hMDMs stained with only Alexa
Fluor 488-conjugated anti-rabbit secondary antibody as a control for GBP1
immunostaining assay. (G) Representative fluorescence micrographs of anti-Lp
primary antibody and Alexa Fluor 488-conjugated anti-rabbit secondary antibody
staining in saponin-permeabilized IFN-g-primed siControl and siGBP1 dsREDT4SS+ Lp-infected hMDMs and (H) quantification of the percentage of anti-Lp Ab
positive hMDMs out of total infected hMDMs. (I) Representative fluorescence
micrographs of IFN-g-primed siControl and siGBP1 dsRED-T4SS+ Lp-infected
hMDMs stained with only Alexa Fluor 488-conjugated anti-rabbit secondary
antibody as a control for digitonin phagosome integrity assay. (A-I) Data and
images are representative of three independent experiments using hMDMs from
different healthy human donors. ****P<0.0001 by unpaired t-test.

2.5. Discussion
Our data reveal that human GBP1 is crucial for robust inflammasome
activation in response to L. pneumophila infection in IFN-g-primed primary human
macrophages. These findings are the first to report the role of human GBPs in
inflammasome activation in response to L. pneumophila infection. We show that
IFN-g leads to enhanced cell death and proinflammatory cytokine release during
L. pneumophila infection and that this inflammasome response involves caspase1, capsase-4, caspase-5, and GSDMD processing. Although we conclude that
IFN-g-primed cells lead to a T4SS-dependent inflammasome response to L.
pneumophila, we did observe a small but significant amount of cytokine release in
IFN-g-primed THP-1 cells that were infected with T4SS- Lp compared to unprimed
cells. However, IFN-g-primed THP-1 cells infected with T4SS- Lp showed
significantly decreased cell death and cytokine release compared to cells infected
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with T4SS+ Lp, indicating that there is a T4SS-dependent inflammasome
response. The reason for release of cytokines upon infection with T4SS- Lp may
be due to an alternative IFN-dependent innate immune pathway that is
independent of GBPs, since we did not observe GBP localization to T4SS- Lp, and
would be of interest to investigate in the future. We also find that GBP1 colocalizes
with L. pneumophila in a T4SS-dependent manner and promotes increased access
of L. pneumophila to the host cell cytosol, indicating that GBP1 facilitates disruption
of the LCV. Our findings suggest a model in which human GBP1 promotes the
liberation of L. pneumophila components into the host cell cytosol to allow for
increased inflammasome sensing and activation. Intriguingly, murine GBPs do not
disrupt the LCV, but rather promote outer membrane disruption of cytosolic L.
pneumophila (B. C. Liu et al., 2018). Together, these findings suggest that human
and murine GBPs play distinct roles in mediating inflammasome responses against
L. pneumophila.
Although mice encode 11 GBPs and humans encode seven GBPs, there
are some GBPs shared between mice and humans, with mouse Gbp2 and Gbp5
thought to be the orthologs of human GBP1 and GBP5, respectively (Olszewski et
al., 2006). These murine orthologs may provide insight into the functions of human
GBPs, since most experimental studies aimed at elucidating GBP functions have
been conducted in mice. Mouse GBPs colocalize with pathogens that harbor
bacterial secretion systems or bacterial translocon components (E. M. Feeley et
al., 2017; Zwack et al., 2017). Mouse Gbp2 promotes lysis of the SCV and
activation of the noncanonical inflammasome, while its ortholog human GBP1
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colocalizes with S. Typhimurium and promotes caspase-4-mediated pyroptosis
(Fisch et al., 2019; Meunier et al., 2014). Mouse GBPs do not mediate vacuole
disruption for other bacterial pathogens, but instead facilitate lysis of cytosolic
bacteria (B. C. Liu et al., 2018; Meunier et al., 2014; Meunier et al., 2015). Whether
human GBP1 is recruited to pathogen-containing vacuoles and whether it
promotes lysis of pathogen-containing vacuoles or bacteria was unknown.
Importantly, our findings reveal that GBP1 targets the LCV in a T4SS-dependent
manner and furthermore, that GBP1 promotes vacuolar disruption and increased
exposure of L. pneumophila to the host cell cytosol. Thus, human and mouse
orthologs may have both distinct and overlapping functions. Additional studies will
further elucidate the roles of human GBPs in response to other bacterial infections.
Our data show that human GBP1 and GBP2 colocalize with L. pneumophila
in a T4SS-dependent manner, but whether and how these GBPs are recruited and
bound to the LCV and/or bacterial outer membrane still remains to be determined.
Mouse Gbp2 colocalizes with bacterial pathogens containing bacterial secretion
systems in a galectin-3-dependent manner (E. M. Feeley et al., 2017). Whether
galectins facilitate human GBP1 recruitment to pathogen-containing vacuoles is
unknown. Furthermore, human and mouse GBP1, GBP2, and GBP5 have a Cterminal CaaX prenylation motif that facilitates membrane binding and
oligomerization with other GBPs (Vestal & Jeyaratnam, 2011). Human GBP1
colocalizes to the outer membrane of S. flexneri and colocalizes with S.
Typhimurium in a manner dependent on its isoprenylation and GTPase activity
(Fisch et al., 2019; Piro et al., 2017; Wandel et al., 2017). In addition, human GBP1
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colocalizes with a S. flexneri mutant lacking the O-antigen less frequently than with
the wild-type strain, indicating that host recognition of O-antigen enables GBP1
targeting to S. flexneri (Piro et al., 2017). It would be of interest to determine
whether the CaaX motif in human GBP1 and GBP2 are necessary for
colocalization with L. pneumophila and what bacterial or vacuolar components they
are binding to. Although we found that GBP2 colocalized with L. pneumophila,
siRNA-mediated silencing of GBP2 did not have an effect on inflammasome
activation. It is possible that GBP2 is not required for inflammasome responses to
L. pneumophila or that siRNA-mediated knockdown in primary hMDMs was not
efficient enough to reveal a role for GBP2. Further studies will discern between
these possibilities. Since we found that GBP1 promotes inflammasome activation,
it would also be of interest to determine whether GBP1 may act as an initiator GBP
that recruits additional GBPs, similar to what has been observed with S. flexneri
(Li et al., 2017; Piro et al., 2017; Wandel et al., 2017), and whether there is a
synergistic role for human GBPs.
Inflammasome activation is triggered in response to sensing of bacterial
products within the cytosol. Vacuolar localization of L. pneumophila within its ERderived vacuole would presumably limit the ability of host cells to recognize L.
pneumophila components. However, when the integrity of the LCV is
compromised, either by host factors or in the case of bacterial mutants that cannot
maintain vacuolar integrity L. pneumophila becomes more accessible for
recognition by host cytosolic sensors (B. C. Liu et al., 2018). We show that IFN-g
priming in primary human macrophages results in an increased frequency of
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ruptured LCVs, indicating that IFN-inducible host cell factors promote disruption of
the LCV. Our data indicate that GBP1 is one such factor. While we cannot formally
conclude that GBP1-mediated rupture of the LCV is the proximal cause of
downstream inflammasome activation, this rupture likely results in increased
exposure of L. pneumophila products to the host cell cytosol, thus making the
bacteria vulnerable to inflammasome sensing. Human GBPs may also target and
promote destabilization of the outer membrane of L. pneumophila to enable the
release of bacterial components, including LPS and DNA, for inflammasome
sensing. Murine GBPs encoded on chromosome 3 promote the disruption of the
outer membrane of the cytosolic L. pneumophila mutant lacking the effector SdhA,
which is important for maintaining the vacuole integrity of the LCV (B. C. Liu et al.,
2018). Mouse macrophages lacking chromosome 3 GBPs that were infected with
the DsdhA mutant showed a decrease in pyroptosis and release of DNA into the
cytosol, indicating that one or more chromosome 3 GBPs contribute to
inflammasome activation in response to cytosolic bacteria. Since mouse GBPs
mediate the disruption of cytosolic L. pneumophila, it is possible that human GBP1
or other GBPs may also enable disruption of the L. pneumophila outer membrane
to release bacterial components that subsequently lead to inflammasome
activation.
Overall, our findings reveal a critical role for IFN-g and human GBP1 in
promoting human inflammasome responses against L. pneumophila. In particular,
our study illuminates a key function for human GBP1 in disrupting the pathogencontaining vacuole. These findings indicate that human GBPs have distinct roles
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compared to mouse GBPs in promoting inflammasome responses to L.
pneumophila and provide insight into human cell-autonomous responses to a
vacuolar bacterial pathogen.
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2.7. Materials and Methods
2.7.1. Primary Human Samples
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All studies on primary human monocyte-derived macrophages (hMDMs)
were performed in compliance with the requirements of the US Department of
Health and Human Services and the principles expressed in the Declaration of
Helsinki. Samples obtained from the University of Pennsylvania Human
Immunology Core are considered to be a secondary use of deidentified human
specimens and are exempt via Title 55 Part 46, Subpart A of 46.101 (b) of the
Code of Federal Regulations.

2.7.2. Cell Culture
THP-1 cells (TIB-202; American Type Culture Collection) were maintained
in RPMI supplemented with 10% (vol/vol) heat-inactivated FBS, 0.05 nM bmercaptoethanol, 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37°C in a
humidified incubator. The day before stimulation, cells were replated in media
without antibiotics in a 48-well plate at a concentration of 2 × 105 cells per well or
in a 96-well plate at a concentration of 1 × 105 cells per well and incubated with
phorbol 12-myristate 13-acetate (PMA) for 24 hours to allow differentiation into
macrophages. Media was replaced with RPMI without serum for infections in 48well plate.
Primary human monocytes from deidentified healthy human donors were
obtained from the University of Pennsylvania Human Immunology Core.
Monocytes were cultured in RPMI supplemented with 10% (vol/vol) heatinactivated FBS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin,
and 50 ng/mL recombinant human M-CSF (Gemini Bio Products). Cells were
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cultured for 4 days in 10 mL of media in 10 cm-dishes at 4-5 × 105 cells/mL,
followed by addition of 10 mL of fresh growth media for an additional 2 days for
complete differentiation into macrophages. The day before macrophage
stimulation, cells were rinsed with cold PBS, gently detached with trypsin-EDTA
(0.05%) and replated in media without antibiotics and with 25 ng/mL M-CSF in a
48-well plate at a concentration of 1 × 105 cells per well or in a 24-well plate at a
concentration of 2 × 105 cells per well.

2.7.3. Macrophage Stimulation
In infection experiments, PMA-differentiated THP-1 cells and primary
human monocyte-derived macrophages (hMDMs) were either left unprimed or
were primed overnight with recombinant human IFN-g (R&D Systems) at a
concentration of 100 U/mL. In dose-response experiments, hMDMs were either left
unprimed or primed with 0.1, 1, 10, or 100 U/mL of IFN-g for 20 hours.

2.7.4. Bacterial Strains and Macrophage Infection
All Legionella pneumophila infections used strains derived from the serogroup 1
clinical isolate Philadelphia-1. Where indicated, strains utilized were derived from
the Lp02 strain (rpsL, hsdR, thyA), which is a thymidine auxotroph. The isogenic
Lp02 (rpsL, hsdR, thyA) flagellin mutant, DflaA (T4SS+ Lp), and avirulent dotA
mutant, Lp03 (T4SS- Lp), which are both thymidine auxotrophs, were used to infect
PMA-differentiated THP-1 cells and primary hMDMs (Berger & Isberg, 1993;
Berger et al., 1994; Ren et al., 2006). DflaA (T4SS+) or DdotA (T4SS-) L.
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pneumophila strains on the JR32 background (rpsL, hsdR) carrying pSW001,
which

allows

for

constitutive

dsRED

expression,

were

used

in

immunofluorescence experiments (Mampel et al., 2006; Marra & Shuman, 1989).
All L. pneumophila strains were grown as a stationary patch for 48 hours on
charcoal yeast extract agar plates at 37°C (J. C. Feeley et al., 1979). Bacteria were
resuspended in PBS and added to the cells at a multiplicity of infection (MOI) of 10
in 48-well and 24-well plate experiments. Infected cells were then centrifuged at
290 × g for 10 min and incubated at 37°C. For immunofluorescence experiments,
primary hMDMs were infected for 2 hours. For infection experiments involving
THP-1-derived macrophages, cells were infected for 2 hours. For additional
infection experiments involving primary hMDMs, cells were infected for 4 hours.
For all experiments, mock-infected cells were treated with PBS.

2.7.5. Inhibitor Treatments
25 µM of caspase-1 inhibitor Ac-YVAD-cmk (Sigma-Aldrich SML0429), 20
µM of caspase-8 inhibitor Z-IETD-FMK (SM Biochemicals SMFMK004), 20 µM of
pan-caspase inhibitor Z-VAD(Gomes et al.)-FMK (SM Biochemicals SMFMK001),
and 1 µM of NLRP3 inhibitor MCC950 (Sigma-Aldrich PZ0280) were added to
primary hMDMs 1 hour before infection.

2.7.6. NLRP3 Inflammasome Assay
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The NLRP3 inflammasome was activated by priming primary hMDMs with
0.5 µg/mL E. coli LPS (055:B5;Sigma) for 4 hours followed by 10 µM nigericin
treatment for 4 hours.

2.7.7. siRNA-Mediated Knockdown
All of the Silencer Select siRNA oligos targeting human GBP mRNA were
purchased from Thermo Fisher Scientific. Individual siRNA targeting GBP1
(s5620), GBP2 (s5623), GBP3 (5628), GBP4 (s41805), and GBP5 (s41810) were
used. The two Silencer Select negative control siRNAs (Silencer Select Negative
Control No. 1 siRNA and Silencer Select Negative Control No. 2 siRNA) were
purchased from Life Technologies (Ambion). In experiments where GBP1-5 were
individually knocked down, primary hMDMs were replated in media without
antibiotics in a 48-well plate, as described above, three days before infection. Two
days before infection, 30 nM of total siRNA were transfected into macrophages
using HiPerFect transfection reagent (Qiagen) following the manufacturer’s
protocol. 16 hours before infection, media was replaced with fresh antibiotic-free
media containing 100 U/mL IFN-g. In immunofluorescence experiments where
GBP1 was knocked down, primary hMDMs were replated in media without
antibiotics on glass coverslips in a 24-well plate as described above four days
before infection. Three days before infection, 5 pmol of total siRNA were
transfected into macrophages using Lipofectamine RNAiMAX transfection reagent
(Thermo Fisher Scientific) following the manufacturer’s protocol. 16 hours before
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infection, media was replaced with fresh antibiotic-free media containing 100 U/mL
IFN-g.

2.7.8. Quantitative RT-PCR Analysis
RNA was isolated using the Rneasy Plus Mini Kit (Qiagen) following the
manufacturer’s protocol. Cells were lysed in 350 µL RLT buffer with bmercaptoethanol and centrifuged through a QIAshredder spin column (Qiagen).
cDNA was synthesized from isolated RNA using SuperScript II Reverse
Transcriptase (Invitrogen) following the manufacturer’s protocol. Quantitative PCR
was conducted with the CFX96 real-time system from Bio-Rad using the SsoFast
EvaGreen Supermix with Low ROX (Bio-Rad). Transcript levels for each gene
were normalized to the housekeeping gene HPRT for each sample, and samples
were normalized to unprimed sample or to control siRNA-treated sample using the
2-DDCt (cycle threshold) method to calculate fold change. Relative expression was
calculated by normalizing gene-specific transcript levels to HPRT transcript levels
for each sample using the 2-DCt method. Primer sequences from primer bank used
for HPRT1, GBP1-6, CASP4, and CASP5 or from Lagrange, et al. for GBP7 are
the following (all 5’ à 3’):
HPRT1 forward: CCTGGCGTCGTGATTAGTGAT
HPRT1 reverse: AGACGTTCAGTCCTGTCCATAA
GBP1 forward: AGGAGTTCCTTCAAAGATGTGGA
GBP1 reverse: GCAACTGGACCCTGTCGTT
GBP2 forward: CTATCTGCAATTACGCAGCCT
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GBP2 reverse: TGTTCTGGCTTCTTGGGATGA
GBP3 forward: ATTCCCTGAAGCTAACGCAAG
GBP3 reverse: GGGCAGATCGAAGACAAAACATT
GBP4 forward: ATGGGTGAGAGAACTCTTCACG
GBP4 reverse: TGCGGTATAGCCCTACAATGG
GBP5 forward: CCATGTGCCTCATCGAGAACT
GBP5 reverse: ACAGGTTGCGTAATGGCAGAC
GBP6 forward: ATGGAATCTGGACCCAAAATGTT
GBP6 reverse: GCTGGTTCACCAATAGCTGCT
GBP7 forward: TGCCTTCTTACCAAGTCCAGA
GBP7 reverse: TCTCTGATGCCATGTTCAGG
CASP4 forward: TCTGCGGAACTGTGCATGATG
CASP4 reverse: TGTGTGATGAAGATAGAGCCCAT
CASP5 forward: TCACCTGCCTGCAAGGAATG
CASP5 reverse: TCTTTTCGTCAACCACAGTGTAG

2.7.9. LDH Cytotoxicity Assay
Macrophages were infected in a 48-well plate as described above and
harvested supernatants were assayed for cell death by measuring loss of cellular
membrane integrity via lactate dehydrogenase (LDH) activity. LDH release was
quantified using an LDH Cytotoxicity Detection Kit (Clontech) according to the
manufacturer’s instructions and normalized to mock-infected cells.
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2.7.10. Real-Time Propidium Iodide Uptake Assay
To measure live kinetics of cell membrane permeability, THP-1 cells were
plated as described above in a black, flat-bottom 96-well plate (Cellstar), primed
with 100 U/mL IFN-g for 24 hours, and infected with T4SS+ Lp at an MOI of 50 in
media containing 1X HBSS without phenol red, 20 mM HEPES, and 10% (vol/vol)
heat-inactivated FBS. Infected cells were centrifuged at 290 × g for 10 min. The
cells were supplemented with 5 µM propidium iodide (PI, P3566, Invitrogen) and
incubated for 10 min at 37°C to allow the cells to equilibrate. Then, the plate was
sealed with adhesive optical plate sealing film (Microseal, Bio-Rad) and placed in
a Synergy H1 microplate reader (BioTek) pre-heated to 37°C. PI fluorescence was
measured every hour for 4 hours.

2.7.11. ELISA
Macrophages were infected in a 48-well plate as described above and
harvested supernatants were assayed for cytokine levels using ELISA kits for
human IL-1b (BD Biosciences) and IL-18 (R&D Systems).

2.7.12. Immunoblot Analysis
In experiments where macrophages were plated in a 48-well plate, cells
were lysed in 1X SDS/PAGE sample buffer, and low-volume supernatants (90 µL
media per well of a 48-well plate) were mixed 1:1 with 2× SDS/PAGE sample buffer
containing Complete Mini EDTA-free Protease Inhibitor Mixture (Roche). In
experiments where primary hMDMs were plated in a 24-well plate and infected
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with T4SS- Lp, T4SS+ Lp, or mock infected with PBS, cells were lysed in 1X
SDS/PAGE sample buffer, and supernatants were treated with trichloroacetic acid
(TCA) overnight at 4°C and centrifuged at maximum speed for 15 min. Precipitated
supernatant pellets were washed with ice-cold acetone, centrifuged at maximum
speed for 10 min, and resuspended in 1X SDS/PAGE sample buffer. Protein
samples were boiled for 5 min, separated by SDS/PAGE on a 12% (vol/vol)
acrylamide gel, and transferred to PVDF Immobilon-P membranes (Millipore).
Primary antibodies specific for human IL-1b (clone 8516; R&D Systems), caspase1 (2225S; Cell Signaling), caspase-4 (4450S; Cell Signaling), caspase-5 (D3G4W;
46680S; Cell Signaling), Gasdermin-D (126-138; G7422; Sigma-Aldrich), GBP1
(ab131255, Abcam), GBP2 (sc-271568, Santa Cruz), GBP4 (17746-1-AP,
Proteintech), GBP5 (D3A5O, 67798S; Cell Signaling) and b-actin (4967L; Cell
Signaling) were used. HRP-conjugated secondary antibodies anti-rabbit IgG
(7074S; Cell Signaling) and anti-mouse IgG (7076S; Cell Signaling) were used.
For detection, ECL Western Blotting Substrate or SuperSignal West Femto (both
from Pierce Thermo Scientific) were used as the HRP substrate.

2.7.13. Immunofluorescence Microscopy
Primary hMDMs were plated on glass coverslips in a 24-well plate as
described above. After 2 hours of infection with dsRED-Lp, cells were washed 2
times with PBS and fixed with 4% paraformaldehyde for 10 min at 37°C. Following
fixation, cells were washed and permeabilized with 0.2% Triton X-100 for 10 min.
Cells were washed, blocked with 10% BSA for 1 hour, and stained with primary
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antibodies (identified below) for 1 hour. Cells were washed with PBS and incubated
with the appropriate Alexa-Fluor-conjugated secondary antibodies (identified
below) for 1 hour, followed by washes and mounted on glass slides with DAPI
mounting medium (Sigma Fluoroshield). Primary antibodies used were rabbit antiGBP1 (1:100 dilution; Abcam) and mouse anti-GBP2 (1:50 dilution; Santa Cruz).
Secondary antibodies used at a dilution of 1:4000 were goat anti-rabbit conjugated
to Alexa Fluor 488 (4412S; Cell Signaling) and goat anti-mouse conjugated to
Alexa Fluor 488 (A11029; Life Technologies). Coverslips were imaged on a Leica
SP5 FLIM confocal microscope at a magnification of 63× and the percentage of
infected cells containing GBP1+ or GBP2+ intracellular bacteria out of the total
number of infected cells were quantified.

2.7.14. Phagosome Integrity Assay
The phagosome integrity assay was performed as previously published
(Meunier & Broz, 2015), with some modifications. To distinguish between cytosolic
and vacuolar bacteria, primary hMDMs were plated on glass coverslips in a 24well plate as described above and infected with dsRED-Lp. After 2 hours of
infection, cells were washed 3 times with KHM buffer (110 mM potassium acetate,
20 mM HEPES, and 2mM MgCl2, pH 7.3) and incubated for 1 min in KHM buffer
with 50 µg/mL digitonin (Sigma-Aldrich). Cells were washed 3 times with KHM
buffer and stained for 15 min at 37°C with primary antibody to L. pneumophila
(1:1000 dilution; gift from Craig Roy) in KHM buffer with 3% BSA. Cells were
washed with PBS, fixed, and quenched with 0.1 M glycine for 10 min. Cells were
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washed and incubated with secondary antibody anti-rabbit Alexa Fluor 488 for 1
hour, followed by washes and mounted on glass slides with DAPI mounting
medium. Cells were analyzed by microscopy. 0.1% saponin in KHM buffer was
used as a positive control for this assay. The percentage of infected cells harboring
cytosolic bacteria out of the total number of infected cells were quantified.

2.7.15. Statistical Analysis
GraphPad Prism software was used for graphing of data and all statistical
analyses. Statistical significance for experiments with THP-1 cells was determined
using the unpaired two-way Student’s t test. Statistical significance for hMDMs was
determined using the paired two-way t test in experiments comparing multiple
donors and the unpaired two-way t test in experiments involving infections with
dsRED-expressing Lp for immunofluorescence assay. In hMDM experiments that
compare cells from multiple donors, data are graphed so that each data point
represents the mean of triplicate wells for each donor, and all statistical analysis
was conducted comparing the means of each experiment. Differences were
considered statistically significant if the P value was <0.05.
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CHAPTER 3
IFN-g and GBPs promote human noncanonical inflammasome responses to
LPS variants derived from different bacteria

This chapter contains unpublished data generated by Antonia R. Bass,
Stephanie Shreiner, and Brian Yan and portions of the introduction are part of a
manuscript by Erin Harberts*, Jasmine Alexander-Floyd*, Antonia R. Bass*,
Robert K. Ernst, and Sunny Shin. *indicates co-first authorship
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3.1. Abstract
Cytosolic detection of lipopolysaccharide (LPS), the major outer membrane
lipid component of gram-negative bacteria, is accomplished by the noncanonical
inflammasome and leads to gasdermin-D (GSDMD)-mediated inflammatory cell
death known as pyroptosis as well as downstream IL-1 family cytokine release.
The noncanonical inflammasome is comprised of the cysteine protease caspase11 in mice, while humans possess the two putative orthologs caspase-4 and
caspase-5. Intriguingly, LPS can vary in its acylation and phosphorylation state
contingent on the bacterial species and its environment. Gram-negative bacteria
containing under-acylated LPS has been shown to evade murine caspase-11
detection in macrophages, while hexa-acylated LPS variants robustly activate the
noncanonical inflammasome. In contrast to mice, a recent study found that LPS
with a lower acylation state can activate the human caspase-4 noncanonical
inflammasome. However, the role of caspase-5 still remains unclear and whether
caspase-4 or caspase-5 can be activated in response to LPS variants with
differential acylation and phosphorylation states has not been investigated.
Furthermore,

IFN-inducible

GBPs

promote

noncanonical

inflammasome

responses in murine macrophages and also recently found in human
macrophages. Whether IFN-g and human GBPs promote caspase-4 and caspase5 activation in response to LPS from different bacteria is unknown. Here, we test
the human noncanonical inflammasome response to LPS variants isolated from
Yersinia pestis that vary in the number and position of acyl chains as well as the
number of phosphate groups in primary human macrophages. We also use THP98

1-derived macrophages and CRISPR/Cas9 technology to delineate the roles of
caspase-4, caspase-5, GBP1, and GBP2 in inflammasome responses to
Legionella pneumophila or Escherichia coli LPS. We determine that caspase-4
plays a major role in detecting E. coli LPS, whereas caspase-5 does not and that
human GBP1 may be important for cell death in response to L. pneumophila and
E. coli LPS. This study provides a better understanding of the distinct roles that
caspase-4 and caspase-5 have upon sensing different LPS variants. Additionally,
the CRISPR/Cas9 knockout clones developed in this study offer useful tools in
order to further investigate the functions of the human noncanonical inflammasome
and GBPs in the context of other LPS variants or bacterial infections.

3.2. Significance Statement
Gram-negative bacterial LPS is recognized by two innate immune sensors:
the extracellular sensor, TLR4, and the intracellular sensor, the noncanonical
inflammasome. Detection of LPS by these sensors is crucial for combating host
defense against gram-negative bacterial pathogens. However, overactivation of
these pathways can lead to detrimental outcomes including sepsis, an
overwhelming inflammatory response that can result in organ failure and ultimately
death. As there are treatments for sepsis in mice, there are no successful approved
treatments for sepsis in humans. In addition, the mouse noncanonical
inflammasome is comprised of only one inflammatory caspase, caspase-11,
whereas the human noncanonical inflammasome is made up of two inflammatory
caspases, caspase-4 and caspase-5, and their functions are relatively poorly
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understood. Our study focuses on determining the specific roles of caspase-4 and
caspase-5 in response to LPS variants from different bacteria, as well as
examining whether IFN-inducible GBPs play a role in noncanonical inflammasome
responses. This study elucidates aspects of human innate immune responses to
gram-negative bacterial pathogens and provides insight into identifying potential
therapeutic targets for treating gram-negative sepsis.

3.3. Introduction
Gram-negative bacteria cause more than 30% of hospital-acquired
infections in the US, making them a major public health concern (Peleg & Hooper,
2010). Additionally, antibiotic-resistance is on the rise among gram-negative
bacterial pathogens, further highlighting the need for more therapeutic approaches
to controlling these infections (Exner et al., 2017). Uncontrolled gram-negative
bacterial infections can lead to detrimental outcomes including sepsis, which is an
overwhelming systemic inflammatory immune response to an infection. If left
untreated, the host will succumb to organ failure and ultimately death. Preclinical
studies in mice showed successful treatments for sepsis using immunomodulators
that functioned by neutralizing either host inflammatory mediators or microbial
products (Marshall, 2014). However, over 100 clinical trials testing these
immunomodulators in sepsis patients have failed. The reasons for these clinical
trial failures are unclear but may be due to differences between murine and human
innate immune genes that play a role in responses to gram-negative bacterial
infections. Therefore, it is important to understand human innate immune
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responses to gram-negative bacterial pathogens in order to identify potential novel
therapeutic targets for the treatment of gram-negative sepsis.
Gram-negative

sepsis

is

caused

by

the

bacterial

endotoxin,

lipopolysaccharide (LPS), which is the major lipid component in the outer
membrane of gram-negative bacteria. LPS activates innate immune sensors and
subsequently leads to host defense signaling events including inflammatory
cytokine release as well as cell death of the infected cell. The first identified LPS
sensor is toll-like receptor 4 (TLR4), a membrane-bound receptor located on the
plasma membrane or endosomal compartment membrane and recognizes
extracellular LPS (Takeuchi et al., 1999). Although TLR4 is essential for regulating
responses to gram-negative bacteria, its dysregulation can lead to sepsis. Studies
in mice identified an alternative LPS sensor that leads to TLR4-independent
endotoxic shock (Hagar et al., 2013; Kayagaki et al., 2013). This second LPS
sensor is known as the noncanonical inflammasome and recognizes LPS within
the cytosol.
The noncanonical inflammasome is formed by the cysteine protease
caspase-11 in mice and the two putative orthologs, caspase-4 and caspase-5 in
humans (Kayagaki et al., 2011; Shi et al., 2014). These inflammatory caspases
recognize and bind LPS through their caspase activation and recruitment domain
(CARD) resulting in their oligomerization and activation (Shi et al., 2014). Active
caspase-11, -4, and -5 mediate cleavage of gasdermin-D (GSDMD), the initiator
protein of pyroptosis. The N-terminal fragment of GSDMD translocates to the
plasma membrane and oligomerizes to form a pore resulting in osmotic influx and
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cell lysis. This GSDMD pore also leads to potassium (K+) efflux which triggers
activation of the canonical NLRP3 inflammasome. The NLRP3 inflammasome
involves activation of caspase-1, which also cleaves GSDMD as well as cleaves
IL-1 family cytokines into their mature forms for their release to signal bystander
cells, which are then activated and recruited to the site of infection. This
noncanonical inflammasome response is crucial for controlling intracellular
bacterial infections, but similar to TLR4, its overactivation can result in LPSinduced septic shock. Intriguingly, humans are among the most sensitive to
endotoxins, whereas mice are more resistant (Kajiwara et al., 2014). One
possibility as to why humans are more sensitive to the endotoxin LPS may be due
to the presence of two intracellular LPS sensors compared to mice that contain
only one intracellular LPS sensor. Humans evolved to develop caspase-4 and
caspase-5 most likely due to a gene duplication of the ancestral caspase-11 gene
in order to recognize and respond to a variety of gram-negative bacterial
pathogens they come into contact with. The functions of caspase-4 and caspase5 in response to LPS are relatively poorly understood. Therefore, we aim to
determine how these inflammatory caspases contribute to the human
noncanonical inflammasome response to LPS.
LPS is made up of three distinct components: the lipid A moiety, core
oligosaccharide, and O-antigen polysaccharide. Specifically, the lipid A moiety is
the component that is directly recognized and bound to by the CARD domain. Lipid
A is comprised of two glucosamine residues that contain hydrophobic acyl chains
that vary in number, position and length depending on the bacterial species. Also
102

contingent on the bacterial species, lipid A possesses either one or two phosphate
groups located on the 1 and/or 4’ positions of the two glucosamine residues,
respectively, and these phosphate groups provide a negative charge that help to
facilitate binding to the positively charged amino acid residues in the CARD
domains of caspase-11, -4, and -5. Interestingly, some bacteria within the same
species are able to modify their acylation and phosphorylation states, suggesting
that changing these vital features is important for their pathogenesis and may allow
these bacteria to evade immune detection.
The murine noncanonical inflammasome varies in response to different LPS
variants. It has been determined that LPS with a lower quantity of acyl chains (i.e.
tetra-acylated) evade caspase-11 immune detection, whereas LPS containing
higher number of acyl chains (i.e. hexa-acylated) activate caspase-11 for
downstream pyroptosis and release of inflammatory cytokines (Hagar et al., 2013;
Kayagaki et al., 2013). Interestingly, some penta-acylated LPS variants, such as
Francisella novicida lpxF mutant, can activate caspase-11 (Hagar et al., 2013),
while other penta-acylated LPS variants, like Rhizobium galegae, evade caspase11 detection (Kayagaki et al., 2013). This brings up the question of whether the
number of acyl chains is the only factor involved in promoting noncanonical
inflammasome responses. It was newly discovered that the human noncanonical
inflammasome functions differently than the murine system. The human
noncanonical inflammasome is activated in response to tetra-acylated LPS
variants, including the tetra-acylated F. novicida LPS, as well as penta- and hexaacylated

LPS

variants,

which

indicates
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that

the

human

noncanonical

inflammasome is activated by LPS with different acylation states (Lagrange et al.,
2018). Surprisingly, there are no other studies that further explore the human
noncanonical inflammasome response to different LPS variants. Whether the
position of acyl chains or the number of phosphoryl groups on lipid A play a role in
human noncanonical inflammasome response has not been studied.
Furthermore,

IFN

promotes

inflammasome

activation

in

murine

macrophages in response to gram-negative bacteria as well as to bacterial
components including LPS and outer membrane vesicles (OMVs) (Finethy et al.,
2017; B. C. Liu et al., 2018; Meunier et al., 2014; Meunier et al., 2015; Pilla et al.,
2014; Santos et al., 2018). Specifically, the IFN-inducible family of GTPases known
as guanylate bindings proteins (GBPs) facilitate these enhanced inflammasome
responses by different functions, including the rupture of pathogen-containing
vacuoles and disruption of the outer membrane of cytosol exposed bacteria. It was
recently determined that human GBP2 promotes noncanonical inflammasome
responses to the tetra-acylated LPS derived from F. novicida as well (Lagrange et
al., 2018). However, there are no additional studies that investigate whether IFN
and GBPs promote human noncanonical inflammasome responses to other LPS
variants from different bacteria.
Here, we investigate the activation of the human noncanonical
inflammasome in response to seven lipooligosaccharide variants, which lack the
O-antigen, that were derived from Y. pestis in order to determine whether its
activation differs in response to each LOS variant. Specifically, we explore whether
the number of acyl chains, number of phosphoryl groups, or position of acyl chains
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can influence human noncanonical inflammasome activation and if IFN-g can
promote this response. Additionally, we utilize CRISPR/Cas9 technology to
knockout either caspase-4 (CASP4), caspase-5 (CASP5), human GBP1, or
human GBP2 in the immortalized monocytic cell line, THP-1, in order to determine
the roles of these host proteins in response to LPS variants derived from L.
pneumophila and E. coli. Overall, this study provides a better understanding of
caspase-4 and caspase-5 and how IFN-g and GBPs contribute to human
noncanonical inflammasome activation in response to LPS variants from different
bacteria.

3.4. Results
3.4.1. The human noncanonical inflammasome is activated by different LOS
variants.
Caspase-4 was shown to be activated in response to tetra-acylated LPS
derived from F. novicida, as well as to penta- and hexa-acylated LPS variants from
other bacteria (Lagrange et al., 2018). However, whether the human noncanonical
inflammasome can be activated in response to additional LPS variants that have
differential acylation and phosphorylation states has not been studied. To
determine whether the human noncanonical inflammasome responds to other LPS
variants, we tested seven different LOS variants, which lack the O-antigen, that
were isolated from wild-type (WT) Y. pestis or different mutants of Y. pestis that
were grown at 26°C. The variants tested include four hexa-acylated LOS, two
penta-acylated LOS, and one tetra-acylated LOS. Specifically, the hexa-acylated
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LOS include LOS from WT Y. pestis (358@26), a mutant that lacks one phosphate
group at the 4’ position (468@26), a mutant that is missing an acyl chain at the 3’
position but has an added acyl chain at the 2 position (438@26), and a mutant that
lacks a phosphate group at the 4’ position as well as has a missing acyl chain at
the 2’ position and an added acyl chain at the 2 position (470@26) (Fig. 3.1 A).
The penta-acylated LOS variants are missing an acyl chain at either the 2’ position
(47@26) or at the 3’ position (46@26). Finally, the tetra-acylated LOS variant lacks
the two acyl chains at the 2’ and 3’ positions (48@26). Upon transfection with these
seven LOS variants in primary human monocyte-derived macrophages (hMDMs),
we determined that all of the variants promote cell death and IL-1b release;
however, it does appear that transfection of the tetra-acylated LOS, 48@26, shows
a lower inflammasome response compared to all of the other variants (Fig. 3.1 B
and C). This may indicate that the presence of either the 2’ or 3’ acyl chains that
are missing in this LOS variant help to promote maximal noncanonical
inflammasome responses in human macrophages. Overall, these data suggest
that Y. pestis LOS variants containing different number and position of acyl chains
as well as different number of phosphate groups all activate the human
noncanonical inflammasome.
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dehydrogenase release assay and normalized to mock-infected cells. (B) IL-1β levels in the
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groups (orange circles) and have either four, five, or six acyl chains
supernatant were measured by ELISA. (A and B) Shown are pooled results of two to three
attached that can vary in position. LOS mutants that have missing phosphate
groups or acyl chains or have added acyl chains in a different position compared
to the WT Y. pestis LOS (358@26) are outlined in red circles. (B and C) Primary
hMDMs were primed with Pam3CSK4 (1 µg/mL) for four h and either mock
transfected with FuGENE HD alone or transfected with FuGENE HD and 2 µg/mL
LPS for 20 h. (B) Cell death was measured using lactate dehydrogenase release
assay and normalized to mock-infected cells. (C) IL-1b levels in the supernatant
107

were measured by ELISA. (B and C) Shown are pooled results of two to three
independent experiments using hMDMs from different healthy human donors.
Each data point represents the mean of duplicate wells from an individual donor.
Bar graphs are color coated based on the number of acyl chains (Green=Hexaacylated, Blue=Penta-acylated, Pink=Tetra-acylated).
3.4.2. IFN-g upregulates human noncanonical inflammasome responses to E.
coli and Y. pestis LOS variants.
IFN has been shown to promote inflammasome responses in both mouse
and human macrophages infected with a variety of bacteria including S.
Typhimurium, L. pneumophila, and F. novicida (Lagrange et al., 2018; B. C. Liu et
al., 2018; Meunier et al., 2014; Meunier et al., 2015). In particular, the family of
IFN-inducible GTPases known as GBPs are upregulated by both type I and II IFNs,
but more robustly upregulated by the type II IFN, IFN-g, and are the key players in
promoting these inflammasome responses. Here, we investigated whether IFN-g
promotes human noncanonical inflammasome responses to a hexa-acylated or
tetra-acylated LOS derived from Y. pestis. The 470@26 LOS variant produced a
robust inflammasome response in primary human macrophages (Fig. 3.1 B and
C); therefore, we used this hexa-acylated LOS variant to determine how IFN-g
affects this response along with the tetra-acylated variant that did not produce as
strong of a response. As a control, we looked at human noncanonical
inflammasome activation in response to the hexa-acylated LOS derived from the
W3110 E. coli strain in unprimed and IFN-g-primed THP-1-derived macrophages.
Upon transfection of these three LOS variants in THP-1-derived macrophages, we
observed that IFN-g priming led to a significant increase in IL-1b release compared
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to unprimed cells (Fig. 3.2). Moreover, all of the IFN-g-primed cells have similar
amount of IL-1b release in response to the two hexa-acylated LOS variants and
the tetra-acylated variant. This indicates that IFN-g enhances human noncanonical
inflammasome activation in response to differentially acylated LOS.

Figure 3.2. IFN-g promotes human noncanonical inflammasome responses
to E. coli and Y. pestis LOS variants. Phorbol 12-myristate 13-acetate (PMA)differentiated THP-1 cells were either primed overnight with IFN-g (100 U/mL) or
left unprimed, then primed with Pam3CSK4 (1 µg/mL) for 4 h, and either mock
transfected with FuGENE HD alone or transfected with FuGENE HD and 2 µg/mL
LPS for 20 h. IL-1b levels in the supernatant were measured by ELISA. **P<0.01
and ***P<0.001 by unpaired t-test.
3.4.3. Development of CASP4 or CASP5 knockout THP-1 clones using
CRISPR/Cas9 technology.
Caspase-4

and

caspase-5

comprise

the

human

noncanonical

inflammasome. While most studies of the noncanonical inflammasome have been
conducted using mice and murine macrophages, there are a few studies that
investigated caspase-4 inflammasome activation in response to different gramnegative bacteria including L. pneumophila, E. coli, and F. novicida (Casson et al.,
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2015; Goddard et al., 2019; Lagrange et al., 2018). Very little research has looked
into the role of caspase-5 in macrophages, which may be due to its low relative
expression level in macrophages. However, one study using primary human
macrophages determined that caspase-5 did not undergo processing in response
to transfected E. coli LPS or infection with L. pneumophila, S. Typhimurium, or Y.
pseudotuberculosis, but did undergo proteolytic cleavage in response to treatment
with extracellular E. coli LPS (Casson et al., 2015). In contrast, this study showed
that caspase-4 undergoes processing in response to infection with L. pneumophila
and S. Typhimurium. These results suggest that caspase-4 and caspase-5 may
be activated through different pathways in response to gram-negative bacteria or
LPS. Interestingly, additional studies using human monocytes found that caspase5 undergoes processing in response to extracellular LPS and activation in
response to treatment with Pseudomonas aeruginosa outer membrane vesicles
(OMVs) (Bitto et al., 2018; Vigano et al., 2015). Thus, these results in addition to
the primary human macrophage results indicate that caspase-5 activation may be
initiated through an external pathway, but this has not been thoroughly
investigated. Since caspase-5 has been shown to directly bind LPS via its CARD
domain (Shi et al., 2014), similar to caspase-11 and caspase-4, it is likely that
caspase-5 can be activated in response to intracellular LPS. Therefore, in order to
investigate the distinct roles of caspase-4 (CASP4) and caspase-5 (CASP5) in
response to intracellular LPS variants, we used the Clustered Regularly
Interspaced Short Palindromic Repeat (CRISPR) system together with the RNA-
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guided exonuclease Cas9 to disrupt the CASP4 and CASP5 genes in the
immortalized monocytic THP-1 cell line.
We generated lentivirus using a lentiCRISPR version 2 plasmid, which
contains the Cas9 protein and the guide RNA (gRNA) target sequence for either
CASP4 or CASP5, VSV-G envelope plasmid, and psPAX2 packaging plasmid. The
gRNA sequences for CASP4 or CASP5 are located within exonic regions of the
gene in order to promote a double-stranded break (DSB) at the target DNA site
within the protein coding area. Specifically, the CASP4 gRNA targets exon 3 and
the CASP5 gRNA targets exon 5, both of which targeted sequences are
highlighted in Fig. 3.3 A and B. This DSB results in either non-homologous end
joining (NHEJ) or homology directed repair (HDR), which can cause base-pair
insertions, deletions, or frameshift mutations and lead to a premature stop codon
and nonfunctional gene. After infecting the THP-1 monocytic cell lines with the
generated lentivirus containing either CASP4 or CASP5 gRNA and Cas9 protein,
followed by puromycin selection and clonal selection, we expanded 12 single cell
clones to determine whether their RNA and protein levels of CASP4 or CASP5
were absent. Based on the decreased gene and protein expression we chose three
clones to validate and ensure that they were clones that originated from a single
cell. THP-1 cells are a human monocytic cell line that are derived from an acute
monocytic leukemia patient; however, they possess a diploid karyotype, unlike
other leukemia cell lines (Fleit & Kobasiuk, 1991). Therefore, a single cell clone
should therefore contain only two allelic mutations at the target sequence. Of the
three clones chosen for the CASP5 gene, we validated two clones for CASP5,
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clone 1 and clone 8, both of which possess two distinct allelic mutations (Fig. 3.3
C and D). The sequencing electropherogram for the DNA target sequence and
surrounding regions for both CASP5 alleles of each clone are shown. The
sequence alignment comparing WT THP-1 and CASP5-/- THP-1 clones are also
shown, and the nucleotide deletions within the CASP5 target sequence are
indicated by red boxes. The CASP5 alleles in clone 1 have either 10 or 13
nucleotides deleted, which result in premature stop codons (Fig. 3.3 C). The
CASP5 alleles in clone 8 have either two or four nucleotide deletions and also
result in premature stop codons and therefore nonfunctional CASP5 protein (Fig.
3.3 D). qPCR analyses and western blots revealed decreased RNA and absent
protein expression levels of CASP4-/- clones 2 and 6 (Fig. 3.4 A-B and E). Future
experiments are required to validate these as single cell clones with only two allelic
mutations.
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Figure 3.3. Validation of CASP4 and CASP5 knockout THP-1 clones
generated using CRISPR/Cas9 technology. Schematic representations of the
CASP4 gene (A) or the CASP5 gene (B) with exons (filled boxes) and introns
(lines). The respective guide RNA target sequences for CASP4 and CASP5 are
highlighted in red. Shown are the mutations of the two alleles for CASP5-/- clone 1
(C) or CASP5-/- clone 8 (D) THP-1 genomic DNA by electropherogram and
sequence alignment with WT THP-1 genomic DNA. The CASP5 target sequence
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is underlined and nucleotide deletions are indicated by the red boxes. The mutation
starting point of missing nucleotide is indicated in the electropherogram by a black
line.
Besides one study that showed caspase-4-dependent inflammasome
activation in response to F. novicida in IFN-g-primed human macrophages
(Lagrange et al., 2018), no other studies have investigated the roles of caspase-4
or caspase-5 in IFN-g-primed human macrophages in response to LPS variants
from different bacteria. We compared caspase-4 and caspase-5 RNA and protein
expression levels in WT THP-1 cells as well as the CASP4-/- and CASP5-/- THP-1
clones (Fig. 3.4). This is to confirm that knockout of either gene did not cross react
and lead to unintentional knockout of the other gene. For instance, CASP4-/- THP1 clones 2 and 6 present a decreased fold change and relative expression of
CASP4, but CASP5-/- THP-1 clones 1,6, and 8 have normal CASP4 gene
expression similar to WT THP-1 cells (Fig 3.4 A and B). CASP5-/- THP-1 clone 6
was examined because it initially showed decrease CASP5 expression and absent
protein expression when comparing the original 12 expanded clones; however,
after conducting validation experiments it was revealed that it was not a single cell
clone and had more than two allelic mutations. Additionally, CASP5-/- THP-1 clones
1, 6, and 8 have decreased RNA fold change and relative expression levels of
CASP5, while

CASP4-/- THP-1 clones 2 and 6 have higher CASP5 RNA

expression, although CASP4-/- clone 6 show slightly lower CASP5 RNA expression
compared to WT THP-1 cells (Fig. 3.4 C and D). Finally, we compared the CASP4
and CASP5 protein levels in unprimed and IFN-g-primed WT THP-1 cells and the
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CASP4 and CASP5 knockout clones. Unprimed or IFN-g-primed CASP4-/- THP-1
clones 2 and 6 show no CASP4 protein expression, whereas WT THP-1 and
CASP5-/- THP-1 clones 1 and 8 have CASP4 expressed (Fig. 3.4 E). Notably, IFNg-primed WT THP-1 and CASP5-/- THP-1 clones have increased CASP4 protein
expression compared to unprimed cells. Furthermore, unprimed WT THP-1 cells
as well as the CASP4 and CASP5 knockout clones do not show any CASP5
protein expression (Fig. 3.4 F). CASP5 is not constitutively expressed, unlike
CASP4, and requires a priming signal for its upregulation. In addition, CASP5 has
a very low relative expression compared to CASP4 (Fig. 3.4 B and D). IFN-gprimed WT THP-1 and CASP4-/- THP-1 clones 2 and 6 present CASP5 protein
expression, while CASP5-/- THP-1 clones 1 and 8 do not express CASP5 (Fig. 3.4
F). These results indicate that disruption of the CASP4 gene does not affect
CASP5 expression levels and that mutation of the CASP5 gene does not abrogate
CASP4 expression. Thus, these THP-1 knockout clones can be used to distinguish
the functions of caspase-4 and caspase-5 in response to intracellular LPS variants.
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Figure 3.4.
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for 16 h. CASP4
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and CASP5 transcript levels were determined by quantitative RT-PCR and relative
expression was calculated by normalizing to the housekeeping gene HPRT. Fold
change was further calculated by normalizing to the WT THP-1 sample. (E-F)
PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones, and CASP5-/- THP-1
Figure 3.4. Expression of CASP4 and CASP5 in CASP4 or CASP5 knockout THP-1
clones were either left unprimed or primed with IFN-g (100 -/U/mL) for 18 h.
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normalizing to the WT THP-1 sample. (E-F) PMA-differentiated WT THP-1 cells, CASP4-/
THP-1 clones, and CASP5-/- THP-1 clones were either left unprimed or primed with IFN-γ
(100 U/mL) for 18 h. Immunoblot 116
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representative of one experiment.

3.4.4. CASP4 is activated in response to E. coli LPS, while CASP5 may not
play a role in response to E. coli or L. pneumophila LPS.
The role of caspase-4 and caspase-5 in response to different LPS variants
is not well defined. In addition, whether IFN-g promotes human caspase-4 or
caspase-5 responses to different hexa-acylated LPS variants, including LPS
derived from L. pneumophila or E. coli has not been studied. Here, we use WT,
CASP4-/-, and CASP5-/- THP-1-derived macrophages to define the distinct roles of
caspase-4 and caspase-5. Inflammasomes require an initial priming signal to
upregulate sensor proteins, such as caspase-4 and caspase-5. First, we either
left the THP-1 cells unprimed or primed them with IFN-g in order to compare the
roles of caspase-4 and caspase-5 in these distinguished cell types. Next, we
primed all of the THP-1 cells with the TLR1/2 ligand, Pam3CSK4, which not only
promotes the expression of sensor proteins but also of IL-1 family cytokines
including IL-1b. The noncanonical inflammasome is characterized by cleaving
GSDMD, which is the initiator of pyroptosis, followed by K+ efflux, which activates
the NLRP3 capsase-1-containing inflammasome for IL-1 processing and release.
Upon transfection with E. coli LPS and not L. pneumophila LPS, both CASP4-/- and
CASP5-/- THP-1 cells show a significant decrease in cell death compared to WT
THP-1 cells in the Pam3CSK4-primed only condition (Fig. 3.5 A). Notably, CASP4/-

THP-1 cells show a much greater decrease compared to when CASP5 is

knocked out. This indicates that caspase-4 plays an essential role in cell death in
response to E. coli LPS, while caspase-5 may play a small role. Furthermore, when
these cells are additionally primed with IFN-g and transfected with E. coli LPS,
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CASP4-/- THP-1 cells have significantly reduced cell death, while CASP5-/- THP-1
cells do not (Fig. 3.5 B). This could be due to an upregulated expression of
caspase-4 in the CASP5-/- THP-1 cells upon the treatment of IFN-g. Similar to the
Pam3CSK4-primed cells, additional treatment of IFN-g does not result in a
caspase-4- or caspase-5-dependent cell death in response to L. pneumophila LPS
(Fig. 3.5 B). Interestingly, both CASP4-/- THP-1 clones either primed with
Pam3CSK4 alone or primed with IFN-g and Pam3CSK4, showed significantly
decreased IL-1b release in response to E. coli, while the CASP5-/- THP-1 clones
do not have a reduction (Fig. 3.5 C and D). In addition, for both primed conditions,
only CASP4-/- clone 6 THP-1 cells have a significant reduction in IL-1b release in
response to L. pneumophila LPS. This may suggest that caspase-4 is important
for downstream IL-1b secretion in response to L. pneumophila LPS, but not cell
death. These results are perplexing since cell death is upstream of IL-1 cytokine
release for noncanonical inflammasome activation. Since these experiments were
only conducted two times, repeated experiments are necessary and additional
future experiments involving different timepoints and LPS treatment conditions are
crucial to determine the role of caspase-4 and caspase-5 responses to L.
pneumophila and E. coli LPS. It would be interesting to observe the inflammasome
responses of caspase-4 and caspase-5 to treatment of extracellular LPS. Based
on these results, we conclude that capsase-4 promotes noncanonical
inflammasome responses to E. coli LPS and that caspase-5 may not play a role in
response to E. coli or L. pneumophila LPS.
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Figure 3.5. CASP4 promotes noncanonical inflammasome responses to E.
coli LPS, while CASP5 may not play a role in detecting E. coli or L.
pneumophila LPS. PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones,
and CASP5-/- THP-1 clones were either left unprimed (A and C) or primed
overnight with IFN-g (100 U/mL) (B and D), then primed with Pam3CSK4 (1 µg/mL)
for 4 h and either mock transfected with FuGENE HD alone or transfected with
FuGENE HD and 10 µg/mL L. pneumophila LPS or 2 µg/mL E. coli LPS for 4 h. (A
and B) Cell death was measured using lactate dehydrogenase release assay and
normalized to mock-infected cells. (C and D) IL-1b levels in the supernatant were
measured by ELISA. Shown are results representative of two experiments.
*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 by unpaired t-test.
3.4.5. Development of GBP1 or GBP2 knockout THP-1 clones using
CRISPR/Cas9 technology.
The IFN-inducible family of GTPases known as GBPs promote
inflammasome responses to a variety of gram-negative bacteria as well as to
bacterial components including LPS and OMVs (Finethy et al., 2017; Fisch et al.,
2019; Lagrange et al., 2018; Meunier et al., 2014; Meunier et al., 2015; Pilla et al.,
2014; Santos et al., 2020; Santos et al., 2018). Recent findings for human GBPs
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revealed that human GBP1 promotes caspase-4-dependent inflammasome
responses to S. Typhimurium and E. coli LPS, while human GBP2 promotes
noncanonical inflammasome responses to the under-acylated LPS derived from F.
novicida (Fisch et al., 2019; Lagrange et al., 2018; Santos et al., 2020). In addition,
our lab discovered that human GBP1 is essential for maximal inflammasome
responses to L. pneumophila (Chapter 2); however, we used RNAi-mediated
knockdown techniques rather than a complete cell knockout of GBP1. Although
we show that siRNA specific for GBP1 led to efficient knockdown, a GBP1
knockout cell line would eliminate the remaining residual GBP1 and, therefore,
would abolish any inflammasome response due to the remaining GBP1 left. Here,
we generated human GBP1 as well as GBP2 knockout THP-1 cells using the
lentivirus-mediated CRISPR-Cas9 genome editing technology. The lentiCRISPR
plasmids used contained either GBP1 gRNA that targets exon 8 or GBP2 gRNA
that targets exon 6, both of which these sequences are highlighted in Fig. 3.6 A
and B. Targeting these exonic regions will lead to nucleotide mutations within the
protein coding region and, therefore, will result in a premature stop codon and
nonfunctional protein. Applying the same process we used to develop the CASP4/-

and CASP5-/- THP-1 single cell clones, after infecting THP-1 cells with the

lentivirus containing the gRNA target sequence for GBP1 or GBP2 as well as the
Cas9-exonuclease protein, we treated the cells with puromycin to maintain the
cells that contained the lentivirus. We next expanded 12 single cell clones and
checked for decrease in RNA expression or absence of protein for either GBP1 or
GBP2 in order to select the three best clones for validating that they originated
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from a single cell. We validated two GBP1-/- THP-1 clones that each possess two
allelic mutations. The sequencing electropherogram shows the DNA target
sequence and adjacent nucleotide sequence of both GBP1 alleles for each clone
(Fig. 3.6 C and D). In addition, we show the sequence alignment between the WT
THP-1 and GBP1-/- THP-1 clones, and the nucleotide changes within the GBP1
target sequence are specified by red boxes or outlines. The GBP1 alleles in clone
1 have either five nucleotides deleted or have one nucleotide deleted and a
nucleotide switch (Fig. 3.6 C). Both of these mutations revealed that they lead to
premature stop codons. Additionally, the GBP1 alleles for clone 6 show either two
nucleotides deleted or a nucleotide insertion, which result in premature stop
codons (Fig. 3.6 D). Due to technical complications, we were unable to validate
the GBP2-/- THP-1 clones, although we did choose two clones that showed the
best RNA decrease as well as absence of GBP2 protein to use in experiments.
Future experiments are needed in order to validate and ensure that these GBP2-/THP-1 clones are derived from a single cell.
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Figure 3.6. Validation of GBP1 and GBP2 knockout THP-1
using CRISPR/Cas9 technology. Schematic representations of the GBP1 gene
(A) or the GBP2 gene (B) with exons (filled boxes) and introns (lines). The
respective guide RNA target sequences for GBP1 and GBP2 are highlighted in
red. Shown are the mutations of the two alleles for GBP1-/- clone 1 (C) or GBP1-/clone 6 (D) THP-1 genomic DNA by electropherogram and sequence alignment
with WT THP-1 genomic DNA. The CASP5 target sequence is underlined and
nucleotide deletions are indicated by the red filled-in boxes. Nucleotide insertion
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or switch is marked by a red outline. The mutation starting point of missing or
inserted nucleotide is indicated in the electropherogram by a black line.
After choosing two GBP2-/- THP-1 clones for experimental use, in addition
to the validated GBP1-/- THP-1 clones, we compared the protein expression levels
of GBP1 and GBP2 in these clones as well as in WT THP-1 cells. The purpose of
this is to confirm that the GBP1 gRNA did not affect GBP2 expression and vice
versa. We initially primed the WT THP-1 cells and GBP knockout clones with IFNg to upregulate GBP expression, since GBPs are interferon-inducible and will not
be expressed unless stimulated with IFN. We found that GBP1-/- THP-1 clones 1
and 6 have no GBP1 protein expression, while WT THP-1 and GBP2-/- THP-1
clones 1 and 7 have normal GBP1 levels (Fig. 3.7 A). Moreover, GBP2-/- THP-1
clones 1 and 7 show absent GBP2 protein expression, whereas WT THP-1 and
GBP1-/- THP-1 clone 1 have normal GBP2 expression (Fig. 3.7 B). Interestingly,
GBP1-/- THP-1 clone 6 shows lower GBP2 protein levels, although this observed
decrease may be due to lower amount of lysate added since b-actin levels are
lower in this sample compared to the other samples. A repeat of this western blot
is needed to confirm whether GBP1-/- THP-1 clone 6 has its GBP2 protein levels
affected by the GBP1 gRNA. Since we see that GBP1 is knocked out of the GBP1/-

THP-1 clones and that GBP2 is knocked out of the GBP2-/- THP-1 clones, we felt

that we could continue and conduct experiments with these clones in order to
determine their role in response to intracellular LPS derived from L. pneumophila
and confirm their role in response to E. coli LPS.
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Figure 3.7. Expression of GBP1 and GBP2 in GBP1 or GBP2 knockout THP1 clones. (A and B) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones,
and GBP2-/- THP-1 clones were primed with IFN-g (100 U/mL) for 18 h. Immunoblot
analysis was conducted on lysates for GBP1 and GBP2. Blots were stripped and
reprobed for b-actin.
3.4.6. GBP1 and GBP2 are important for cell death in response to L.
pneumophila, while GBP1 plays a role in cell death in response to LPS
derived from L. pneumophila and E. coli.
We recently found that human GBP1 promotes inflammasome responses
to L. pneumophila and that these inflammasome responses led to caspase-1, -4,
and -5 activation (Chapter 2). In addition to knocking down human GBP1 using
siRNA, we also individually knockdown GBP2, 3, 4, and 5, but we did not see a
decrease in inflammasome activation upon knockdown of these GBPs. We sought
to use the newly developed GBP1-/- and GBP2-/- THP-1 clones in order to confirm
the role of human GBP1 in inflammasome responses to L. pneumophila and
whether the complete absence of GBP2 influences inflammasome responses as
well. Since THP-1 cells have different kinetics of inflammatory responses to
pathogens compared to primary human macrophages, we conducted a time
course experiment using IFN-g-primed WT THP-1 cells, GBP1-/- THP-1 clones, and
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GBP2-/- THP-1 clones that were infected with L. pneumophila. We determined at
each time point (1, 2, or 4 hpi) that knockout of GBP1 and GBP2 in THP-1 cells
results in a significant decrease of cell death but not IL-1b secretion (Fig. 3.8 A
and B). These results are in partial agreement with our previous findings that
knockdown of GBP1 leads to a decrease in cell death. However, IL-1b is not
decreased upon knockout of GBP1, contrary to what we found with siRNA
knockdown of GBP1. Additionally, our results reveal a new finding that human
GBP2 may also be important for promoting cell death during L. pneumophila
infection.
Previous studies showed that GBPs are important for promoting
noncanonical inflammasome responses to LPS. Specifically, it was found that
human GBP1 promotes caspase-4 activation in response to E. coli LPS, while
human GBP2 promotes caspase-4 activation in response to F. novicida LPS and
not E. coli LPS (Lagrange et al., 2018; Santos et al., 2020). In addition, mouse
GBPs located on chromosome 3 promote caspase-11 activation in response to
LPS derived from L. pneumophila (Pilla et al., 2014). Therefore, we wanted to
investigate whether human GBP1 or GBP2 promoted noncanonical inflammasome
responses to L. pneumophila LPS as well as to confirm that human GBP1 and not
GBP2 promotes inflammasome activation in response to E. coli LPS. Using the
GBP1-/- and GBP2-/- THP-1 clones, we found that knockout of only GBP1 resulted
in decreased cell death in response to L. pneumophila LPS and E. coli LPS, while
IL-1b release was not affected (Fig. 3.8 C and D). These results are in agreement
with the previous findings that human GBP1, and not GBP2, is important for
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stimulating inflammasome response to E. coli LPS. It is also interesting that the
absence of GBP2 does not lead to decrease in cell death in response to L.
pneumophila LPS as it does in response to L. pneumophila bacteria. This may
suggest that GBP2 is activated in response to a different bacterial component of
L. pneumophila other than LPS. Overall, these data indicate that human GBP1 and
GBP2 promote cell death during infection with L. pneumophila, while GBP1
stimulates cell death in response to LPS derived from L. pneumophila and E. coli.

126

WT THP-1
GBP1 clone 1
GBP1 clone 6

Figure 3.8.

LDH all time points

GBP2 clone 1
GBP2 clone 7

A
80
60

*
**
**

GBP1-/- Clone 1
GBP1-/- Clone 6

i

hp

GBP1 clone 6
4

2

hp

i

GBP1 clone 1

GBP2 clone 1
L. pneumophila
GBP2
clone 7
T4SS+
Lp

0

20000

1

hp

i

IL-1β

20

i

WT THP-1

40

hp

i
2

hp

i
hp
1

Mock

60

Mock

B

GBP2-/- Clone 7

*
**

4

20

GBP2-/- Clone 1

*

80

0

IL-1β (pg/mL)

WT THP-1

*

LDH

40

% Cytotoxicity

% Cytotoxicity

*
*

Mock

L. pneumophila LPS

E. coli LPS

15000
10000
5000

Mock

D

i
hp
4

IL-1β

GBP1-/- Clone 6
GBP2-/- Clone 1

**

60

*

40
**

20
Mock

L. pneumophila LPS

E. coli LPS

IL-1β (pg/mL)

-/- Clone 7
GBP2
25000

80
% Cytotoxicity

i

ΔflaA

GBP1-/- Clone 1

LDH

0

2

WT L.
THP-1
pneumophila

Mock
C

hp

i
1

hp

i
4

hp

i
hp
2

1

hp

i

0

20000
15000
10000
5000
0

Mock

L. pneumophila LPS

E. coli LPS

Figure
3.8. 3.8.
GBP1GBP1
and GBP2
a role
in cell
deathin
but
notdeath
IL-1β release
in response
to L. pneumophila,
Figure
andplay
GBP2
play
a role
cell
but not
IL-1b release
in
while GBP1 plays a role in cell death in response to LPS derived from L. pneumophila or E. coli in THP-1
response to L. pneumophila, while GBP1 plays a role in cell death in
cells. (A and B) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, and GBP2-/- THP-1 clones were
response
to(100
LPSU/mL)
derived
from
pneumophila
or E.
coli
in THP-1
cells.Lp
(Afor the
primed
with IFN-γ
overnight
andL.
either
mock infected with
PBS
or infected
with T4SS+
-/-/- clones, and GBP2-/and
B)
PMA-differentiated
WT
THP-1
cells,
GBP1
THP-1
timepoints indicated. (C and D) PMA-differentiated WT THP-1 cells, GBP1 THP-1 clones, and GBP2-/- THP-1
clones
wereclones
primed with
IFN-γ
(100 U/mL)
and either
mockovernight
transfected with
alone or
THP-1
were
primed
withovernight
IFN-g (100
U/mL)
andFuGENE
either HD
mock
transfected
with
FuGENE
HD
and
10
µg/mL
L.
pneumophila
LPS
or
2
µg/mL
E.
coli
LPS
for
2.5
h.
(A
and C) Cell
infected with PBS or infected with T4SS+ Lp for the timepoints indicated. (C and
death was measured using lactate dehydrogenase release-/-assay and normalized to mock-infected
cells. (B and
-/D) PMA-differentiated WT THP-1 cells, GBP1 THP-1 clones, and GBP2 THP-1
D) IL-1β levels in the supernatant were measured by ELISA. Shown are the results representative of one
clones were primed with IFN-g (100 U/mL) overnight and either mock transfected
experiment.

with FuGENE HD alone or transfected with FuGENE HD and 10 µg/mL L.
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measured using lactate dehydrogenase release assay and normalized to mockinfected cells. (B and D) IL-1b levels in the supernatant were measured by ELISA.
3.5. Discussion
Our data suggests that the human noncanonical inflammasome is activated
in response to differentially acylated and phosphorylated LOS derived from Y.
pestis, and that IFN-g promotes these inflammatory responses. One possibility of
why the human noncanonical inflammasome is activated by these various LOS
structures, in contrast to the murine noncanonical inflammasome that is not
activated by under-acylated LPS, is that humans possess two putative orthologs
of murine caspase-11, which are caspase-4 and caspase-5. Thus, these two
inflammatory caspases may be working together in order to recognize different
types of LPS structures. The CASP4-/- and CASP5-/- THP-1 clones we developed
using CRISPR/Cas9 genome editing technology are useful tools that can help to
distinguish the functions of caspase-4 and caspase-5 to differentially
phosphorylated and acylated LPS variants. Future studies testing the
inflammasome responses to the seven LOS variants from Y. pestis in these THP1 clones are needed to fully examine the distinct roles of caspase-4 and caspase5. Additionally, previous work found that caspase-5 may be activated by a different
pathway compared to caspase-4. Specifically, caspase-5 is cleaved and activated
in response to treatment with extracellular E. coli LPS in monocytes and
macrophages (Casson et al., 2015; Vigano et al., 2015). No additional work has
been done to investigate this alternative LPS activation process. Thus, additional
experiments testing extracellular LPS treatment in these CASP4-/- and CASP5-/128

THP-1 clones either left as monocytes or in differentiated macrophages to
determine whether there is a difference in caspase-5 activation. It would be of
interest to also determine whether TLR4 is important for the activation of caspase5, as TLR4 is the extracellular LPS sensor and may somehow internalize LPS after
binding and transport LPS to caspase-5 directly. Therefore, caspase-4 and
caspase-5 may be activated by different LPS structures but may also be involved
in different mechanisms of activation depending on the route of LPS entry into the
cytosol.
Our data indicate that caspase-4 promotes noncanonical inflammasome
responses to E. coli LPS in both Pam3CSK4-primed macrophages as well as in
Pam3CSK4 and IFN-g-primed macrophages, while we do not see a role for
caspase-5 in response to transfected L. pneumophila LPS or E. coli LPS. However,
we did see that CASP4-/- THP-1 clone 6 transfected with L. pneumophila LPS
resulted in significantly decreased IL-1b release, indicating that caspase-4 is
important for promoting inflammatory cytokine release. It is intriguing, however,
that we see decreased IL-1b release but no decrease in cell death, since cell death
is initiated before cytokine release during noncanonical inflammasome activation.
Therefore, an alternative and more sensitive cell death assay, such as propidium
iodide (PI) uptake, is needed in order to determine whether the cell death
phenotype of the CASP4-/- THP-1 clones in response to L. pneumophila LPS is
accurate. PI is a DNA-binding dye that is significantly smaller in size compared to
the LDH enzyme. Thus, PI is able to enter cells more easily through smaller pores,
while LDH may not be released from these pores.
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We also developed GBP1-/- and GBP2-/- THP-1 clones to determine the roles
of human GBP1 and GBP2 in response to intracellular L. pneumophila LPS and to
confirm the role of human GBP1 in response to L. pneumophila bacteria. Our data
suggest that GBP1 and GBP2 were necessary for cell death in response to L.
pneumophila, highlighting a potential new role for GBP2 that we did not observe in
previous experiments using siRNA-mediated knockdown. It is possible that siRNA
treatment results in residual amounts of GBP2 protein and that this remaining
presence of GBP2 may account for the observed cell death. Therefore, this may
be why we detect a decrease in cell death only in the complete absence of GBP2.
The mechanism of how GBP2 is promoting cell death during L. pneumophila
infection is unclear, but future experiments that test whether GBP2 is important for
vacuolar or outer membrane rupture would be of interest and would reveal another
human GBP that facilitates the exposure of L. pneumophila into the cytosol, as we
previously saw with human GBP1 (Chapter 2).
Additionally, we observed that GBP1 may be important for promoting cell
death in response to L. pneumophila LPS, whereas GBP2 does not. However, we
only observed this phenotype with GBP1-/- THP-1 clone 1. Thus, repeated
experiments are required to confirm whether human GBP1 is an essential mediator
of cell death in response to L. pneumophila LPS and whether the second GBP1-/THP-1 clone reveals the same phenotype. Additionally, we noticed that there was
no change in IL-1b release between WT THP-1 cells and the GBP1-/- and GBP2-/THP-1 clones. One reason as to why there is no difference in IL-1b secretion
between WT and GBP knockout cells is that these THP-1 cells are differentiated
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into macrophages using PMA, which robustly promotes IL-1b production.
Consequently, there may be such a high background of IL-1b being produced that
knockout of one gene that is partially responsible for IL-1b release is not sufficient
enough to see a difference. Therefore, we may need to change the differentiation
conditions to generate THP-1-derived macrophages that have normal IL-1b
production as well as may need to conduct a time course since we may be looking
too early for IL-1b release. Different differentiation conditions, such as with Vitamin
D3, may generate THP-1-derived macrophages that produce normal amounts of
IL-1b in order to examine the role of human GBPs in inflammatory cytokine release
in response to LPS.
Our study focuses on the individual roles of caspase-4 and caspase-5.
Whether knockout of both caspase-4 and caspase-5 would produce a synergistic
effect and greater decrease in inflammasome responses to LPS is unclear. The
development of a double CASP4/5-/- THP-1 cell line is needed to address this
question. Since caspase-4 and caspase-5 may be activated through different
mechanisms, it would be helpful to compare the inflammasome response to the
treatment of extracellular LPS or transfection of LPS into the cytosol using these
CASP4/5-/- cells in addition to the CASP4-/- and CASP5-/- THP-1 clones.
Furthermore, the GBP knockout experiments in this study suggest that
human GBP1 plays a role in response to L. pneumophila LPS and E. coli LPS. It
would be of interest to determine how GBP1 is promoting this cell death response
in THP-1-derived macrophages. A couple of experiments that could be done are
to conduct confocal microscopy after transfection of biotinylated LPS and staining
131

of GBP1 or perform an LPS pull-down assay and determine whether these LPS
variants are binding to GBP1, which may be transferring the LPS directly to these
inflammatory caspases. Thus, GBP1 may be acting as an LPS binding protein,
similar to the TLR4 pathway.
This study provides a better understanding of the roles of caspase-4 and
caspase-5 to LPS variants and how IFN-inducible GBPs contribute to these
inflammasome responses. Our findings provide insight into potential therapeutic
targets for gram-negative sepsis.
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3.7. Materials and Methods
3.7.1. Primary Human Samples
All studies on primary human monocyte-derived macrophages (hMDMs)
were performed in compliance with the requirements of the US Department of
Health and Human Services and the principles expressed in the Declaration of
Helsinki. Samples obtained from the University of Pennsylvania Human
Immunology Core are considered to be a secondary use of deidentified human
specimens and are exempt via Title 55 Part 46, Subpart A of 46.101 (b) of the
Code of Federal Regulations.

3.7.2. Cell Culture
Primary human monocytes from deidentified healthy human donors were
obtained from the University of Pennsylvania Human Immunology Core.
Monocytes were cultured in RPMI supplemented with 10% (vol/vol) heatinactivated FBS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin,
and 50 ng/mL recombinant human M-CSF (Gemini Bio Products). Cells were
cultured for 4 days in 10 mL of media in 10 cm-dishes at 4-5 × 105 cells/mL,
followed by addition of 10 mL of fresh growth media for an additional 2 days for
complete differentiation into macrophages. The day before macrophage
stimulation, cells were rinsed with cold PBS, gently detached with trypsin-EDTA
(0.05%) and replated in media without antibiotics and with 25 ng/mL M-CSF in a
48-well plate at a concentration of 1 × 105 cells per well.
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THP-1 cells (TIB-202; American Type Culture Collection) were maintained
in RPMI supplemented with 10% (vol/vol) heat-inactivated FBS, 0.05 nM bmercaptoethanol, 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37°C in a
humidified incubator. One or two days before stimulation with IFN-g or Pam3CSK4,
respectively, cells were replated in media without antibiotics in a 48-well plate at a
concentration of 2 × 105 cells per well and incubated with phorbol 12-myristate 13acetate (PMA) for 24 hours to allow differentiation into macrophages. Media was
replaced with RPMI without serum for L. pneumophila infections or replaced with
Opti-MEM I Reduced Serum Media for LPS transfection experiments.

3.7.3. Macrophage Stimulation
For the experiment using primary human macrophages, cells were primed
with Pam3CSK4 (1 µg/mL) for four hours before LPS transfection.
For the LPS transfection experiment using only PMA-differentiated WT
THP-1 or the LPS transfection experiment using PMA-differentiation WT THP-1
cells, CASP4-/- THP-1 clones, and CASP5-/- THP-1 clones, cells were either left
unprimed or were primed overnight with recombinant human IFN-g (R&D Systems)
at a concentration of 100 U/mL, followed by priming with Pam3CSK4 (1 µg/mL) for
four hours before LPS transfection.
For the L. pneumophila infection and LPS transfection experiment using
PMA-differentiated WT THP-1 cells, or GBP1-/- THP-1 clones, and GBP2-/- THP-1
clones, cells were primed overnight with recombinant human IFN-g at a
concentration of 100 U/mL before infection or transfection.
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For experiments involving harvesting lysates for RNA and protein analyses
from PMA-differentiated WT THP-1, CASP4-/- and CASP5-/- THP-1 clones, and
GBP1-/- and GBP2-/- THP-1 clones, cells were either left unprimed or primed with
recombinant human IFN-g at a concentration of 100 U/mL for 16 or 18 hours.

3.7.4. Bacterial Strain and Macrophage Infection
The Legionella pneumophila infection experiment comparing WT THP-1
cells to GBP1-/- and GBP2-/- THP-1 clones used the strain derived from the
serogroup 1 clinical isolate Philadelphia-1. The strain utilized was a flagellin
mutant, DflaA, derived from the Lp02 strain (rpsL, hsdR, thyA), which is a thymidine
auxotroph (Ren et al., 2006). L. pneumophila DflaA was grown as a stationary
patch for 48 hours on charcoal yeast extract agar plates at 37°C (J. C. Feeley et
al., 1979). Bacteria were resuspended in PBS and added to the cells at a
multiplicity of infection (MOI) of 10 in a 48-well plate. Infected cells were then
centrifuged at 290 × g for 10 min and incubated at 37°C for 1, 2, or 4 hours. Mockinfected cells were treated with PBS.

3.7.5. Lipopolysaccharide (LPS) or Lipooligosaccharide (LOS) Variants and
Macrophage Transfection
All LPS and LOS used in this study were isolated from whole bacteria in the
laboratory of Robert Ernst. L. pneumophila LPS was isolated from L. pneumophila
LP02 DflaA strain. E. coli LPS was isolated from E. coli K-12 W3110 strain. Y.
pestis LOS was isolated from Y. pestis grown at 26°C, including the WT strain as
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well as the mutants generated through the addition of specific enzymes to the WT
strain. After stimulation of primary human macrophages or THP-1-derived
macrophages with IFN-g and/or Pam3CSK4 as described above, the media was
replaced with 300 µL of Opti-MEM I Reduced Serum Media per well. Cells were
either mock-transfected with FuGENE HD (Promega) alone or transfected with a
mixture of 0.75 µL FuGENE HD [0.25%(vol/vol)] plus LPS or LOS (2 µg/mL of Y.
pestis LOS or E. coli LPS and 10 µg/mL L. pneumophila LPS). Plates were then
centrifuged at 805 × g for 5 min and incubated at 37°C for 4 or 20 hours.

3.7.6. LDH Cytotoxicity Assay
Macrophages were infected or transfected in a 48-well plate as described
above and harvested supernatants were assayed for cell death by measuring loss
of cellular membrane integrity through lactate dehydrogenase (LDH) release from
cells. LDH release was quantified using an LDH Cytotoxicity Detection Kit
(Clontech) according to the manufacturer’s instructions and normalized to mockinfected cells.

3.7.7. ELISA
Macrophages were infected or transfected in a 48-well plate as described
above and harvested supernatants were assayed for cytokine levels using ELISA
kits for human IL-1b (BD Biosciences).

3.7.8. Quantitative RT-PCR Analysis
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RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) following the
manufacturer’s protocol. Cells were lysed in 350 µL RLT buffer with bmercaptoethanol and centrifuged through a QIAshredder spin column (Qiagen).
cDNA was synthesized from isolated RNA using SuperScript II Reverse
Transcriptase (Invitrogen) following the manufacturer’s protocol. Quantitative PCR
was conducted with the CFX96 real-time system from Bio-Rad using the SsoFast
EvaGreen Supermix with Low ROX (Bio-Rad). Transcript levels for each gene
were normalized to the housekeeping gene HPRT for each sample, and samples
were normalized to unprimed sample or to control siRNA-treated sample using the
2-DDCt (cycle threshold) method to calculate fold change. Relative expression was
calculated by normalizing gene-specific transcript levels to HPRT transcript levels
for each sample using the 2-DCt method. Primer sequences from primer bank used
for HPRT1, CASP4, CASP5, GBP1, and GBP2 are the following (all 5’ à 3’):
HPRT1 forward: CCTGGCGTCGTGATTAGTGAT
HPRT1 reverse: AGACGTTCAGTCCTGTCCATAA
CASP4 forward: TCTGCGGAACTGTGCATGATG
CASP4 reverse: TGTGTGATGAAGATAGAGCCCAT
CASP5 forward: TCACCTGCCTGCAAGGAATG
CASP5 reverse: TCTTTTCGTCAACCACAGTGTAG
GBP1 forward: AGGAGTTCCTTCAAAGATGTGGA
GBP1 reverse: GCAACTGGACCCTGTCGTT
GBP2 forward: CTATCTGCAATTACGCAGCCT
GBP2 reverse: TGTTCTGGCTTCTTGGGATGA
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3.7.9. Immunoblot Analysis
In experiments where THP-1-derived macrophages were used, cells were
lysed in 1X SDS/PAGE sample buffer. Protein samples were boiled for 5 min,
separated by SDS/PAGE on a 12% (vol/vol) acrylamide gel, and transferred to
PVDF Immobilon-P membranes (Millipore). Primary antibodies specific for
caspase-4 (4450S; Cell Signaling), caspase-5 (D3G4W; 46680S; Cell Signaling),
GBP1 (ab131255, Abcam), GBP2 (sc-271568, Santa Cruz), and b-actin (4967L;
Cell Signaling) were used. HRP-conjugated secondary antibodies anti-rabbit IgG
(7074S; Cell Signaling) and anti-mouse IgG (7076S; Cell Signaling) were used.
For detection, ECL Western Blotting Substrate or SuperSignal West Femto (both
from Pierce Thermo Scientific) were used as the HRP substrate.

3.7.10. Development of CRISPR/Cas9 Knockout THP-1 cells
To generate CASP4, CASP5, GBP1, or GBP2 knockout in THP-1 cells,
pLentiCRISPR v2 plasmids encoding the specific gRNA and Cas9 were purchased
from GenScript. The following target sequences were used:
CASP4 gRNA 1: TCCTGCAGCTCATCCGAATA
CASP5 gRNA 2: CGTCAACCACAGTGTAGCCC
GBP1 gRNA 3: ACAAAGAGACGATAGCCCCC
GBP2 gRNA 2: AACTTTCGGATGCACAACCG
Initial production of lentiviral particles were made using the pCMV-VSV-G
and psPAX2 plasmids that were generously provided by Paul Bates at the
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University of Pennsylvania. HEK293T cells were plated at 2.0 × 106 cells in a 10
cm-dish in 10 mL of DMEM supplemented with 10% (vol/vol) heat-inactivated FBS,
2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin. 24 hours after
plating HEK293T cells, the plasmids were transfected using the Lipofectamine
2000 protocol. A DNA master mix of the plasmids contained 1 µg of pCMV-VSVG, 2.5 µg of psPAX2, and 5 µg of pLentiCRISPR v2 with the specific gRNA. 50 µL
of Lipofectamine 2000 transfection reagent was used per 10 cm-dish. Transfected
HEK293T cells were incubated at 37°C for 18 hours, followed by careful removal
of the media and replacement with 6 mL of fresh HEK293T cell growth media per
dish. 24 hours later, the supernatant containing the lentiviral particles was
harvested and filtered using a 0.22 µM filter. 5 × 105 THP-1 cells were infected with
1 mL of lentiviral particles treated with 8 µg/mL of polybrene and plated in a TCtreated 12-well plate. Infected THP-1 cells were then centrifuged at 1250 × g for
90 min at 25°C. Cells were then carefully pipetted out of the wells and added to a
conical tube respective for each gRNA condition. Cells were centrifuged at 805 ×
g for 3 min at 25°C. Media was aspirated and cells were resuspended in fresh
THP-1 growth media and 2 mL of resuspended cells were added per well of a 12well plate. Cells were incubated at 37°C for 48 hours. After 48 hours, puromycin
was added at a final concentration of 1 µg/mL. Cells were maintained in puromycin
for 2-3 weeks and then harvested for western blot analysis and clonal selection.
For clonal selection, cells were plated at a concentration of 0.5 cell per 200 µL of
THP-1 growth media in flat-bottom 96-well plates and incubated at 37°C for 4-6
weeks until single clones were noticeable at the bottom of the well. 12 single cell
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clones for each gene were expanded from the 96-well plate to a 48-well plate, 24well plate, 12-well plate, 6-well plate, and finally 10 cm-dish. The cells from each
single cell clone were plated in a 48-well plate at a concentration of 2 × 105 cells
per well in 500 µL of media treated with PMA for differentiation into macrophages,
the next day either stimulated with IFN-g overnight or left unstimulated, and
harvested for DNA, RNA, and western blot analyses.

3.7.11. Validation of CRISPR/Cas9 Knockout THP-1 Single Cell Clones for
CASP5 and GBP1
After choosing three single cell clones for CASP5 or GBP1 based on RNA
knocked down and protein knocked out, DNA from the selected single cell clones
was purified using the DNeasy Blood and Tissue Kit (Qiagen). The genomic region
comprising the gRNA target sequence for each gene was amplified by PCR using
the following primers (all 5’ à 3’):
CASP5 forward: GGTTAGGGAAGGTGGCAGC
CASP5 reverse: GGGGCTACATCCCAATCACC
GBP1 forward: GGTGAGGAGGCTGTCAGTTTC
GBP1 reverse: ACTCTCTTTGATGAGCACCTAGGAC
The PCR product was purified using the QIAquick PCR purification Kit
(Qiagen). The purified PCR product was then ligated into the pGEM-T vector
(Promega) and transformed into DH5a high efficiency competent cells using the
protocol from the pGEM-T Vector Systems Protocol. Following blue-white
screening, colony PCR was conducted on 10-15 white colonies using the primer
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sequences shown above and PCR product was run on an agarose gel. Positive
colonies showing the correct bp amount were sequenced using the M13/pUC
primer: 5’ CCCAGTCACGACGTTGTAAAACG 3’.

3.7.12. Statistical Analysis
GraphPad Prism software was used for graphing of data and all statistical
analyses. Statistical significance for experiments with THP-1 cells was determined
using the unpaired two-way Student’s t test. Statistical significance for hMDMs was
determined using the paired two-way t test in experiments comparing multiple
donors. In hMDM experiments that compare cells from multiple donors, data are
graphed so that each data point represents the mean of duplicate wells for each
donor, and all statistical analysis was conducted comparing the means of each
experiment. Differences were considered statistically significant if the P value was
<0.05.
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CHAPTER 4
A. Data Summary
The innate immune response to bacterial pathogens is crucial for pathogen
clearance and host survival. Specifically, the inflammasome, which is a cytosolic
multimeric protein complex activated in response to bacterial components or
danger signals, is important for initiating an inflammatory form of cell death known
as pyroptosis and IL-1 family cytokine release to signal to additional immune cells
for their recruitment and/or activation. IL-1 family cytokines can act in an autocrine
or paracrine manner to upregulate a family of cytokines termed interferons (IFNs).
For instance, IL-18 is a cytokine produced and released by infected cells that can
then stimulate other immune cells, such as NK or T cells, to produce the cytokine
IFN-g. IFN-g has been shown to promote inflammasome responses to a variety of
gram-negative bacterial pathogens as well as to bacterial components.
Specifically, a family of IFN-induced GTPases known as guanylate binding
proteins (GBPs) are the key factors responsible for promoting inflammasome
responses through a number of functions, including the rupture of pathogencontaining vacuoles or bacteriolysis of bacterial outer membranes. Although most
studies focused on the role of GBPs during inflammasome activation have been
conducted using murine models, recent findings using human cells have identified
key human GBPs for promoting inflammasome responses to certain bacteria.
However, the role of human GBPs in inflammasome responses during infection
with the vacuolar bacterium Legionella pneumophila has not been investigated.
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Additionally, the noncanonical inflammasome, which is activated by
intracellular LPS from gram-negative bacteria, is comprised of caspase-11 in mice
and the two orthologs, caspase-4 and caspase-5, in humans. LPS can vary in its
acylation and phosphorylation state depending on the bacterial species and
environmental conditions. Recent findings revealed key differences between
murine caspase-11 and human caspase-4 activation. Specifically, tetra-acylated
LPS was found to evade caspase-11 detection, while it activates caspase-4 in
human macrophages. Moreover, the role of caspase-5 in response to intracellular
LPS is unclear and whether IFN or human GBPs promote inflammasome
responses to LPS from L. pneumophila has not been studied.
Mice and humans possess differences in their innate immune genes and
these differences may play a role in how they respond to invading pathogens.
Therefore, it is essential to gain a better understanding of human inflammasome
responses to the vacuolar intracellular bacterial pathogen, L. pneumophila, and its
corresponding LPS and whether IFN or human GBPs play a role in these
responses.
In Chapter 2, we determined that IFN-g promotes caspase-1, caspase-4,
and caspase-5 inflammasome responses to L. pneumophila in human
macrophages. By utilizing siRNA-mediated knockdown of the individual human
GBPs, we found that human GBP1 is essential for this maximal inflammasome
response. Furthermore, we revealed that IFN-g treatment leads to the rupture of L.
pneumophila-containing vacuoles (LCVs) and that GBP1 contributes to this
rupture. In contrast to the murine model which shows that GBPs do not rupture the
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LCV but instead rupture the outer membrane of L. pneumophila, our findings
indicate that human GBP1 does rupture the LCV. It remains to be determined
whether additional human GBPs, along with human GBP1, help promote the
rupture of the LCV or whether human GBPs also induce bacteriolysis of the outer
membrane of L. pneumophila.
In Chapter 3, we found that the human noncanonical inflammasome is
activated by a variety of differential acylated and phosphorylated LPS variants
isolated from Y. pestis in primary human macrophages, and that IFN-g promotes
this response to both tetra-acylated and hexa-acylated Y. pestis LPS. We also
utilized CRISPR/Cas9 gene editing technology to knockout caspase-4, caspase5, GBP1, and GBP2 in the THP-1 monocytic cell line. We used these generated
knockout cell lines to elucidate the role of these genes in response to LPS derived
from L. pneumophila and E. coli. We found that caspase-4 is essential for
promoting noncanonical inflammasome responses to E. coli LPS, while caspase5 may not play a role in detecting intracellular E. coli or L. pneumophila LPS.
Furthermore, we found that human GBP1 may play a role in promoting cell death
to L. pneumophila LPS and E. coli LPS, while human GBP2 may not. While these
experiments need to be repeated to confirm these findings, they suggest that
caspase-4 and caspase-5 have distinct roles in response to different LPS variants,
and that human GBP2 does not promote inflammasome responses to L.
pneumophila LPS but may promote cell death during L. pneumophila infection.
Overall, our studies bring insight into human inflammasome responses to
the vacuolar pathogen, L. pneumophila, as well as to LPS variants from different
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bacteria. Moreover, our studies reveal key findings on how IFN-g and, more
specifically, IFN-inducible GBPs contribute to the activation of the human
inflammasome. However, there are additional questions pertaining human GBPs
and the human noncanonical inflammasome that are still left unanswered. In this
chapter, I will discuss these questions and propose future experiments in order to
gain a better understanding of human inflammasome responses to gram-negative
bacterial pathogens (Fig. 4.1 and 4.2).

B. Future Directions

Figure 4.1. Model and future directions for human inflammasome responses
to L. pneumophila. Our data reveal that human GBP1 is important for maximal
inflammasome responses during L. pneumophila infection and indicate that human
GBP1 mediates the rupture of the LCV. Whether and how additional human GBPs
or host factors are involved in inflammasome responses to L. pneumophila are
unknown. Future directions for these studies are discussed in this chapter.
Does human GBP1 have a synergistic role with additional human GBPs to
promote inflammasome responses to L. pneumophila?
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We find that upon individual knockdown of human GBP1-5 using siRNA,
only knockdown of GBP1 resulted in significantly decreased cell death and IL-1
family cytokine release, indicating that human GBP1 is important for maximal
inflammasome response to L. pneumophila. One possible reason as to why only
GBP1 was shown to be essential for inflammasome response compared to the
remaining GBPs tested is that human GBP1 may be the initiator GBP that
responds during L. pneumophila infection and additional GBPs follow suit. This
assumption is based on human GBP findings during Shigella flexneri infection.
Specifically, it was revealed that human GBP1 is recruited to the outer membrane
of S. flexneri, followed by human GBP2, 3, 4, and 6 to inhibit the actin motility of
S. flexneri (Piro et al., 2017; Wandel et al., 2017). In addition to S. flexneri, human
GBP1 initiates the assembly of a GBP complex, including GBP1-4, on the surface
of S. Typhimurium outer membrane in order to recruit caspase-4 for inflammasome
activation (Santos et al., 2020; Wandel et al., 2020). Therefore, human GBP1 may
also initiate binding to the LCV as well as the outer membrane of L. pneumophila
in order to recruit additional GBPs for their disruption of the LCV and outer
membrane to release L. pneumophila components into the cytosol for downstream
inflammasome sensing. In fact, we found that GBP2, in addition to GBP1, is also
recruited to L. pneumophila. However, we did not test whether GBP1 knockdown
resulted in decreased GBP2 binding.
Since GBPs can homo- or hetero-dimerize (Britzen-Laurent et al., 2010),
we want to investigate whether knockdown of other human GBPs, in addition to
human GBP1, leads to a further decrease in inflammasome response during L.
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pneumophila infection compared to knockdown of human GBP1 alone. This
experiment can be accomplished by conducting double knockdowns of human
GBP1 with either human GBP2, 3, 4, or 5, followed by IFN-g priming and L.
pneumophila infection. In addition, we can conduct siRNA-mediated knockdown of
human GBP2, 3, 4, or 5 in the GBP1-/- THP-1 clones. These experiments will
determine whether human GBPs play a synergistic role with human GBP1 to
stimulate inflammasome responses during L. pneumophila infection.

Does human GBP1 directly interact with and rupture the LCV?
Our study in Chapter 2 indicates that human GBP1 ruptures the LCV of L.
pneumophila, however the precise mechanism of vacuolar rupture as well as the
vacuolar components that GBP1 may be binding to are unknown. Experiments to
address these questions are technically challenging because L. pneumophila
derives its vacuole from the ER and, thus, isolation of the LCV following infection
with L. pneumophila in human macrophages may include ER components as well
as the LCV. However, purification of LCVs from amoebae and phagocytes has
been conducted (Hoffmann, Finsel, & Hilbi, 2012). Therefore, we can purify the
LCV from L. pneumophila infected human macrophages using this specific
optimized protocol followed by proteomic approaches to identify any interacting
proteins. An additional step that would be needed to specifically determine what
vacuolar components are interacting with human GBP1, would be to conduct a
pull-down of GBP1 following the LCV purification and then use mass spectrometry
to identify the interacting protein partners of GBP1. Furthermore, super-resolution
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microscopy may also be used to stain for any identified interacting LCV proteins
with GBP1 to visualize these interactions. Although technically challenging, if these
proposed methods are successful, then this study would reveal novel human
GBP1 interactions with bacterial vacuolar components.
In Chapter 2, the phagosome integrity assay we conducted in control
siRNA-treated and GBP1 siRNA-treated primary human macrophages suggests
that GBP1 is essential for LCV rupture, since we saw decreased anti-L.
pneumophila antibody staining in macrophages with GBP1 knocked down.
However, these results may also indicate that GBP1 simply promotes anti-L.
pneumophila antibody binding to the bacterial surface. Thus, additional
experiments are needed to address whether GBP1 actually promotes rupture of
the LCV. An alternative experiment to assess the vacuolar integrity of the LCV
would be to stain for galectin proteins. Galectins are a family of b-galactosidebinding proteins that target the inner leaflet of ruptured vacuoles and are therefore
characterized as being markers for vacuolar rupture (E. M. Feeley et al., 2017). To
determine if human GBP1 induces rupture of the LCV, we can stain for galectin-3
or galectin-8 in IFN-g-primed primary human macrophages that are treated with
control siRNA or GBP1 siRNA and infected with dsRED-expressing L.
pneumophila. If we observe a decreased presence of galectin staining with L.
pneumophila upon GBP1 knockdown, then these results indicate that there are
fewer disrupted vacuoles in the absence of GBP1 and would reveal that human
GBP1 contributes to the rupture of the LCV. Additionally, another approach of
quantifying the amount of cytosolic L. pneumophila or L. pneumophila with
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ruptured vacuoles would be to conduct a flow cytometry-based assay in digitonin
and saponin permeabilized primary human macrophages in the presence and
absence of GBP1. These results would reveal whether or not human GBP1
contributes to the presence of cytosolic L. pneumophila, as we see using
microscopy. Flow-cytometry can also be used to stain galectin as previously
mentioned and can therefore serve as a confirmatory assay for our microscopybased experiments. These proposed experiments may provide insight on whether
human GBP1 contributes to the vacuolar rupture of L. pneumophila or just allows
the anti-L. pneumophila antibody to target the bacteria more efficiently.

Does human GBP1, as well as other human GBPs, disrupt the outer
membrane of L. pneumophila?
Mouse GBPs on chromosome 3 do not rupture the LCV, but they induce
bacteriolysis on the outer membrane of L. pneumophila (B. C. Liu et al., 2018). In
contrast, our study in Chapter 2 indicates that human GBP1 ruptures the LCV,
although it is possible that GBP1 can disrupt the outer membrane as well. Recent
studies focused on human GBPs revealed that human GBP1-4 bind to the outer
membrane of cytosol exposed S. Typhimurium and potentially result in the loss of
membrane integrity, thus making LPS more accessible for caspase-4 detection
(Santos et al., 2020; Wandel et al., 2020). Therefore, in order to determine whether
human GBP1 facilitates the disruption of the L. pneumophila outer membrane, we
need to utilize the cytosol-exposed L. pneumophila DsdhA mutant, which is not
able to maintain the vacuole integrity of the LCV. We can conduct a bacterial
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morphology assay coupled with super-resolution microscopy as a way to
qualitatively determine whether the L. pneumophila DsdhA mutant either sustains
its rod-shape, indicating that its outer membrane is intact, or assumes a swollen
and truncated morphology, signifying that its outer membrane was disrupted. This
assay would be conducted in IFN-g-primed WT and GBP1-/- THP-1-derived
macrophages infected with a dsRED-expressing L. pneumophila DsdhA mutant.
Thus, if human GBP1 facilitates the disruption of the L. pneumophila outer
membrane, WT macrophages would show a perturbed L. pneumophila shape,
while GBP1-/- THP-1-derived macrophages would reveal an undamaged L.
pneumophila. Furthermore, we can also test whether additional human GBPs
disrupt the L. pneumophila outer membrane by applying RNAi-mediated
knockdown of an individual GBP compared to control-knockdown in either primary
human macrophages or in THP-1-derived macrophages, followed by IFN-g
treatment and infection with the dsRED-expressing L. pneumophila DsdhA mutant.
Another method to determine whether the L. pneumophila outer membrane
is disrupted is by measuring the amount of L. pneumophila DNA released into the
cytosol comparing WT macrophages or macrophages with individual human GBPs
knocked down. This experiment requires a L. pneumophila DsdhA mutant that
harbors a non-transferable pJB908 plasmid that is only released into the cytosol if
the outer membrane is disturbed (B. C. Liu et al., 2018). Altogether, this proposed
experiment along with the bacterial morphology assay will reveal whether human
GBPs promote bacteriolysis of L. pneumophila, ultimately leading to its increased
access in the host cytosol for inflammasome sensing.
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Are additional host factors involved in promoting inflammasome responses
during L. pneumophila infection?
In addition to GBPs, another IFN-inducible family of GTPases was
discovered to promote inflammasome responses to bacterial pathogens in mice—
the immunity related GTPases (IRGs). Specifically, IRGB10 is recruited to F.
novicida in a GBP-dependent manner and is essential for mediating bacterial killing
for downstream AIM2 inflammasome activation in mice (Man et al., 2016). In
contrast to mice, which have 23 IRG proteins, humans only possess two IRG
proteins, IRGM and IRGC, both of which are not interferon inducible due to the
loss of the interferon response element ahead of their transcription start site
(Bekpen et al., 2005). Additionally, there is no human ortholog of mouse IRGB10
and the only function that human IRGM has been shown to have during bacterial
infections is to limit M. tuberculosis infection through an autophagy-mediated
pathway (Singh et al., 2006). It is unknown whether human IRG proteins are
involved in inflammasome responses during bacterial infections. We have
previously conducted knockdown experiments of IRGM and IRGC in primary
human macrophages, followed by infection with L. pneumophila, and found that
the relative expression levels of these genes are very low and their knockdown
does not lead to decreased inflammasome response. Therefore, IRGM and IRGC
may not play a role in inflammasome responses during L. pneumophila infection
in human macrophages.
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There are most likely additional undiscovered host factors that are important
in promoting inflammasome responses to L. pneumophila in human macrophages.
A genome-wide RNAi screen followed by L. pneumophila infection and analysis of
cell death and IL-18 or IL-1b release is one way to discover novel host genes that
are important for contributing to the inflammasome response. An alternative
method would be to conduct a pull-down followed by mass spectrometry. In
Chapter 2, we show that L. pneumophila activates both canonical and
noncanonical inflammasomes and that human GBP1 plays a large role in these
inflammasome responses. To identify additional host factors that may play a role
with human GBP1, we can conduct a pull-down assay of GST-tagged GBP1 using
glutathione agarose beads. This experiment would involve initial transfection of
GST-tagged recombinant GBP1 into human macrophages, then infection with L.
pneumophila. The cell lysate from these infected macrophages would be incubated
with glutathione agarose beads and, after washing steps, would elute the GSTtagged GBP1. Any bound proteins to human GBP1 can be analyzed by mass
spectrometry to identify these unknown interactors. Therefore, this experiment
may bring insight into host proteins that interact with human GBP1 to help facilitate
the rupture of the LCV and/or promote inflammasome responses to L.
pneumophila.
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Figure 4.2. Future directions for human inflammasome responses to LPS
variants. Our data suggest that the human noncanonical inflammasome is
activated by different LPS variants and that IFN-g-promotes these responses.
However, the specific roles that caspase-4 and caspase-5 have in response to
different LPS variants are unclear and whether human GBP1 is directly involved in
recognizing L. pneumophila LPS is unknown. Future directions for these studies
are discussed in this chapter.
Do caspase-4 and caspase-5 have a synergistic function or play distinct
roles in response to intracellular LPS from different gram-negative bacteria?
It is intriguing that humans possess two inflammatory intracellular caspases
that bind to LPS, whereas mice only have one caspase that recognizes LPS.
Human caspase-4 and caspase-5 are thought to have resulted from a gene
duplication event from the ancestral gene, caspase-11. It is also known that
humans are more sensitive to LPS compared to mice. Since human caspase-4
was found be activated in response to tetra-acylated LPS, which is known to evade
murine caspase-11 detection in addition to other under-acylated LPS, it is possible
that humans need two LPS-sensing caspases in order to identify diverse LPS from
different gram-negative bacteria to initiate inflammatory responses to eliminate the
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these invading pathogens. Thus, it would be of interest to determine whether
caspase-4 and caspase-5 work together to respond to different gram-negative
bacterial infections, either through synergistic functions or distinct roles. Using
CASP4-/- and CASP5-/- THP-1 cells, we observed in Chapter 3 that caspase-4 is
important for mounting an inflammasome response to E. coli LPS as well as
possibly to L. pneumophila LPS, while caspase-5 did not seem to play a strong
role in response to either LPS. This indicates that caspase-4 and caspase-5 may
respond to LPS variants from different bacteria. Moreover, we can use these
CASP4-/- and CASP5-/- THP-1 cells to test the roles of caspase-4 and caspase-5
to other LPS variants, including the seven differential acylated and phosphorylated
LOS variants derived from Y. pestis that we determined all activate the human
noncanonical inflammasome. This investigation will be a starting point to determine
whether caspase-4 and caspase-5 identify and respond to distinct LPS variants.
However, it may be also possible that caspase-4 and caspase-5 are
activated by the same LPS variants from specific gram-negative bacteria.
Therefore, comparing the single knockout clones of CASP4-/- and CASP5-/- THP-1
cells to double CASP4/5-/- THP-1 cells will be necessary to determine whether
caspase-4 and caspase-5 stimulate a synergistic response to LPS. If the CASP4/5/-

THP-1 cells show a decreased inflammasome response compared to the CASP4-

/-

and CASP5-/- THP-1 cells, then capase-4 and caspase-5 carry out a synergistic

role. Following LPS binding on the CARD domains of caspase-4 and caspase-5,
these caspases oligomerize before activation (Shi et al., 2014). In addition, the
caspase-4 and caspase-5 CARD domains share 56% protein identity, suggesting
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that they are capable of interacting with each other through their CARD domains.
Therefore, it may be possible that caspase-4 and caspase-5 hetero-oligomerize to
generate a stronger inflammasome response. To test whether caspase-4 and
caspase-5 form a hetero-dimer, we can conduct a bimolecular fluorescence
complementation (BiFC) assay to visualize the interactions of caspase-4 and
caspase-5. First, we will fuse the N- and C-terminal non-fluorescent fragments of
Venus fluorescent protein, a variant of yellow fluorescent protein (YFP), to the
amino-terminus of caspase-4 and caspase-5, respectively. Then, we will clone
these fused proteins into a mammalian expression vector, followed by transfection
of these caspase-4 and caspase-5 vectors into HEK293T cells, which do not
possess inflammasome components, and subsequent transfection of LPS. If
caspase-4 and caspase-5 hetero-dimerize, then the N- and C-terminal nonfluorescent fragments would come together to produce a fluorescent signal, which
we would visualize by microscopy. This study would provide molecular insight into
caspase-4 and caspase-5 interactions that may contribute to noncanonical
inflammasome activation.

Do caspase-4 and caspase-5 engage in different pathways of activation
depending on the mode of entry of LPS?
Caspase-4 and caspase-5 were previously shown to have different
mechanisms of activation in response to E. coli LPS. Specifically, caspase-4 was
found to be cleaved and activated in response to transfected LPS, whereas
caspase-5 is cleaved in response to extracellular LPS treatment in primary human
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macrophages (Casson et al., 2015). These results suggest that caspase-4 and
caspase-5 may engage in distinct pathways of activation based on the mode of
entry of LPS. Additional experiments in monocytes revealed that caspase-5 is
activated upon extracellular treatment with E. coli LPS or P. aeruginosa OMVs,
both of which enter the monocytes via endocytosis (Bitto et al., 2018; Vigano et
al., 2015). These combined findings indicate that caspase-5 activation may involve
an alternative extracellular pathway through endocytosis. TLR4 is present on the
plasma membrane and is known as the extracellular LPS sensor that is
endocytosed upon LPS detection. Whether TLR4 and its cofactors are involved in
caspase-5 activation through this extracellular LPS sensing mechanism has not
been studied. Since we have only looked at the role of caspase-4 and caspase-5
in THP-1-derived macrophages that are transfected with LPS derived from L.
pneumophila or E. coli, we additionally want to investigate the role of caspase-4
and caspase-5 in human macrophages that are extracellularly treated with these
LPS variants. Thus, we would conduct an experiment in which either WT, CASP4/-

, and CASP5-/- THP-1-derived macrophages are either extracellularly treated or

transfected with LPS from L. pneumophila or E. coli in order to distinguish the
conditions in which caspase-4 and caspase-5 are activated. Additionally, to
determine whether TLR4 is involved in the activation of caspase-4 or caspase-5
during treatment or transfection with these LPS variants, we can treat the three
different THP-1 cells with the TLR4 pharmacological inhibitor, TAK-242, before
introduction of LPS. These findings would bring insight into the mechanism of
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human noncanonical inflammasome activation by extracellular LPS or intracellular
LPS and how TLR4 may be involved.

Does human GBP1 directly bind to L. pneumophila LPS?
Human GBPs localize to the outer membrane of different gram-negative
bacteria including S. flexneri, S. Typhimurium, and F. novicida (Kutsch et al., 2020;
Lagrange et al., 2018; Piro et al., 2017; Santos et al., 2020; Wandel et al., 2020;
Wandel et al., 2017). Human GBP1 was found to target the S. flexneri rough
mutant, which lacks the O-antigen on its LPS, less efficiently compared to S.
flexneri that possesses its O-antigen (Piro et al., 2017). More specifically, the Oantigen is important for allowing the transition of surface-docked GBP1 polymers
into GBP1 protein sheets that coat the entire surface of S. flexneri outer membrane
(Kutsch et al., 2020). These results combined with recent findings that human
GBP1 directly binds to LPS from E. coli and S. Typhimurium indicate that human
GBP1 initially binds to LPS on the outer membrane of these bacteria followed by
recruitment of addition GBPs to control host response against these pathogens
(Santos et al., 2020). However, whether human GBP1 or other GBPs can bind to
L. pneumophila LPS has not been investigated. Our results in Chapter 3 showed
that human GBP1 may be promoting cell death in response to L. pneumophila
LPS, therefore, GBP1 may be directly binding to LPS in this setting. A pull-down
assay would be one way to determine whether this human GBP1-L. pneumophila
LPS interaction is occurring. To test this, we would transfect biotinylated L.
pneumophila LPS in human macrophages, followed by a pull-down using
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streptavidin magnetic beads, washes, and immunoblot for human GBP1. These
results may bring a better understanding of human GBP1 interactions and may
reveal that human GBP1 also binds to the outer membrane in addition to the LCV.

Concluding Remarks
Our results bring insight into human inflammasome responses to L.
pneumophila and LPS variants from different bacteria. We found that human GBP1
is important for promoting inflammasome responses and vacuolar disruption
during L. pneumophila infection, which is in contrast to mouse GBPs that rupture
the outer membrane of L. pneumophila. Additional experiments must be conducted
to understand the mechanism of GBP1 rupture of the LCV and whether human
GBPs contribute to bacteriolysis as well. We also show that the human
noncanonical inflammasome is activated by LPS variants that differ in their
acylation and phosphorylation state and that caspase-4 plays a significant role in
response transfected LPS. Future studies must be conducted to establish the role
of caspase-5 and human GBPs in response to LPS.
Overall, these studies provide insight into the role that IFN-g plays during
infection with gram-negative bacteria in human macrophages. There are currently
no approved treatments for sepsis in humans and studies in mice do not always
correlate to what happens in humans. Therefore, it is important to understand
human innate immune responses involved in combatting bacterial infections,
which, if left unregulated, can ultimately lead to septic shock and death. These
studies investigate host-pathogen interactions in human macrophages, which are
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one of the first responders to invading pathogens, and reveal potential therapeutic
host targets that can be used to treat gram-negative sepsis in humans.
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